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Abstract
Spreading depolarization (SD) is a slowly propagating wave of depolarization of
neurons and glia. Since its original discovery in 1944, SD has been observed in
various experimental settings, both in vitro and in vivo.

SD has recently been

detected in brains of human patients with various injuries, and a contribution of
SD to deleterious consequences of acute brain injury is increasingly accepted.
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The present dissertation work focus mainly on the characterization of SD and
cellular events associated with it.

Main interests of these studies are on

underlying mechanisms that convert non-injurious factors into mediators of acute
neuronal injury.
One of the major findings is an important role of NMDA-type glutamate
receptors (NMDAR) in the injurious consequences of SD. Prior to my work,
contributions of NMDARs to the initiation and propagation of SD were well
acknowledged,

however

there

was

little

evidence

regarding

NMDAR

contributions to injurious consequences of SD. My studies have identified a brief
period of sustained glutamate release and concomitant NMDAR activation
following the onset of SD, and demonstrate a significant contribution of this
excitatory phase to neuronal injury in the setting of metabolic compromise.
Selective block of this later excitatory phase was sufficient to prevent Ca2+
deregulation and membrane damage in metabolically compromised tissue.
These glutamate-dependent injury processes suggest a novel link between SD
and previous studies of acute excitotoxic neuronal injury.
Another important focus of the present dissertation is Zn2+ physiology and
its contribution to SD. In the mammalian brain, Zn 2+ is enriched in synaptic
vesicles of many glutamergic neurons and is released as a neuromodulator.
Importantly Zn2+ is well known as a potent antagonist of NMDARs. Based on the
significant contribution of NMDAR activation to SDs, Zn2+ could potentially play a
protective role in brain injury by reducing the number of SD occurring in the
injured brain. However Zn2+ is also often considered as a neurotoxic factor. In
iv

fact, it is suggested that synaptically released Zn2+ can translocate in
postsynaptic neurons and contribute to neuronal death.

My studies have

evaluated roles of synaptic Zn2+ release in regulation of SD as well as the
contribution to potentially toxic intracellular Zn2+ accumulation as a consequence
of transmembrane Zn2+ flux.
My studies revealed that extracellular actions of Zn2+ indeed inhibit SD
initiation and propagation in healthy tissue. However the inhibitory effects of Zn2+
were highly sensitive to oxygen concentration, such that in severe hypoxia or
anoxic conditions, Zn2+ antagonisms of NMDARs and SD were profoundly
reduced. Studies on potential mechanism revealed that this was partly due to
redox potential shit and resultant modification of the receptors. Interestingly,
such redox modulation mechanism could partly contribute to ineffectiveness of
other NMDAR antagonists.

Thus loss of oxygen supply in metabolic

compromised tissue could be important modulator of the effects of Zn2+ on SD.
Another line of study examined potential use of intracellular dialysis for
detection of Zn2+ influx to postsynaptic neurons.

One of the confounds for

studying intracellular Zn2+ responses was how to distinguish contributions from
transmembrane Zn2+ influx and Zn2+ release from intracellular sites.

A Key

finding of this part of studies is that intracellular dialysis significantly disrupt
intracellular Zn2+ homeostasis mechanisms and enabled to selective detect
transmembrane Zn2+ influx over intracellular Zn2+ release. Development of the
new detection method significantly improved understanding of intracellular Zn 2+
signal sources in SD and related events.
v

In summary, these studies show that the metabolic state of tissue can
significantly influence regulation of NMDAR activation and synaptic Zn 2+ release.
These findings should be of value for developing novel interventions to minimize
the deleterious consequences of SD in acute brain injury.

vi
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1. Introduction

Brain information is carried by depolarization and hyperpolarization of
single neurons and intercellular communication via chemical synapses. These
processes involve tightly regulated ion fluxes across the plasma membrane. The
continuous maintenance of transmembrane ionic gradients throughout the
network of ~100 billion neurons in the brain (Azevedo et al., 2009) demand a
very large amount of energy. The energy demand is particularly pronounced in
the human. It was estimated that adult human brain accounts for ~20-25% of
total resting metabolic rate, significantly higher than other primates (8-10%), and
far higher than in non-primate mammals (3-5%) (Leonard et al., 2007). The high
energy demand makes the brain significantly vulnerability to injury following loss
of cerebral blood flow. In a study published in 1943, occlusion of the cerebral
blood supply in human subjects (using a cervical pressure cuff) resulted in
fixation of eye movement within 5-6 seconds, followed by immediate loss of
consciousness (Rossen et al., 1943). Further prolongation of ischemia is critical
for viability of neurons, and even 4-10 minutes losses of cardiac function has
been reported to cause irrecoverable loss of brain activity (Grenell, 1946; Cole
and Corday, 1956).
The high vulnerability of brain tissue to ischemia results in very short timewindows for reperfusion therapy of ischemic stroke patients. Currently the only
available pharmacological intervention for thrombotic stroke is thrombolysis with
tPA, but the time-window of the treatment is only within 3-4 hours after stroke
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onset (Hacke et al., 2004). In a large scale study, it was shown that only 23.5%
(88/374) patients could arrive at the hospital within 3 hours and only 4.3%
(16/374) of them could receive thrombolytic treatment (CASPR Investigators,
2005). There are some successful clinical studies showing a small extension of
successful

treatment time-windows (up to 4.5 hours) and improve diagnosis

methods (e.g. mobile stroke unit) that could also increase the numbers of
patients receiving tPA therapy (e.g. Stemer and Lyden, 2010; Walter et al.,
2012).

However, the treatment window is still very short and most ongoing

research is focused on the later deleterious events.
Following the initial onset of acute brain injury, a slow progressive
enlargement of infarction or development of neurological deficits often occurs for
days (Dirnagl et al., 1999). Such delayed aggravation of brain injury is often
called “secondary injury”. The incidence of secondary injury is not restricted to
ischemic stroke, but also occurs in other acute brain injuries such as intracranial
hemorrhage and brain trauma (Aronowski and Zhao, 2011; Haddad and Arabi,
2012). Because of difficulties in treatment of initial acute injuries, prevention of
secondary injury has been actively studied, because of the much longer time
window for potential intervention.

While multiple mechanisms underlying the

secondary injury have been proposed (Dirnagl et al., 1999), currently no effective
pharmacological intervention is available. Development of effective therapeutics
would undoubtedly be of benefit to a large number of patients. The present
dissertation work has studied exclusively the mechanisms underlying the delayed

2

injury process, with a main focus on the events termed “spreading depolarization”
(SD).

1.1 Spreading depolarization

1.1.1 SD initiation and propagation
SD is a propagating wave of near complete depolarization of a volume of
tissue, including both neurons and glia. SD is generally initiated by a harsh
stimulation (e.g. potassium, ischemia) that severely depolarizes local brain tissue
and rapidly depletes intracellular ATP. This initiating depolarization results in
loss of transmembrane ionic gradients, significant cellular swelling, continuous
potassium efflux and release of neurotransmitters including glutamate (Somjen,
2001). Together with release of these mediators, concomitant shrinkage of the
extracellular

space

concentrations.

steeply

elevates

local

glutamate

and

potassium

Extracellular accumulation and diffusion of these excitatory

solutes trigger severe depolarization of neurons and glia in the surrounding
tissue, resulting in a feed-forward depolarization that slowly spreads across brain
tissue at a rate of 2-5 mm/min (Somjen, 2001).
Both

potassium

and

glutamate

can

contribute

to

feed-forward

depolarization, however their relative contributions vary significantly depending
on the specific SD model tested. Thus when SD is generated by severe hypoxia
or oxygen glucose deprivation, potassium appears to play a predominant role in
maintaining propagation throughout tissues. This potassium-dependent model
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was originally proposed by Grafstein (Grafstein, 1956). Based on her model, a
ramp increase of local potassium ion concentration occurs at the wavefront of SD
and is alone sufficient to mediate feed-forward depolarization. Consistent with
this hypothesis, a brief excitatory period has been observed to precede the large
depolarization of SD (termed prodromal excitation, Herreras et al., 1994; Larrosa
et al., 2006). Such prodromal discharge may contribute to the ramp potassium
elevation observed ahead of SD propagation. However, potassium elevations do
not appear to be absolutely required for all forms of SD, as prodromal K +
elevations have not been observed in some forms of SD (such as SD generated
with local KCl injection).
An alternative, glutamate-dependent SD propagation model was proposed
by van Harreveld (Van Harreveld, 1959). In his model, glutamate (or a related
excitatory neurotransmitter) is proposed as the critical component of SD
propagation.

During SD, extracellular glutamate concentration is generally

elevated to ~30-100 µM (Fabricius et al., 1993; Iijima et al., 1998; Rossi et al.,
2007) and most subtypes of ionotropic glutamate receptors are expected to be
activated. Virtually all of the ionotropic glutamate receptors in the brain are nonselective cation channels and receptor activation at the severely depolarized
membrane potential leads to potassium efflux (Yu et al., 1999). Thus glutamate
receptor activation can contribute to elevated local potassium concentrations,
thereby depolarizing non-neuronal cells and priming feed-forward depolarization.
The specific sources of glutamate accumulation can be variable depending on
the model used to generate SD. Thus release from presynaptic terminals may
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contribute to most of SD, while glutamate release from astrocytes via volumesensitive anion channels significantly contributes to glutamate accumulation in
the SD generated by the Na+/K+ ATPase inhibitor ouabain (Basarsky et al.,
1999).

Under conditions of extreme severe metabolic stress, glutamate can

accumulate due to the reverse action of glutamate transporters (Rossi et al.,
2000). The indispensable role of glutamate receptor activation in some form of
SD initiation/propagation has been supported by full block of SD with glutamate
receptor antagonists (discussed below, section 1.3.3).
However, similar to the potassium hypothesis, the glutamate hypothesis is
not always valid, as some forms of SD are insensitive to glutamate receptor
antagonists. Thus currently the most widely-accepted model is a dual hypothesis
which states both glutamate and potassium contribute to SD, but the relative
contribution can vary significantly between forms of SD (Somjen, 2001). While
mechanisms determining the relative contributions of glutamate and potassium
are not clearly established, regulation of extracellular solute concentrations
should be an important determinant. As will be discussed below (section 1.3) ,
SD is a significant contributor to some forms of brain injury, and thus
understanding propagation mechanisms of SD should be important for
development of pharmacological interventions, for a range of conditions.

1.1.2 Terminology of spreading depolarization
A famous consequence of spreading depolarization was originally
described by Leao in 1944 as “spreading depression”, a propagation of
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suppression of local brain activity.

However spreading depression of brain

activity is only one of the important consequences of spreading depolarization.
In fact, spreading depolarization triggers multiple consequences, and multiple
“spreading” events have been described (e.g. spreading ischemia, spreading
hyperemia, spreading convultions)(Dreier, 2011).
underlying

mechanisms,

a

suggestion

was

In order to clarify the

made

to

use

“spreading

depolarization (hereafter SD)” to specifically describe depolarization events
(Dreier, 2011), and the present study follows the suggestion. However the use of
SD is sometimes confusing especially when discussing mechanisms of SD. This
is due to the fact that SD has been studied by multiple groups, generated by
different stimuli in different recording conditions and in different brain tissues. In
order to make this introduction most relevant to my dissertation studies, most of
reference studies cited in this introduction are limited to SD recorded in similar
experimental system and preparations used in the present studies, otherwise
difference will be appropriately explained. Terms such as anoxic depolarization
(AD) and periinfarct depolarization (PID) also describe specific spreading
depolarization events, but will be used to emphasize their contributions to brain
injury.

1.1.3 Ionic deregulation and tissue swelling during SD
The large ion fluxes associated with SD result in modulation of
extracellular ionic concentrations and cause large shifts in extracellular field
potential (Martins-Ferreira et al., 2000). The wavefront of SD is thus electrically
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detected as a steep extracellular DC potential shift. This sharp potential shift
coincides with a steep drop in the extracellular sodium concentration (to ~55 mM)
and increase in extracellular potassium concentration (~30 mM).

Ca 2+

concentration also severely decreased to 10% of basal level. Given that the
extracellular space occupies only ~20% of total brain volume at rest (Sykova and
Nicholson, 2008), local transmembrane ionic gradients are severely destroyed.
During SD generated in brain slice, severe neuronal depolarization continues for
~1 minute. Brain tissue is surprisingly effective at restoring these ionic gradients
and neurons promptly repolarize in the presence of sufficient energy supplies.
Restoration of ionic deregulation is mediated mainly by activities of ATP
dependent

pumps

(e.g.

Na+/K+

ATPase,

Ca2+-ATPase)(Somjen,

2001).

Intracellular Na+ and Ca2+ loads serve as a trigger for mitochondrial biogenesis
and the tissue oxygen consumption rate increases (Galeffi et al., 2011). In fact,
tissue oxygen concentration declines steeply for ~10 minutes after SD in brain
slice (Galeffi et al., 2011) and in vivo (Takano et al., 2007).
The massive fluxes and tissue swelling make SD easily detectable.
However these same features also provide technical challenges for mechanistic
studies. For example, tissue swelling is a significant problem for imaging study
because the volume changes associated with SD significantly modulate the
transparency and reflectance of brain tissue, and influence interpretation of
fluorescence responses. The tissue volume changes also make it challenging to
obtain stable single-cell electrophysiological recordings during SD. Finally, large
changes in extracellular potential require correction of membrane potential during
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SD, and make it difficult to accurately measure absolute potential changes
associated with SD. In fact many recent SD studies use extracellular recording
or computer modeling, rather than single cell recordings, for SD characterization.
However most of cation fluxes can be masked in extracellular recordings during
SD because of the near complete depolarization during SD.

In order to

characterize conductance changes associated with SD, voltage clamp recording
is required. There have been very few voltage-clamp recordings of SD (Czeh et
al., 1993; Zhou et al., 2010a), and these studies have only characterized the
large current during SD and have not characterized synaptic activity change
associated with these events. Fine electrophysiological recordings of SD may
enable detailed characterization of events ongoing during SD, and provide new
insights into mechanisms involved in injury following SD in metabolically
compromised tissues.

1.2 SD and brain injury

1.2.1 Hypothetical mechanism for SD induced injury
As described above, the large ionic deregulation during SD impose a
significant metabolic burden to the neurons. However SD generated in healthy
tissue is normally a non-injurious event.

In brain slice studies, this can be

attributed to the presence of a continuous supply of high concentrations of
oxygen and glucose. When SD is generated in vivo, the large energy demand is
compensated for by massive recruitment of blood flow to the depolarized brain
tissue (i.e. spreading hyperemia) (Dreier, 2011).
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The hyperemia is chiefly

mediated by dilation of arterioles and passive dilation of capillaries (FernandezKlett et al., 2010). Although the signaling pathway(s) responsible for functional
hyperemia during SD is not well established, contributions of NO generated in
parenchyma, acetyl-choline release from parasympathetic nerves, and calcitonin
gene-related peptide release from trigeminal nerves have been demonstrated
during SD (Busija et al., 2008). Such hyperemia could facilitate restoration of
ionic homeostasis by providing energy substrates as well as increasing clearance
rates of extracellular solutes. These observations suggest that failure to recruit
blood flow during SD could lead to injurious consequences in ischemic injury.
The significance of SD to brain injury in ischemic stroke models has been
consistently reported.

SD generated in vivo by global ischemia without

reperfusion, or in vitro by oxygen glucose deprivation can immediately cause
irrecoverable damage to brain tissue (Jarvis et al., 2001; Takano et al., 2007).
Such depolarization is often termed anoxic depolarization (AD) and this is likely
an underlying mechanism for irrecoverable brain damage formed during initial
injury. In a focal ischemia model in vivo, AD also occurs after focal ischemia and
creates ischemic core.

Neurons in the tissue surrounding ischemic core are

continuously experiencing severe metabolic stress, but still maintain their
membrane potential based on the collateral blood supply from vessels in healthy
brain tissue. These vulnerable tissues are often termed penumbra tissue and
considered to be a volume of tissue that undergoes progressive degeneration.
Studies have revealed that SD can propagate in penumbral tissues and
contribute to secondary injury. SD propagating within penumbral tissue is usually
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termed peri-infarct depolarization (PID). Recurrent PIDs were observed days
after stroke onset and the incidence significantly contributed to delayed infarct
enlargement in rodents (Gill et al., 1992; Iijima et al., 1992; Nedergaard and
Hansen, 1993; Hartings et al., 2003), cats (Ohta et al., 2001) and non-human
primates (Strong et al., 2000). Pharmacological studies confirmed significant
contribution of PID to infarct enlargement as intervention of PID correlatively
decreased numbers of PID and infarct size (Gill et al., 1992; Hartings et al., 2003;
Lu et al., 2005). While PIDs can occur in recurrent form, recent imaging studies
revealed that some PID clusters can be explained by multiple detection of single
PID circulating around the ischemic core (Nakamura et al., 2010). These PIDs
selectively depolarize hypoperfused brain tissue (penumbra) that surrounds the
ischemic core and produce large metabolic burdens to the already compromised
tissue.

It appears very likely that such a repetitive metabolic challenge

contributes to irrecoverable brain damage.
While it is widely assumed that SD generated in metabolically
compromised tissue sets up an additional metabolic burden that contributes to
neuronal damage, very little is known at cellular level about how energy-depleted
neurons are damaged following SD. Duration of extracellular potential shift during
SD is generally prolonged in metabolically compromised tissue and correlated
with poor outcomes (Takano et al., 2007; Oliveira-Ferreira et al., 2010; Hartings
et al., 2011b).

This suggests that events during the late-SD phase may

contribute to brain injury. Identification of cellular mechanisms of SD dependent
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neuronal injury may help in the development of approaches to save neurons at
risk of injury following SD in compromised tissues.

1.2.2 SD in human patients
The significance of SD in human brain injury had not been well
appreciated by clinical researchers until a recent series of studies, which
convincingly demonstrated SD in human patients (Strong et al., 2002; Fabricius
et al., 2006; Dohmen et al., 2008; Dreier et al., 2009; Bosche et al., 2010;
Hartings et al., 2011c; Hartings et al., 2011b; Dreier et al., 2012; Drenckhahn et
al., 2012; Hertle et al., 2012a; Woitzik et al., 2012).

In 2008, the COSBID

(Cooperative Studies of Brain Injury Depolarization) group first recorded cortical
activity in human stroke patients with electrode strips placed directly on the
cortical surface (electro-corticography; ECoG) (Dohmen et al., 2008). This study
detected SD in virtually all stroke patients. SD was detected days after stroke
onset. In some patients SD triggered irrecoverable loss of local brain activity and
radiographic evidence of infarct growth, strongly suggesting that SD can
contribute to secondary injury in human stroke patients.

Subsequently, large

numbers of clinical recordings made with similar approaches have detected SD
in multiple brain pathology (e.g. subarachnoid hemorrhage, brain trauma). A
recent prospective study confirmed that the incidence of SD was a significant risk
factor that predicted outcomes in patients with head trauma (Hartings et al.,
2011c). Based on the incidence of SD during days after initial treatments in the
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ICU, it has now been suggested that SD is an important target to prevent
progression of injury (Strong et al., 2007; Lauritzen et al., 2011).
An additional noteworthy finding from these recent clinical studies is the
confirmation of the significance of earlier findings from preclinical studies of SD in
small animals. For example seizure-like excitatory phases associated with SD
seen in brain slice in vitro and rodent brain in vivo (Van Harreveld and Stamm,
1953; Hablitz and Heinemann, 1989) were recently detected in human patients
(Dreier et al., 2012).

In addition, SD-induced ischemia (spreading ischemia

Dreier et al., 1998), which once was considered to be an artifact of harsh stimuli
in animal studies, has been observed in patients with subarachnoid hemorrhage
(SAH) and is now considered to be a significant contributor to the onset of
delayed ischemic neurological deficit (DIND) (Dreier et al., 2009; Strong and
Macdonald, 2012). Thus these clinical observations validate the potential utility
of data obtained from small animals (e.g. rabbits, rodents) for understanding
important aspects of SD and subsequent injury in human subjects.

1.2.3 Sensitivity of SD to NMDAR antagonists
Based on its significant contribution to brain injury, there has been long
standing interest in the pharmacological intervention of initiation and propagation
of SD. Currently the most studied pharmacological compounds to inhibit SD are
antagonists of NMDA-type glutamate receptors (NMDAR).
The efficacy of NMDA antagonists to inhibit initiation and propagation of
SD are variable depending on the model used. It has been consistently shown
12

that SD generated in healthy tissue is effectively prevented by NMADR
antagonists both in vitro and in vivo (Anderson and Andrew, 2002; Faria and
Mody, 2004; Peeters et al., 2007).
In contrast, the efficacy of NMDAR antagonists to prevent SD induced in
stroke models is variable and likely sensitive to local tissue metabolism. SD (or
AD) generated by either global ischemia or oxygen glucose deprivation (OGD) is
highly resistant to NMDAR antagonists (e.g. Jarvis et al., 2001; Murphy et al.,
2008). Thus initial SD events that contribute to formation of initial ischemic core
do not appear to require NMDAR activity for propagation (Jarvis et al., 2001;
Murphy et al., 2008).

In contrast to these initial events, subsequent PIDs

occurring days after stroke onset seems to have a higher sensitivity to NMDAR
antagonist. Thus NMDAR antagonists significantly decreased the incidence of
PIDs generated following focal ischemia and reduced infarct volumes (Gill et al.,
1992; Ohta et al., 2001; Hartings et al., 2003). While PIDs were not recorded, a
number of studies also reported that NMDAR antagonists significantly reduced
the infarct volume following focal stroke (Takamatsu et al., 1998; Li et al., 2004;
Woitzik and Schilling, 2007; Eikermann-Haerter et al., 2012).

Because PIDs

appear to contribute to delayed injury formation, NMDAR antagonist may be
useful for limiting PIDs that contribute to progressive infarct enlargement. The
mechanisms underlying differential NMDAR antagonist sensitivity of SD events
involved in ischemic infarct development are not well understood. One potential
explanation is a differential capacity of ischemic tissues to clear extracellular
potassium. In severe ischemia, mechanisms required to decrease extracellular
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potassium can be impaired (e.g. by loss of clearance by local blood flow, or due
to astrocyte depolarization). Under such conditions, tissue depolarization during
SD could readily elevate extracellular potassium concentrations ahead of the
propagating wave, allowing SD propagation without NMDAR activation. However
because of profound changes in the extracellular environment during ischemia, it
is also possible that other factors related to differences in extracellular redox
potential and modification of NMDAR sensitivity could also contribute.
Recently, there has been a growing interest in utilizing NMDAR
antagonists for clinical intervention for SD. The most widely studied antagonist is
ketamine, because this is already used as a sedative for human patients (Sinner
and Graf, 2008). A preliminary clinical report has shown a reduced number of
SDs with ketamine administration (Sakowitz et al., 2009), and a retrospective
clinical study has also demonstrated a significant reduction of SD incidence by
ketamine (Hertle et al., 2012a). These preliminary clinical studies support the
potential usefulness of NMDAR antagonist for preventing SD in human patients.

1.3 Roles of NMDAR in SD

1.3.1 NMDA-type glutamate receptor
As noted above (section 1.2.1) extracellular glutamate concentration reach
~30-100 µM during SD (Fabricius et al., 1993; Iijima et al., 1998; Rossi et al.,
2007) and most glutamate receptors are expected to be in an activated state.
Three classes of ionotropic glutamate receptors, (AMPA, kainate and NMDA) are
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expressed in the brain. Among these three receptor types, the NMDAR has
unique biophysical properties suitable for mediating charge transfer during SD.
The NMDAR is ubiquitously expressed in the mammalian brain and its
activity is involved in multiple brain functions. NMDARs are formed as tetramers
of GluN subunits. A pair of GluN1 subunits is mandatory for channel formation
and formation of the coagonist (D-serine, glycine) binding sites. Most NMDARs
contain an additional two GluN2 (A-D) subunits to form a functional tetramer.
GluN3A/B subunits can also contribute to formation of functional NMDAR
tetramers with significantly reduced open probability and less Ca 2+ permeability
when expressed as GluN1/2/3 heterotetramers (Ciabarra et al., 1995). GluN3
subunits can also form excitatory glycine receptors as GluN1/GluN3 tetramers
(Chatterton et al., 2002).

However the physiological relevance of GluN3

containing NMDA receptor in adult brain is not well established (Pachernegg et
al., 2012) and will not be further discussed.

GluN2 subunit composition

significantly alters the kinetics of NMDAR currents. GluN2A containing receptors
have higher open probabilities than GluN2B-containing receptors, whereas
GluN2B containing receptors usually show slower currents than GluN2Acontaining receptors (Erreger et al., 2005).

Such different kinetics predicted

stimulation-dependent activation of different GluN2 containing receptors. Thus
low frequency stimulation preferentially activates GluN2B containing receptors,
whereas high frequency stimulation evokes more GluN2A- containing NMDAR
current.
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The biophysical properties of NMDARs are unique when compared with
other glutamate receptors.

The NMDAR has an extraordinarily large charge

transfer capacity compared with other glutamate receptors. One study reported
that, in single nucleated (out-side-out) patches obtained from dendrites of CA1
pyramidal neurons, NMDAR currents showed >40 pS unitary conductance with a
~3 sec total deactivation time constant. In contrast, AMPA currents in the same
preparation had ~10 pS unitary conductance with ~10 ms deactivation kinetics
(Spruston et al., 1995). The fast kinetics of non-NMDAR glutamate receptors are
partly due to the presence of auxiliary subunits. For example, AMPAR requires
transmembrane AMPA receptor regulatory proteins (TARPs) for surface
expression and antagonist sensitivity (Nicoll et al., 2006; Maclean and Bowie,
2011), and kainate receptor interaction with Neto1 is also important for shaping
kinetics of kainate receptor currents (Straub et al., 2011). It is not yet known
whether similar auxiliary subunits are present for NMDARs.
While the NMDAR has extremely slow deactivation kinetics and large
conductance, NMDAR current is limited by endogenous inhibitors. In fact, gating
of NMDARs is strongly inhibited by cations such as Mg2+, Zn2+ and H+, which
may important for compensating for the slow channel desensitization. Among
endogenous inhibitors, voltage dependent channel block by Mg2+ is highly
effective and almost completely eliminates NMDAR current at resting membrane
potentials.

When neurons are severely depolarized, voltage sensitive ion

channels are rapidly inactivated. In contrast severe depolarization relieves Mg2+
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block and rather potentiate NMDAR current.

Thus during the severe

depolarization of SD, NMDAR is suitable for generating ionic deregulation.
Another important property of NMDARs is their high permeability for Ca 2+,
compared with very poor Ca2+ permeability in the most of other glutamate
receptors expressed in adult (while some AMPA/kainate receptors exhibit
considerable Ca2+ permeability (Liu and Zukin, 2007; Perrais et al., 2010)).
However the importance of Ca2+ permeability of NMDAR to SD propagation is not
well defined. While Ca2+ influx is critical for propagation some SD, such a Ca2+
requirement seems to be due to essential role of P/Q type calcium channels in
transmitter release during some SD.

In fact, inhibition of P/Q channels can

prevent generation of some forms of SD (Kunkler and Kraig, 2004), and a
mutation in P/Q type channel gene (Cav2.1) that enhances channel function
resulted in higher susceptibility to SD (Tottene et al., 2009). As will be discussed
later, the Ca2+ permeability of NMDAR is often discussed in the context of
intracellular signaling in excitotoxicity (see section). SD involves profound Ca 2+
deregulation which invades proximal dendrites to soma (Dietz et al., 2008).
However it was not determined whether NMDAR activation contributes to the
Ca2+ deregulation and neuronal injury during SD.

1.3.2 Evolution of interest in excitotoxicity and NMDAR
While the discussion of NMDARs has so far centered on SD, there has
long been interest in NMDAR contribution to ischemic brain injury.

This is

because aberrant glutamate signaling plays critical roles in the neuronal injury
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induced by hypocxia or ischemia in vitro. The neuronal damage due to excitatory
amino acid is generally called excitotoxicity. The concept of excitotoxicity was
initially developed based on the vulnerability of retinal neurons to glutamate, and
the subsequent demonstration of vulnerability of large parts of the brain to high
concentrations of glutamate (Olney, 1969). It was later shown that exposure to
100-500 µM glutamate reliably triggered neuronal death in cortical cultures (e.g.
Choi et al., 1987). The link between excitotoxicity and ischemic neuronal death
was concluded based on a large numbers of studies using neuronal cultures
system. In neuronal culture, ischemia is simulated with oxygen and/or glucose
deprivation (OGD) and/or by the addition of metabolic inhibitors (e.g. chemical
ischemia), and these stimuli reliably cause neuronal death (e.g. Rothman, 1983;
Rothman, 1984; Goldberg et al., 1986). One of the most important observations
made from these early studies was that neuronal cultures studied early after
plating (~2 days) were far more resistant to simulated ischemia than neurons
which had been maintained in culture long enough to develop large numbers of
synaptic connections (>14 days) (Rothman, 1983).

It was hypothesized that

aberrant excitatory synaptic activation is an important contributor to ischemic
neuronal death. Supporting a role for glutamate excitotoxicity in vivo, extremely
high extracellular glutamate concentrations (100-300 µM) were recorded in brain
following experimental stroke in rat and rabbit (Benveniste et al., 1984; Hagberg
et al., 1985).
Efforts to evaluate the contribution of excitotoxicity to ischemic neuronal
death were greatly facilitated by development of selective glutamate receptor
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antagonists (Beal, 1992).

A series of in vivo stroke studies revealed that

glutamate receptor antagonists are effective (Simon et al., 1984; Faden et al.,
1989).

Based on increased

understanding of

mechanism

underlying

excitotoxicity, glutamate receptor antagonists, especially those targeting the
NMDAR became attractive as potential therapies (Choi and Rothman, 1990).
However clinical trials of NMDAR antagonists for acute stroke treatment failed
miserably.

The reasons for these failures have not been clearly identified,

however poor clinical study designs and differences in evaluation standards
between basic research (e.g. infarct size) and clinical studies (e.g. neurological
deficit) have often been raised as key issues (see reviews in Ikonomidou and
Turski, 2002; Hoyte et al., 2004). NMDAR activation is involved in regeneration
of brain function following injury and continuous suppression may decrease
infarct volume but would hinder recovery of neurological function.

Thus

continuous suppression of NMDAR activity may be protective by decreasing
infarct size, but may worsen clinical outcomes. As described above, SD has now
emerged as a novel and clinically relevant target for many acute brain injuries.
The prevention of SD by NMDAR antagonist can be designed quite differently
from previously failed idea of simply reducing NMDAR activity. Thus prevention
of SD generally would require much higher concentration of NMDAR antagonists
but NMDAR antagonism can be limited to a very short time window if SD
incidence can be monitored at the intensive care unit. Based on failures of large
number of clinical trials on NMDAR antagonists, it is important to carefully
determine how NMDARs contribute to SD and consequent brain injury.
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1.4 Intracellular Ca2+ deregulation in neuronal injury

1.4.1 Intracellular Ca2+ signaling
One of the most important mediators of excitotoxicity is intracellular Ca 2+
The contribution of Ca2+ to excitotoxic neuronal death has been

influx.

repeatedly confirmed by significant prevention of neuronal death by removal of
extracellular Ca2+ or intracellular loading of a Ca2+ chelator (Goldberg et al.,
1986; Choi, 1987; Manev et al., 1989; Tymianski et al., 1993b). In the 1970 and
1980s,

Ca2+

sensitive

fluorescence

probes

became

available

for

neurophysiological experiments (Tsien, 1980), allowing direct evaluation of
intracellular Ca2+ responses to physiological stimulation as well as Ca2+
deregulation in excitotoxicity. These studies revealed that strong glutamate
exposure generates rapid initial Ca2+ increase and that neurons subsequently
develop larger secondary Ca2+ deregulation (Manev et al., 1989). Importantly
development of such a secondary Ca2+ response significantly correlates with
reactivity to vital staining (e.g. trypan blue, ethidium bromide)(Tymianski et al.,
1993a), indicating that secondary Ca2+ deregulation can represent early sign of
neuronal degeneration.
Ratiometric

indicators

allowed

concentration by using optical methods.

estimation

of

intracellular

Ca2+

Studies revealed that synaptic

stimulation can raise dendritic Ca2+ concentration from 100 nM to above 1 µM
(Petrozzino et al., 1995), which is a good range to control Ca2+ sensitive
channels and signaling molecules (e.g. EC50 for Ca2+: SK channels: 0.4-5 µM
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(Pedarzani et al., 2001), BK channels 1-10 µM (at -50mV) (Vergara et al., 1998),
soluble adenylcyclase: 0.3-4 µM and 100 µM (Jaiswal and Conti, 2003), PKCs
(conventional): 0.7-1.4 µM (Kohout et al., 2002)). Cytoplasmic Ca2+ at this range
can be effectively cleared, by the activities of Ca2+ exchangers, Ca2+ ATPase and
mitochondria.

In contrast, during the secondary Ca2+ deregulation in

excitotoxicity models, intracellular Ca2+ concentrations often remain elevated to
higher levels (above 30 µM) and for longer periods (Abele et al., 1990; Vander
Jagt et al., 2008). As will be discussed later, excitotoxic Ca2+ elevations are not
always recoverable or may take substantially more time to be cleared, likely
because buffering and clearance mechanisms are impaired. For example, Ca 2+
activated calpain has been shown to cleave Na +/Ca2+ exchangers and hinder
cytoplasmic Ca2+ clearance (Bano et al., 2005).

In addition, excessive Ca2+

uptake by mitochondria results in opening of a large conductance pore in
mitochondria, called the permeability transition pore (mPTP). mPTP opening
impairs mitochondrial Ca2+ buffer functions, and also limits ATP production
needed to fuel Ca2+ ATPase activity. The release of cytochrome c following
mPTP formation can also serve as an important trigger for apoptotic signaling.

1.4.2 Dendritic Ca2+ deregulation in excitotoxicity
Most first generation Ca2+ probes had affinities that were too high to
accurately assess Ca2+ signals during excitotoxicity, and the indicators were
often saturated in ischemia or glutamate exposure studies. When lower affinity
Ca2+ probes were developed, highly localized Ca2+ responses became better
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resolved. Thus the secondary Ca2+ deregulation seen in excitotoxicity studies
are originated in distal dendritic, thus suggested an important concept that
dendritic compartments serve as the origin of Ca 2+ deregulation in excitotoxicity.
When isolated neurons were briefly stimulated with glutamate, most of initial
glutamate application cause recoverable transient Ca2+ increase, while repetitive
stimulations generate sustained and sometimes irrecoverable elevation of
dendritic Ca2+ deregulation (Connor et al., 1988; Wadman and Connor, 1992). In
the

studies

in

acute

brain

slice

preparations,

repetitive

glutamate

microapplication or kainate application resulted in similar secondary Ca 2+
deregulation originated in distal dendrite which slowly progress toward soma
(Connor and Cormier, 2000; Shuttleworth and Connor, 2001). In this model, the
latter study confirmed that secondary Ca2+ deregulation is due to sustained Ca2+
influx and prevented by NMDAR antagonist.

In a study using bath NMDA

application (Vander Jagt et al., 2008), transient intracellular Ca2+ increase
occurred immediately after NMDA application, followed by a slowly propagating
secondary Ca2+ deregulation originated in distal dendrite.

This study also

showed that delayed application of NMDAR antagonist (MK801) could prevent
progressing Ca2+ deregulation (Vander Jagt et al., 2008). These results strongly
suggest NMDAR contribution to secondary Ca2+ deregulation in various models.
In addition to significant correlation between secondary Ca 2+ deregulation and
neuronal viability (Tymianski et al., 1993a), these studies suggest a dendritic
origin of neurotoxic Ca2+ signaling in excitotoxicity.
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The dendritic origin of neuronal damage is consistent with the vulnerability
of these small compartments to ischemic challenge. When neurons in culture or
in brain slices were exposed to oxygen glucose deprivation, or a high
concentration of an excitatory amino acid, dramatic structural changes have been
observed in dendrites (Joshi and Andrew, 2001; Zeng et al., 2007).

This is

characterized by obvious swellings interspersed by dramatic thinning of dendritic
shafts.

This morphology is often termed “dendritic beading” as the structure

appears quite similar to beads on a string (Park et al., 1996). While dendritic
beading is a characteristic of injured neurons, beading itself could be a neuronal
defense system against excitotoxicity to limit conductance in the stressed
compartments.
The large surface/volume ratio and high ion channel density reasonably
suggest dendritic origin of injurious signal. During SD, dendritic Ca 2+
concentrations are sustained at very high levels for a relatively long period of
time (minutes) following the passage of SD (Dietz et al., 2008). In addition, SD
generated with oxygen glucose deprivation or ischemia in vivo triggers dendritic
beading of pyramidal neurons (Jarvis et al., 1999; Murphy et al., 2008). The
massive glutamate release during SD and Ca2+ deregulation suggest that SD
may trigger neuronal injury similar to those seen in excitotoxicity studies.
However the relationship between excitotoxicity and SD has not been well
explored. As noted above, extracellular glutamate concentrations are highly
elevated during SD propagation and massive NMDAR activation is expected.
However whether or not NMDAR activation during SD can contribute to the
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injurious consequences of SD in metabolically compromised tissues is not well
established.

1.5 Zn2+ deregulation in ischemic injury

1.5.1 Zn2+ toxicity
Roles of Zn2+ in ischemic brain injury and SD are another major interest in
the present study. The currently most widely accepted hypothesis in the Zn 2+
field is that Zn2+ accumulates in the injured brain and contributes to neuronal
death.

The concept of neuronal Zn2+ toxicity was developed by a series of

studies by Choi and Koh. In their first study, exogenous Zn 2+ was shown to
ameliorate some forms of excitotoxicity in neuronal cultures (Koh and Choi,
1988). The Zn2+ toxicity was quite different from NMDAR mediated excitotoxicity,
in that it was not mainly due to toxic Ca2+ overload. In fact Zn2+ toxicity was
enhanced by AMPA receptor activation and augmented by removal of
extracellular Ca2+ in neuronal culture (Weiss et al., 1993). Subsequent works
showed that Ca2+-permeable GluR2 lacking AMPA receptors are important
contributor to toxic Zn2+ influx in these preparations. The significance of Zn2+
toxicity was later tested in a global ischemia model.

The study revealed

significantly high intracellular labile Zn2+ concentration in damaged neurons and
demonstrated that delayed administration of a Zn 2+ chelator (CaEDTA) could
provide a significant neuroprotection (Koh et al., 1996). Because CaEDTA is
membrane impermeable, this early study suggested that transmembrane Zn 2+
influx to the damaged neurons contributed to ischemic neuronal death. A similar
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protective effect of CaEDTA was later reproduced in several studies using
different stroke models (Lee et al., 2002; Calderone et al., 2004)
While many pathways are proposed, one of the well established toxic
mechanisms of intracellular Zn2+ is inhibition of cellular energy metabolisms. One
of the most profound toxic Zn2+ activities is opening of mPTP and release of
cytochrome c from isolated mitochondria which can be elicited by 10-100 nM
extramitochondrial Zn2+ (Jiang et al., 2001). In addition to its mitochondrial effect,
Zn2+ can also inhibit glycolytic enzymes such as GAPDH while concentration
required for inhibition was not strictly determined (Sheline et al., 2000).

In

addition to these pathways, Zn2+ is now implicated in autophagy and necrotic cell
death (Hwang et al., 2008; Sensi et al., 2009).
In addition to direct Zn2+ toxicity, intracellular Zn2+ accumulation
significantly contributes to the onset of secondary Ca2+ deregulation in
excitotoxicity and initiation of some SD.

Intracellular Zn 2+ concentrations

increase during NMDA challenge in an acute brain slice and removal of Zn 2+ with
a membrane permeable Zn2+ chelator (TPEN) significantly delayed onset of
secondary Ca2+ response in neuronal dendrites (Vander Jagt et al., 2009). In
addition, stimuli used to generate SD (ouabain, oxygen glucose deprivation) also
elevate intracellular Zn2+ concentration and removal of intracellular Zn2+ with
TPEN significantly delayed or abolished SD (Dietz et al., 2008; Medvedeva et al.,
2009). These results suggested that intracellular Zn2+ accumulation contributes
to acute neuronal injury by facilitating neurotoxic events, rather than intracellular
Zn2+ by itself. It is important to note that (unlike in vivo stroke studies) membrane
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impermeable Zn2+ chelator CaEDTA did not show any protective effects in these
models.

This suggests that intracellular Zn2+ accumulation in these in vitro

models could be mediated by mechanism(s) distinct from Zn 2+ accumulation
seen

in experimental stroke

studies. However mechanisms underlying

intracellular Zn2+ accumulation occurring prior to acute excitotoxic injury and SD
have not been clarified.

1.5.2 Synaptic Zn2+ release and its intracellular accumulation
One important hypothesis in ischemic Zn2+ toxicity is that toxic intracellular
Zn2+ accumulation occurs by uptake of synaptically released Zn2+ (hereafter
synaptic Zn2+ translocation) (Koh et al., 1996; Koh, 2001). Activity dependent
Zn2+ release from mammalian brain tissue was originally discovered in 1984
(Assaf and Chung, 1984; Howell et al., 1984), and one of these studies estimated
that extracellular Zn2+ concentrations in synaptic clefts can reach ~300 µM.
Histological detection of brain free Zn2+ revealed high concentration of Zn2+
present in synaptic vesicles of many glutamergic neurons and Zn 2+ was
proposed to be a modulator of synaptic functions (Frederickson et al., 1992).
Evidence for the indispensable roles of the ZnT3 transporter for establishing the
vesicular Zn2+ pool was demonstrated in transgenic animal with ZnT3 gene
deletion (Cole et al., 1999). Later studies by applying high affinity fluorescence
indicator, FluoZin3, in the bath medium revealed strong correlation between
extracellular Zn2+ concentration and local presynaptic activity (Qian and Noebels,
2005, 2006).

The contribution of synaptic Zn2+ release to intracellular Zn2+
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accumulation was established by an imaging study using bulk loading of low
affinity Zn2+ indicator which revealed extremely slow intracellular Zn2+
accumulation which became evident ~5 minutes after brief synaptic stimulation
(Suh, 2009).
The significance of synaptic Zn2+ translocation is better supported by
functional studies. In the mammalian brain vesicular Zn 2+ content is highest in
mossy fiber synaptic vesicles and mossyfiber-CA3 synapses provides a good
model to study the significance of Zn2+ release and translocation to postsynaptic
neurons (Lee et al., 2011). One such study showed that high concentrations of
CaEDTA (10 mM) could prevent uptake of synaptically released Zn 2+ by CA3
neurons, and also block induction of long term potentiation (Li et al., 2001a).
Later studies have suggested that Zn2+ influx activates Src kinase, potentiation of
TrkB receptor and potentiates these synapses (Huang et al., 2008). ZnT3 KO
animals lack virtually all vesicular Zn2+ (Cole et al., 1999) and the phenotype of
these animals can be useful for examining roles of vesicular Zn 2+. In an early
report, young ZnT-3 KO animals did not show any behavioral deficits (Cole et al.,
2001), however a later study showed impaired spatial memory in 6-month old
ZnT3 KO animals,

with associated decrease in AMPA and NMDAR subunit

expression (Adlard et al., 2010).

ZnT3 expression generally decreases in older

animals and the latter study proposed that vesicular Zn 2+ is important for
maintaining neuronal function in aged animals. However data obtained from
ZnT3 animal need to be analyzed carefully because ZnT3 KO animals could
develop significant adaptive mechanism to compensate for lack of vesicular Zn 2+.
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In fact, these animals express mossy fiber-CA3 LTP independent of postsynaptic
Zn2+ accumulation (Pan et al., 2011).
In contrast to functional significances of synaptic Zn 2+ translocation in
synaptic physiology, evidence for deleterious role of synaptic Zn2+ translocation
is rather weak in pathological situations. The toxicity of Zn 2+ influx is supported
by the protective effect of membrane impermeable Zn 2+ chelator CaEDTA.
However Zn2+ chelation by CaEDTA requires prior dissociation from Ca 2+ to
capture Zn2+ and this significantly limits its ability to chelate rapid Zn 2+ transient.
In fact, CaEDTA at lower concentration (1 mM) cannot eliminate synaptically
released Zn2+ (Qian and Noebels, 2005, 2006). Together with a short functional
half-life of CaEDTA in vivo (90 miniutes Frederickson et al., 2002), it is unlikely
that CaEDTA could effectively block synaptic Zn2+ translocation.
Instead of targeting synaptically released Zn2+, protective effect of
CaEDTA is also considered as a consequence of intracellular Zn2+ chelation.
While mechanism is not conclusive, high concentration of CaEDTA (~150 mM,
estimated from Lavoie et al., 2007) significantly reduced intracellular Zn2+
concentration in vivo (Frederickson et al., 2002; Calderone et al., 2004; Lavoie et
al., 2007).

Contribution of intracellular Zn2+ chelation by CaEDFTA was

supported by a study that showed that Zn2+ can be released from an intracellular
pool following exposure to oxidative stress and the resultant intracellular Zn 2+
accumulation was sufficient to trigger neuronal death (Aizenman et al., 2000;
Aras and Aizenman, 2011). The non-essential role of synaptic Zn2+ release in
intracellular Zn2+ accumulatoin following seizure was also demonstrated, in which
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study intracellular Zn2+ accumulation was observed in ZnT3 KO animals (Lee et
al., 2000).

These evidences indicate that synaptically released Zn 2+ is not

always required for histologically detectable Zn2+ accumulation seen in ischemic
brain injury.

Excessive Zn2+ chelation is generally toxic (Hyun et al., 2000;

Maclean et al., 2001) and identification and selective targeting of intracellular
Zn2+ accumulation mechanism is important.

1.5.3 Intracellular Zn2+ homeostasis
As described above, excessive intracellular Zn2+ accumulation can
significantly contribute to neuronal death. However intracellular Zn 2+ is also an
essential component of cellular physiology. In fact Zn2+ is required for catalytic
centers of

enzymes

(e.g.

catalase,

superoxide

dismutase

and

matrix

metalloproteinases) as well as for structural component (e.g. Zn 2+ fingers). In
order to minimize Zn2+ toxicity, while keeping Zn2+ available for essential
functions, neurons have a finely-tuned Zn2+ homeostasis mechanism.

In

mammalian neurons, the total intracellular Zn2+ content is at range between 100200 µM (Colvin et al., 2010).

However cytoplasmic Zn2+ concentrations are

considered to be extremely low or even absent because of the tightly-regulated
activity of Zn2+ transporters and buffer molecules.
There are two classes of Zn2+ transporter family; Zn2+ transporters (ZnTs)
and Zn2+ importer proteins (ZIPs). ZnTs either extrude or sequester Zn 2+ from
the cytoplasm. ZnT1 is expressed in cortical neurons and its gene expression
level is regulated in feedback manner.
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When cytoplasmic metal ion

concentrations elevate, metal ions bind to the transcription factor MTF-1 and
transactivates ZnT1 gene expression (Langmade et al., 2000). Upregulation of
ZnT1 expression may thus be important for extruding intracellular Zn 2+
concentrations. ZnT1 gene expression is upregulated by transient ischemia and
such mechanism may contribute to limiting Zn2+ toxicity in brain after stroke
(Tsuda et al., 1997). Cytoplasmic Zn2+ is also sequestered in lysosomes and
mitochondria by activities potentially involving ZnT2, 4 and 5 (Sensi et al., 2009).
In contrast to ZnT transporters, ZIP transporters drive Zn2+ into the cytoplasmic
fraction. ZIP activity may be important for maintaining intracellular Zn 2+ content
needed for essential functions, however excessive activity of ZIPs can be
neurotoxic. In fact knock-out of ZIP1,3 significantly reduced Zn2+ uptake into
hippocampal neurons and reduce seizure-induced neuronal degeneration (Qian
et al., 2011).
In addition to the Zn2+ transporter systems, Zn2+ binding molecules
contribute to maintenance of extremely low intracellular Zn2+ concentrations.
Intracellular Zn2+ binding molecules such as glutathione, thionein and
metallothionein (MT) are considered to be important for buffering intracellular
Zn2+. MT generally is involved in a defense mechanism against metalotoxicity.
Mammalian genomes encode MT1, -2, -3 and -4 genese, while significant
numbers of subtypes (e.g. MT2A, MT2B) can present in each gene family
(Moleirinho et al., 2011). Similar to ZnT1, MT1 and 2 are upregulated by MTF-1
transcription factor activation in response to increased intracellular metal
concentrations, and plays protective roles against metalotoxicity in ubiquities cell
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types (Heuchel et al., 1994).

In contrast, Metallothionein 3 (MT3) is the

predominantly expressed MT isoform in brain. MT3 was originally purified from
neuroblastoma as a Growth Inhibitory Factor (GIF) and inclusion of MT3 in
culture medium significantly inhibited outgrowth of cortical neurons (Uchida et al.,
1991).

Such inhibitory activity is not shared by MT1 and MT2, and it was

proposed that high Cu2+ binding of MT3 due to its unique N-terminal amino acid
sequence contribute to the inhibitory effects (Faller and Vasak, 1997). MT3 KO
mice develop behavioral abnormalities (Koumura et al., 2009) and such growth
inhibitory effect may play role in proprer brain development.
MT3 is constitutively expressed (unlike MT1 and MT2) and considered to
play physiological roles in intracellular Zn2+ homeostasis.

Biophysical

characterization revealed that different Zn2+ binding sites of MT3 have different
Zn2+ affinities and one of the weakest Zn2+ binding sites has an estimated 10-8 M
affinity for Zn2+ (Krezel and Maret, 2007). The presence of multiple Zn2+ affinities
in a MT3 molecule explain why MT1 or 2 usually equilibrate in a 7-Zn2+ bound
complex when incubated with high ZnCl2, while MT3 can equilibrate in multiple
Zn2+ binding states multiple complexes of up to 10 Zn2+-bound forms (Palumaa et
al., 2005). Such dynamic binding characteristics predict effective transfer of Zn2+
to other high affinity Zn2+ binding sites. Thus Zn2+ binding to MT3 is not the
terminal equilibrate state, rather serves as an intermediate hub to control
distribution of intracellular Zn2+ throughout a neuron. Zn2+ binding to MT3 is
mediated by thiol groups and is highly sensitive to oxidation and acidification
(Toriumi et al., 2005).

These sensitivities of MT3-Zn2+ binding should be
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important for controlled Zn2+ release from MT3 to distribute Zn2+ to transporters
or high affinity Zn2+ binding proteins.

However intracellular oxidation and

acidosis occur in injured tissue and Zn2+ release from MT may also contribute to
the toxic intracellular Zn2+ accumulation.
While these Zn2+ homeostasis mechanisms are important for cellular physiology,
it becomes a significant confound when measuring the intracellular Zn 2+
dynamics.

1.5.4 Extracellular action of synaptically released Zn2+
Discussion so far concentrated on intracellular Zn2+ actions, howewver
extracellular Zn2+ also plays significant roles in the modulation of neuronal
excitability.

Accumulating evidence suggests that virtually almost all ion

channels or receptors have some sensitivity to inhibition by extracellular Zn 2+
(Frederickson et al., 2005), while it is likely that the degree of inhibition
significantly differs between experimental models (further discussed in
Discussion section). Among many Zn2+-sensitive ion channels, the NMDAR is
one of the most well-studied and most sensitive to Zn2+ (Westbrook and Mayer,
1987). High sensitivity of NMDAR was subsequently characterized in detail
(Paoletti et al., 1997). This work not only demonstrated inhibition of NMDAR by
nanomolar Zn2+, but also suggested that NMDAR potentiation seen with reducing
agents (e.g. DTT) is mediated by removal of contaminating Zn 2+, rather than by
redox modulation of the channel itself. (Tauck, 1992) Prior work had shown that
reducing agents such as DTT potentiate NMDAR currents (Reynolds et al., 1990;
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Kohr et al., 1994), and redox modulation had been shown to potentiate NMDAR
current and was implicated to some injurious processes (Hammond et al., 1994;
Sanchez et al., 2000). Given the high affinity for NMDAR and extracellular Zn 2+
concentration at synaptic cleft, Zn2+ release should be able to play roles in
NMDAR inhibition in physiological conditions. In fact it was shown that at mossy
fiber CA3 synapses, synaptic Zn2+ release limits postsynaptic NMDAR current
(Vogt et al., 2000; Pan et al., 2011). It is thus of considerable interest that Zn2+
inhibition of NMDAR may be a central mechanism of these effects.
Because excessive NMDAR activation contributes to neuronal injury,
extracellular Zn2+ potentially suppress some forms of excitotoxic injury.

In

seizure studies some reported that ZnT3 KO animals and Zn 2+ deficient animals
(which had decreased Zn2+ content) have a lower threshold for seizure (Cole et
al., 2000; Lee et al., 2000; Dominguez et al., 2003; Takeda et al., 2003; but see
also Qian et al., 2011). In addition one study revealed higher vulnerability of
ZnT3 KO to brain trauma (Doering et al., 2010). Even in some ischemia models,
low concentration of CaEDTA has been shown to accelerate infarct enlargement
(Kitamura et al., 2006), whereas significant neuroprotection was observed
following Zn2+ administration (Zhao et al., 1996). While Zn2+ toxicity in ischemia
model is well developed, these suggest that Zn2+ can play a protective role in
certain circumstances. However the question still remains whether endogenous
synaptically released Zn2+ can limit NMDAR dependent toxic events and what
factors determine the relative contribution of synaptically released Zn 2+ to
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potentially neurotoxic intracellular Zn2+ accumulation and potential protective
extracellular Zn2+ functions.

1.6 Summary
The primarily goal of the present studies was to elucidate mechanisms
converting non-injurious event to events that bring harmful consequences in
metabolically compromised brain tissue.

NMDA receptor mechanisms and

complex roles of extracellular and intracellular Zn 2+ in SD were examined in both
healthy and metabolically compromised condition.
Studies in Chapter 1 examined mechanisms underlying neuronal injury
caused by SD induced with potassium chloride microinjection. These studies
tested the hypothesis that NMDA receptor activation occurring after the onset of
SD is responsible for initiating excitotoxic injury in neuronal dendrites. This work
provided the first detailed characterization of an excitatory phase during the lateSD phase and revealed that NMDAR activation during this phase can be
sufficient to convert a recoverable SD into an irrecoverable event in metabolically
compromised neurons.
Studies in Chapter 2 were driven by the hypothesis that Zn 2+ released
from synaptic vesicles can limit SD by inhibiting NMDARs. The results of this
study generally supported the hypothesis in a model of potassium induced SD in
vitro and in vivo, and revealed potentially protective roles of extracellular Zn2+.
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Chapter 3 contains studies promoted by results in Chapter 2, and
examined whether inhibitory effects of extracellular Zn 2+ were effective in
ischemic tissues. These studies showed a dramatic difference in sensitivity that
appeared to be due extracellular redox modulation.
Experiments in Chapter 4 focused on an important technical aspect of
intracellular Zn2+ measurements from single neurons. This study tested and
supported the hypothesis that intracellular dialysis removes neuronal MT3 and
greatly distorts analysis of intracellular Zn2+ accumulation. These findings were
then exploited to provide the first evidence that both intracellular and extracellular
sources of Zn2+ contribute to postsynaptic accumulation of Zn2+ after synaptic
activation.
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2.1 ABSTRACT
Spreading depolarizations (SD) are slowly propagating waves of near-complete
neuronal and glial depolarization. SD have been recorded in patients with brain
injury and the incidence of SD significantly correlates with outcome severity.
Although it is well-accepted that the ionic dyshomeostasis of SD presents a
severe metabolic burden, there is currently limited understanding of SD-induced
injury processes at a cellular level. In the current study we characterized events
accompanying SD in the hippocampal CA1 region of murine brain slices, using
whole-cell recordings and single-cell Ca2+ imaging. We identified an excitatory
phase that persisted for approximately 2 min following SD onset, and
accompanied with delayed dendritic ionic dyshomeostasis. The excitatory phase
coincided with a significant increase in presynaptic glutamate release, evidenced
by a transient increase in spontaneous EPSC frequency and paired-pulse
depression of evoked EPSCs. Activation of NMDA receptors (NMDARs) during
this late excitatory phase contributed to the duration of individual neuronal
depolarizations and delayed recovery of extracellular slow potential changes.
Selectively targeting the NMDAR activation following SD onset (by delayed
pressure application of a competitive NMDAR antagonist) significantly decreased
the duration of cellular depolarizations. Recovery of dendritic Ca2+ elevations
following SD were also sensitive to delayed NMDA antagonist application.
Partial inhibition of neuronal energy metabolism converted SD into an
irrecoverable event with persistent Ca2+ overload and membrane compromise.
Delayed NMDAR block was sufficient to prevent these acute injurious events in
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metabolically-compromised neurons.

These results identify a significant

contribution of a late component of SD that could underlie neuronal injury in
pathologic circumstances.

2.2 INTRODUCTION
Spreading depression (SD) was originally described as a slowly
propagating suppression of electrocorticographic (ECoG) activity (Leao, 1944)
and was subsequently characterized as a slowly propagating wave of nearcomplete cellular depolarization of neurons and glia (Somjen, 2001).

Stimuli

such as elevated potassium or ischemia can cause localized depolarization of a
volume of neurons and glia sufficient to trigger a propagating event, and result in
a characteristic large slow field potential shift.

Accumulation of extracellular

potassium and glutamate mediates the feed-forward depolarization event as it
spreads slowly (2-4 mm/min) through gray matter (Somjen, 2001). Because
suppression of ECoG activity is a consequence of the depolarizing event, the
general term spreading depolarization (SD) is used in the current study to
emphasize the underlying mechanism (see Dreier, 2011).
Recent clinical recordings confirm a relatively high incidence of SD in
injured brain and it is hypothesized that the cumulative metabolic burden of
recovery from long lasting depolarizations underlies neuronal injury in
metabolically-compromised tissue (Dreier, 2011; Lauritzen et al., 2011). Thus
SDs recorded from these tissue regions often show prolonged slow potential
shifts (Shin et al., 2006; Oliveira-Ferreira et al., 2010; Takeda et al., 2011), the
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duration of which is correlated with the severity of injury (Oliveira-Ferreira et al.,
2010; Hartings et al., 2011b) and considered to be a useful parameter to assess
damaging effects of SD.

However, the cellular event(s) that contribute to

pathologically long-lasting slow extracellular potential changes are not fully
understood.
Previous studies have shown a significant contribution of NMDA-type
glutamate receptors (NMDARs) to SD. Thus NMDAR antagonists have been
shown to inhibit initiation and/or propagation of SD in experimental models (Gill
et al., 1992; Anderson and Andrew, 2002; Hartings et al., 2003; Faria and Mody,
2004; Peeters et al., 2007; Aiba et al., 2012) and a preliminary clinical study has
suggested prevention of SD in injured brain with ketamine, a nonspecific NMDAR
antagonist (Sakowitz et al., 2009; Hertle et al., 2012b).

NMDAR antagonists

have also been shown to reduce the duration of slow extracellular potential shifts,
both in vitro and in vivo. The fact that NMDAR antagonists could selectively
reduce the secondary phase of DC shifts without significantly affecting the initial
phase has implied a role for NMDAR activation during the late SD period
(Marrannes et al., 1988; Herreras and Somjen, 1993b; Larrosa et al., 2006) but
such activation has not been directly demonstrated.
Coordinated glutamate release and intracellular Ca2+ loading as a
consequence of SD may be similar in many ways to excitotoxic events mediated
by NMDAR stimulation.

SD results in substantial intracellular neuronal Ca 2+

transients, which recover fully in healthy tissue, but are irrecoverable when
metabolic substrates are lacking (Kunkler and Kraig, 2004; Dietz et al., 2008;
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Gniel and Martin, 2010). However, the cellular events and Ca2+ sources
responsible for conversion from recoverable to irrecoverable Ca 2+ loading are not
known.

Previous studies identified dendritic compartments as likely initiation

sites for excitotoxic injury in CA1 neurons (Connor et al., 1988; Wadman and
Connor, 1992; Shuttleworth and Connor, 2001; Vander Jagt et al., 2008) and we
examine here whether Ca2+ deregulation in dendrites may also be responsible for
triggering NMDAR-dependent injury associated with SD.
In the current study we utilized whole-cell recordings to characterize a
significant excitatory event following the initial depolarization of SD, generated in
hippocampal area CA1 of murine brain slices. This excitatory period resulted in
sustained NMDAR activation, and was responsible for prolonged Ca 2+ elevations
in dendrites.

Suppression of this activity during the late phase of SD was

sufficient to prevent neuronal injury in metabolically compromised neurons.
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2.3 METHODS

2.3.1 Ethical approval
All experimental protocols were approved by the institutional animal care
and use committee (IACUC) of the University of New Mexico.

2.3.2 Slice preparation
Brain slices were prepared from 53 adult (4-10 week old) male C57BL/6
mice. For all experiments that involved pharmacological interventions, control
and drug-treated slices from the same experimental animals were interleaved
throughout the study. Animals were deeply anesthetized by an injection (0.2 ml
S.C.)

of a ketamine/xylazine mixture (85 and 15 mg/ml, respectively) and

decapitated. Brains were quickly extracted into ice cold cutting solution (in mM):
3 KCl, 1.25 NaH2PO4, 6 MgSO4, 26 NaHCO3, 0.2 CaCl2, 10 glucose, 220
sucrose, equilibrated with 95% O2/5% CO2), hemisected, and then 350 µm
coronal corticohippocampal slices were prepared by using a vibratome. Slices
were allowed to recover in artificial cerebrospinal fluid (ACSF, containing (in
mM): 126 NaCl, 3 KCl, 1.25 NaH2PO4, 1 MgSO4, 26 NaHCO3, 2 CaCl2, and 10
glucose, equilibrated with 95% O2/5% CO2) at 35ºC for 1 hour and then
maintained in ACSF at room temperature until transfer to the recording chamber.

41

2.3.3 Generation of SD
Slices were maintained in a submerged chamber superfused with ACSF at
2 ml/min at 31-33ºC.

SD was generated in the hippocampal CA1 stratum

radiatum subfield by local pressure ejection of 1 M KCl via micropipettes (1-5 µm
tip diameter, 10-40 ms, 40psi) using a picospritzer (Parker Hannifin, OH). The
ejection volume was estimated at ~10 nl, based on CCD imaging and diameter
measurements of ejected drops onto a glass coverslip. Such measurements
could be reliably made from drops generated by 10 ejection pulses and
comparison with a 1 µl standard. Electrophysiological recordings of SD were
made from single CA1 pyramidal neurons and/or stratum radiatum for
extracellular potentials, at locations >200 µm from the KCl ejection site.
Recording at this distance avoided contamination from the KCl micro-injection,
and ensured that recordings were of SD-associated events occurring >3 seconds
after propagation from the application site. In some experiments (Figure 3) the
effects of SD were assessed on responses evoked by stimulating Schaffer
collateral inputs (0.1-0.4 mA, 70 µs) with a concentric bipolar electrode placed in
stratum radiatum.

Test stimuli that generated 30% of maximal amplitude

responses were selected from input output curves.

2.3.4 General recordings
Extracellular recordings were made from CA1 stratum radiatum, using
glass microelectrodes filled with ACSF (0.5-1.0 MΩ) slowly advanced 50 µm
below the slice surface.

Extracellular DC potential was acquired at 2-10 kHz
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using a Multiclamp 700A amplifier, digitized (Digidata 1332) and analyzed using
pClamp 9.2 software (Molecular Devices, Foster City, CA).
Single-cell loading of fluorescent indicators and electrophysiological
recordings were made using whole-cell clamp techniques and a Multiclamp 700A
amplifier with CV-7B headstage (Molecular Devices, Foster City, CA). Single
CA1 pyramidal neurons were visually identified and whole-cell access was
established with low resistance patch pipettes (1-2 MΩ) filled with a potassium
gluconate-based internal solution containing (in mM): 135 potassium gluconate, 8
NaCl, 1 MgCl2, 2 Na2ATP, 0.3 NaGTP, 10 Hepes, 0.05 EGTA, pH 7.2 adjusted
with KOH.

Fluorescence indicators or blockers were supplemented to this

standard solution depending on the specific experiments, as described in
appropriate Methods and Results sections below. The quality of recordings was
assessed by using the membrane test command of Clampex (Molecular Devices,
Foster City, CA). Recorded CA1 pyramidal neurons had characteristic low input
resistances (120.9 ± 6.6 MΩ), high capacitances (190.8 ± 8.3 pF) and I h currents
in response to hyperpolarizing voltage-steps (n=30).

2.3.5 Fluorescence imaging
Intracellular Ca2+ measurements were made from single CA1 pyramidal
neurons as described previously with minor modifications (Vander Jagt et al.,
2008). Indicator loading was via whole-cell pipettes filled with standard internal
solution supplemented with low affinity Ca2+ indicator, Fura-6F (0.5 mM, Life
technologies, Grand Island, NY). Dialysis duration was strictly limited to either 3

43

or 5 min depending on the experiments (see Results), and electrodes were then
carefully removed. The combination of high pipette indicator concentration and
brief dialysis time typically resulted in a final intracellular indicator concentration
of ~100 µM, as determined by comparison with neurons extensively dialyzed with
test indicator concentrations. Because of its low affinity, the temporal and spatial
dynamics of intracellular Ca2+ were unlikely perturbed by Fura-6F at this final
intracellular concentration (Neher, 1995). Following indicator loading, neurons
were allowed to recover for 10 min.

During SD, Fura-6F fluorescence was

monitored at its isobestic wavelength (360 nm), and focus was adjusted to
maintain a segment of proximal apical dendrite in the focal plane.

Fura-6F

fluorescence also excited at 350, 380 nm for Ca 2+ measurements, with the three
excitation wavelengths each being delivered at 1 Hz from a monochromator
(Polychrome V, Till Photonics GmbH, NY). Emission signals passed through a
dichroic mirror (400 nm LP), band pass emission filter (510/35 nm) and were
collected with a CCD camera (Till Imago), controlled by Till Vision software
(Version 4.00). Intracellular Ca2+ dynamics were evaluated after generation of
background-subtracted ratio images (350 nm/380 nm) and Ca2+ concentrations
estimated by comparison with in vitro calibration standards (Life Technologies,
Grand Island, NY) and calculation using the equations described in (Grynkiewicz
et al., 1985). Pseudo-color images of estimated intracellular Ca2+ were prepared
by applying a mask generated from filtered 380 or 350 nm fluorescence images
to the raw pseudocolored ratio image. The kinetics of intracellular Ca 2+ dynamics
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were obtained from regions of interest set within the soma and proximal apical
dendrite (50-100 µm from soma).
In some experiments, neuronal morphology after SD was assessed in
neurons loaded with Lucifer yellow (Life Technologies, NY). Internal solution was
supplemented with 0.2% Lucifer yellow, and fluorescence was excited at 410 nm
excitation and long-pass filtered emission signals (>420 nm) collected by CCD
camera at 0.67 Hz. Loss of indicator was estimated by the relative change in
fluorescence intensity from region within cell bodies.

2.3.6 Whole-cell electrophysiological recordings
Voltage-clamp recordings were made at -50 mV after liquid junction
potential correction. The sodium channel blocker QX314 (5 mM) was included in
the internal solution for all voltage-clamp recordings. A holding voltage of -50 mV
(after 10 mV liquid junction potential correction) was chosen in order to enable
simultaneous detection of spontaneous EPSCs and SD currents. Spontaneous
EPSCs were detected with Mini analysis software (version 6.0.3, Synaptosoft
Inc., NJ), using a high threshold (10 pA) in order to minimize detection of false
positives. We excluded EPSCs detected during the initial 20 seconds following
the onset of large SD currents, because input resistance and capacitance
currents decreased to less than 10% of baseline levels, preventing reliable
monitoring of recording quality. Except for this period, series resistance was
maintained (<20% variance) in successful recordings (see Figure 3C).
Recordings with >20% changes in series resistance or apparent voltage error
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during SD (as determined by readout of holding voltage and distortion of SD
current waveform) were excluded from analysis.
All current-clamp recordings were made without any holding current
applied (voltage-follower mode). In some recordings, test current pulses (-200
pA, 500 ms) were manually injected to monitor recovery of input resistance
following SD. Current-clamp recordings with >20% changes in bridge balance or
input resistance following recovery from SD were discarded.
Successful whole-cell recordings of SD required electrodes with relatively
large tip diameters (>3 µm) and initial series resistances less than 20 MΩ as
determined by the membrane test in Clampex (Molecular Devices, CA). SD
involves tissue swelling, and therefore continuous fine adjustment of electrode
position was needed throughout the whole-cell recordings.

On the criteria

described above, we obtained an overall success rate ~50% for these whole-cell
studies.
Extracellular potential changes during SD in our submerged slices (5-10
mV) were substantially smaller compared with previous reports from recordings
from interface chambers, and were highly sensitive to the depth of electrodes.
Thus we did not apply any voltage correction to our recordings (whole-cell
current and membrane potential) and acknowledge that cellular responses may
be under-estimated (Somjen, 2001). In addition, some voltage error also occurs
during the large SD current (Hamann et al., 2002), and complicates absolute
measurements of whole-cell currents.

However, interpretation of the present
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data does not rely on absolute current and voltage changes, and series
resistance and cellular capacitance measurements were similar between
neurons throughout the study. For these reasons we did not apply any arithmetic
corrections of data, and possible confounds are discussed in the appropriate
results section.

2.3.7 Drugs
All chemicals were obtained from Sigma-Aldrich (St Louis, MO) unless
otherwise noted. DL-AP5 was prepared as a 10 mM stock in water and stored at
-20oC and used within 1 week of preparation.

2.3.8 Data analysis
Unless otherwise described, statistical analyses were made with MannWhitney U-tests for two-group comparisons and Kruskal-Wallis tests with posthoc Dunn’s multiple comparison test for additional group comparisons using
GraphPad Prism version 4.03 (GraphPad Software, La Jolla, CA) software.
Individual data points are shown as dots together with bar graph presenting
mean ± SEM. In experiments with repetitive measurement, corresponding data
points are connected with a dash line. A p-value <0.05 was considered
statistically significant.
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2.4 RESULTS

2.4.1 NMDAR activation contributes to prolonged dendritic Ca2+ elevations
following SD
Figure 1 shows intracellular Ca2+ dynamics in CA1 pyramidal neurons
during and after SD. Single neurons were loaded with a low affinity ratiometric
Ca2+ indicator (Fura-6F, KD~5 µM) via patch pipettes (final concentration
approximately 100 µM following the brief loading period, see Methods).
Following SD, large rises in intracellular Ca2+ concentration occurred initially in
distal dendrites and then propagated toward the soma (Figures 1A-C).
Intracellular Ca2+ concentration returned first to baseline levels in soma, but Ca2+
remained at levels estimated above 10 µM in dendrites for significantly longer
periods of time (~2 min), before recovering to baseline levels (Figures 1A&B
show a representative example, and Figure 1C shows mean data from 8
neurons).
The sustained dendritic Ca2+ elevations were highly sensitive to the
competitive NMDA receptor antagonist DL-AP5. Figures 1D-F show effects of
bath application of a low concentration of DL-AP5 (20 µM). This concentration
was chosen as it did not prevent the initiation and propagation of SD under these
conditions (Aiba et al., 2012; see also Figure 4). With bath application of DLAP5, initial Ca2+ concentration increases at the soma were indistinguishable from
those observed in control experiments (peak Ca2+ concentration, Control: 11.5 ±
0.8 µM (n=8), DL-AP5: 12.5 ± 1.0 µM (n=7), p>0.1, Figures 1C vs. 1F), however
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the duration of dendritic Ca2+ elevations were markedly shortened such that
dendritic recovery was almost coincident with recovery in soma in the presence
of DL-AP5 (Figures 1E&F).

2.4.2 Increased glutamate release during the repolarization phase of SD
To investigate mechanism(s) underlying NMDAR-dependent dendritic
Ca2+ loading, we first characterized excitatory synaptic inputs during the course
of SD (Figure 2).

The baseline frequency of spontaneous excitatory

postsynaptic currents (sEPSCs) was low (0.9 ± 0.16 Hz, n=9, Figure 2Aa), and
application of the SD stimulus resulted in an immediate increase in the frequency
of sEPSCs that persisted until the arrival of SD at the recording electrode (20.4 ±
3.5 Hz, mean duration of prodromal period: 4.6 ± 0.9 s, n=9, Figure 2Ab). The
arrival of SD was then detected as a large monophasic inward whole-cell current
~3 seconds after stimulus application, with an accompanying initial rapid
extracellular potential change. Input resistance decreased to ~10% of baseline
levels during the large inward current, preventing reliable measurements of
sEPSCs during the early phase of SD.
sEPSCs reappeared during the decay of the SD current (Figure 2Ac) and
Figure 2B emphasizes that the mean sEPSC frequency during the recovery from
the large SD current was invariably greatly increased, before declining back to
baseline levels. Figures 1B, C show quantitative analyses of sEPSC frequency
and amplitude during the late SD phase. The increased sEPSC frequency was
not due to the fact that sEPSC amplitudes were increased and allowed
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previously sub-threshold events to be detected. In fact, the amplitudes of sEPSC
were significantly decreased compared to baseline during the late SD phase
(baseline: 32.0 ± 3.6 pA, late-SD phase: 22.8 ± 2.8 pA, n=9, p<0.001),
suggesting that the increased apparent EPSC frequency is largely attributable to
increased presynaptic release.
In addition to increased sEPSC frequencies, we occasionally observed
large (>1 nA) inward sEPSCs during the late SD phase (data not shown). These
events may be related to burst discharges reported following SD (see
Discussion), however these events were not reproducibly detected in the current
study and were excluded from analysis.
Action potential dependent release made a contribution to increased
sEPSC frequencies. In a separate set of experiments, block of voltage-gated
sodium channels with tetrodotoxin (TTX, 1 µM) prevented sEPSC frequency
increases during the prodromal excitation phase (n=12) and significantly reduced
the frequency of events recorded immediately following the large SD current
(Figure 2B), with less effect on subsequent recovery to baseline. Activation of
presynaptic NMDARs has been shown to increase release probability (Larsen et
al., 2011; McGuinness et al., 2011), however addition of DL-AP5 (20 µM)
together with TTX did not significantly affect sEPSC frequency in the present
study (Figure 2B). TTX and DL-AP5 also had no significant effect on sEPSC
amplitudes (Figure 2C, p=0.09). Thus, glutamate release during the late SD
phase appeared to be mediated by both action potential-dependent and independent release mechanisms.

The effect of DL-AP5 alone on sEPSC
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frequency was also analyzed in a different set of experiments (used also to
generate Figures 4F&G, below) and was without effect (n=6, p>0.1). The lack of
effect of DL-AP5 on sEPSC frequency also suggests that activation of
postsynaptic NMDAR, rather than presynaptic NMDAR are responsible for
prolonged dendritic Ca2+ loading after SD.

2.4.3 Increased evoked release during the late-SD phase
Increased release probability following SD was confirmed from changes in
paired pulse ratio (PPR) of evoked EPSCs (Figure 3).

EPSCs could not be

evoked during the SD inward current, but reappeared with greatly decreased
PPR only after full recovery of the current (Figures 3A&B). During this period,
membrane responses to test pulses had recovered to control levels, but the rise
times and decay time constants of evoked EPSCs were significantly increased
(Figure 3C, time to peak: 388.4 ± 33.5%, decay tau: 204.7 ± 20.0% of baseline,
n=8). Traces in the late SD period were heavily contaminated with sEPSCs as
discussed above (Figure 3C).

Bath application of DL-AP5 (20 µM) partially

normalized the slow decay time constants of EPSCs during this period (151.7 ±
38.2%, n=8, p<0.05 vs. control), implying a role for NMDAR activation. Similar to
lack of effects on sEPSC frequency, DL-AP5 did not affect changes in PPR
associated with SD (Figure 3B). Taken together with results of Figure 2, these
results suggest that both action potential-dependent and -independent release
mechanisms can be enhanced during the late SD phase.
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Following the period of excitation, a prominent suppression of evoked
activity occurred after SD (mean duration 5.14 ± 0.71 min, measured using 70%
recovery as a threshold, n=8).

This secondary suppression is likely due to

activation of adenosine A1 receptors (Lindquist and Shuttleworth, 2011). The
present report concentrates only on consequences of increased NMDAR
activation that occur earlier, immediately following the onset of SD.

2.4.4 NMDAR activation contributes to the duration of SD depolarizations
The relationship between single cell membrane potential changes and
extracellular DC potential shifts is shown in Figure 4A.

Similar to previous

recordings with sharp electrodes (Canals et al., 2005), whole-cell recordings of
KCl-induced SD in CA1 pyramidal neurons showed complete depolarization and
full recovery took ~1 min. The secondary phase of extracellular DC signals (i.e.
the second maximum of the inverted saddle-like waveform) coincided with the
slow single-neuron repolarization.

Because no correction for extracellular

voltage shifts was applied to single cell recordings, neuronal depolarizations are
likely underestimated (see Methods).

Thus during the late SD phase,

depolarization is expected to be sufficient to relieve Mg2+ block of NMDARs and,
when coupled with increased glutamate release described above, should result in
substantial NMDAR activation. This was confirmed in studies showing that bath
application of DL-AP5 significantly decreased the duration of neuronal
depolarization (Figures 4B&C), without affecting peak depolarization (peak
amplitudes: 0.79 ± 5.7 mV vs. -2.06 ± 6.6 mV, control and DL-AP5, respectively
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p>0.5, n=7). Full washout of DL-AP5 effects was confirmed in two experiments
where whole-cell recordings were maintained through three consecutive SDs.
Furthermore, the duration of the secondary phase of extracellular DC shifts was
also reversibly decreased by DL-AP5 application (Figures 4D&E). Finally, the
duration of the large inward current during SD was also significantly reduced by
DL-AP5 (Figures 4F&G).

These experiments imply that NMDAR activation

during the late SD phase is an important contributor to the long lasting neuronal
depolarization.

2.4.5 Delayed antagonist applications confirmed a contribution of NMDAR
activation during the late-SD phase
The results above suggested that increased release and consequent
activation of NMDARs following the onset of SD could contribute to prolonged
ionic deregulation. This possibility was first examined by testing the effects of
localized application of DL-AP5 selectively in the period immediately following the
onset of SD onset, when recording extracellular DC shifts (Figure 5A-C). The
antagonist was delivered with pressure pulses from glass micropipettes (5-10 µm
diameter) placed close (<20 µm) to the recording electrode.

High pipette

concentrations of NMDAR antagonists were used (500 µM DL-AP5 or 200 µM
MK801) to obtain rapid onset and localized block, and in the first set of
experiments the pulse application was initiated immediately following onset of the
initial potential shift (Figure 5A&B). In each experiment, a single SD (SD1) was
first generated in the presence of the delivery electrode, but without drug
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ejection, and this was followed by a second SD (SD2) in which the antagonist
was delivered with pressure pulses (20 ms, 10-15 repetitions at 1.5 Hz).
Selective application of DL-AP5 immediately following SD significantly decreased
the duration of extracellular potential changes and similar results were obtained
with MK801 (200 µM, duration SD2/SD1: 0.745 ± 0.004, p<0.05 vs. vehicle, n=5).
Pressure pulses of vehicle solution (ACSF with 0.1% DMSO) showed no
significant effect (Figure 5A&C), indicating that any mechanical stress induced by
the pressure pulses did not contribute to these effects. These results imply that
NMDAR activation during the late-SD phase is a significant contributor to the
secondary extracellular potential change.
We next tested the possibility that prolonged Ca2+ elevations described in
Figure 1 could be a consequence of NMDAR activation following SD, using the
same localized DL-AP5 applications described above. This possibility was tested
by localized pressure application of DL-AP5 only during the period of dendritic
Ca2+ overload immediately following the onset of SD. As shown in Figure 5D-F,
sustained dendritic Ca2+ elevations were completely prevented by this approach.
No effect was observed in control studies with ACSF-filled ejection electrodes
(n=3). These data suggest that NMDAR activation during the late-SD phase
could underlie sustained dendritic Ca2+ loading.
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2.4.6 NMDAR inhibition during the late-SD phase is protective against SD in
energy- depleted neurons
We have previously reported that sustained dendritic Ca2+ elevations can
be a key contributor to excitotoxic injury of neurons in slice (Shuttleworth and
Connor, 2001), and in a model of NMDAR overactivation this can be due to
energy depletion in these vulnerable compartments (Vander Jagt et al., 2008).
We tested here whether the late-SD NMDAR activation could cause neuronal
injury by a similar mechanism.

We tested this hypothesis by increasing the

vulnerability to SD-induced injury in single cells without changing the population
response (and thereby the initiation or propagation of SD). This was done by
dialyzing single neurons with an internal solution containing an inhibitor of
mitochondrial respiration (NaN3, sodium azide, in dialysis pipette) and reduced
ATP.

The composition of the pipette solution and dialysis duration was

determined from a series of pilot experiments modifying both ATP and sodium
azide concentrations during brief (3-5 min) application, to obtain conditions that
induced metabolic stress, but did not alone cause acute injury. Dialysis (5 min)
with internal solution containing 1 mM sodium azide and lacking any added ATP
resulted in a significantly decreased input resistance (% change; -40.4 ± 5.0% vs.
+1.1 ± 5.2%, azide vs. control, n=5, p<0.01), likely due to the activation of ATP
sensitive potassium currents (Sun et al., 2006). It is noted that equilibration of
the pipette content and the cytosol would be incomplete with these short dialysis
periods. No progressive depolarization or action potential bursts were observed
with this dialysis and in addition, basal Ca2+ concentrations were maintained at
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physiological levels until SD challenge (estimated Ca 2+ concentration in soma:
0.170 ± 0.041 µM, n=10).
Dialysis with the metabolic inhibitor greatly impaired recoverability from
Ca2+ elevations after SD (Figure 6). Thus in control experiments, dendritic Ca2+
concentrations were sustained at high levels following initial Ca2+ increases
(Figure 6A&B), with no signs of recovery throughout the duration of recordings.
Ca2+ levels in the soma showed some transient recovery after SD, but invariably
increased again to very prolonged Ca2+ elevations above 10 µM (Figure 6A&B).
Under these conditions, 4 out of 5 neurons showed no recovery of soma or
dendrite Ca2+ levels within 10 min (Figure 6E). It is emphasized here that such
prolonged Ca2+ deregulation was never observed in the neurons dialyzed with a
control internal solution (see Figure 1A-C above). Delayed application of DL-AP5
was very effective at preventing loss of Ca2+ homeostasis in these metabolically
compromised neurons (Figure 6C-E).

Thus in neurons dialyzed with the

metabolic inhibitor, late DL-AP5 exposure resulted in prompt and complete
recovery of Ca2+ levels in both soma and dendrites (n=5). When the same
neurons were then challenged with another SD following DL-AP5 washout (>15
min), all cells generated sustained Ca2+ overloading similar to the pressure
controls (n=5).
Ca2+ deregulation following SD was associated with significant loss of the
Ca2+ indicator, (Fura-6F), and this was suggestive of acute injury as discussed
previously (Vander Jagt et al., 2008). However reliable analyses of membrane
permeability were difficult because of poor signal-noise ratio with the low Fura-6F
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concentrations used here, and background autofluorescence changes during SD.
Therefore a parallel set of studies was conducted with neurons loaded with the
membrane impermeable fluorescent indicator Lucifer Yellow (0.2% in NaN 3
containing internal solution, hereafter termed LY). Indictor leak was assessed
from fluorescence intensity in soma, and showed that profound loss of
intracellular LY always occurred after SD in metabolically-compromised neurons
(Figure 7A&C).

This fluorescence loss was attributable to acute increase in

membrane permeability, caused by NMDAR activation during the late-SD phase,
rather than photobleaching or other detection artifact. Thus indicator levels were
well-maintained by delayed NMDAR block after SD (localized pressure
application of DL-AP5, as described above, Figure 7B&C) and profound indicator
loss was then observed in the same neurons after DL-AP5 washout and
subsequent challenge with a second SD (Figure 7C). These results suggest that
the NMDAR activation that occurs specifically in the late phase of SD contributed
to the development of Ca2+ overload and decreased membrane integrity in
metabolically-compromised neurons.

2.4.7 NMDAR activation contributes to extended depolarization of SD in energydepleted preparations
We first examined the effect of partial metabolic inhibition on the duration
of extracellular DC shifts and sensitivity to delayed NMDAR block.

In each

experiment, a pair of SDs was generated and slices were exposed to sodium
azide prior to the second SD. The effects of delayed DL-AP5 application (or
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saline control) were tested on the second SD, using the localized pressure
application method described above (Figure 5). A series of pilot experiments
was conducted and determined that exposure to 1 mM sodium azide for 5 min
prior to SD (and maintained throughout the experiment) was the maximum that
could be tolerated without disrupting the initiation of SD. Under these conditions,
the duration of extracellular potential shift was increased by sodium azide preexposure in all preparations tested with the saline control pulse (n=5, 32.6 ±
3.6% increase from control, p<0.005, paired t-test, Figure 8A&B). In contrast,
delayed DL-AP5 pressure application prevented the prolongation of DC duration
in sodium azide. The smaller effect of NaN3 on the duration of extracellular
potential (compared with Ca2+ deregulation in Figure 6) may be due in part to
less severe metabolic inhibition compared with direct intracellular dialysis of
azide without added ATP.
We next examined the effects of metabolic compromise and NMDAR
activation on the duration of single neuron depolarizations. We used a similar
intracellular dialysis approach as described above (Figures 6&7) but with lower
sodium azide concentrations so that whole-cell configuration could be maintained
during dialysis and subsequent SD challenge (total ~30min recording).

The

composition of the pipette solution was determined from a series of pilot
experiments modifying sodium azide concentrations (20 µM-1 mM) in ATP-free
internal solution.

From these studies, 300 µM was the maximal sodium azide

concentration that could be used. Under these conditions, the durations of single
cell depolarizations were significantly increased (Figures 8C&D).
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Delayed

applications of high DL-AP5 concentrations could not be tested in these
experiments, because of sensitivity to movement caused by pressure pulses.
However bath application of a moderate concentration of DL-AP5 (20 µM, 10
min, which was not sufficient to prevent SD; see above) significantly reduced the
prolongation of depolarization in energy-depleted neurons (Figures 8C&D).
Together, these data are consistent with a role for NMDAR activation in
prolonged depolarization and extracellular DC shifts in the context of metabolic
compromise.
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2.5 DISCUSSION

2.5.1 General
The present study characterized an excitatory event during the recovery
phase of SD that could contribute to neuronal injury. Our recordings of sEPSC
frequency and PPR suggest that presynaptic glutamate release is enhanced
during the late-SD phase, while neurons are still repolarizing.

Both action

potential-dependent and -independent mechanisms can contribute to enhanced
release, and NMDAR activation during late-SD phase contributed to extended
neuronal depolarization.

This excitatory event during the late-SD phase

contributed to prolonged intracellular Ca2+ elevations in neuronal dendrites and
(when combined with metabolic compromise) was sufficient to lead to neuronal
injury. These findings identify a link between SD and excitotoxic signaling at the
cellular level, and could suggest novel approaches to prevent conversion of SD
to a damaging event in metabolically compromised tissue.

2.5.2 Characterization of a late excitatory phase of SD
Spontaneous EPSC frequency was initially elevated during the brief
prodromal excitation phase.

During the large inward current of SD, a large

reduction in membrane resistance hindered EPSC detection, but enhanced
EPSCs were detected as soon as membrane resistance recovered (Figure 2A).
Thus although not directly tested, these data leave open the possibility that
presynaptic release probability was continuously elevated throughout the SD
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event. Significant NMDAR-dependent cation loading should be dependent on
both release probability and the level of postsynaptic depolarization, and a
substantial contribution would be expected during the late SD phase when
neurons remain partly depolarized and with significant gradients for ion influx.
The recorded increases in EPSC frequency likely reflect increased
presynaptic release, rather than increased sensitivity of event detection due to
changes in either input resistance or extracellular glutamate accumulation. Thus
in addition to increased EPSC frequencies observed after complete recovery of
membrane resistance (see Figure 3C) significant decreases in PPR (consistent
with increased initial presynaptic release probability) were also demonstrated
throughout the late-SD phase. It is noted that that evoked synaptic transmission
(requiring TTX-sensitive channels) was beginning to recover at an early time
point (~35s in the example shown in 3A), when postsynaptic repolarizations was
likely incomplete (see Figure 3&4, see also Canal et al., 2005). This early
presynaptic recovery likely underlies the TTX-sensitivity of sEPSCs seen in
Figure 2B.

The mechanism(s) underlying increased release probability will be

important to identify, and could include a combination of factors including
presynaptic Ca2+ elevations and saturation of presynaptic Ca2+ buffers, as well as
changes in extracellular osmolarity and potassium concentrations (Sara et al.,
2002; Somjen, 2002; Blatow et al., 2003).
There have been several prior voltage-clamp recordings of SD, but none
appear to report an increase in release during the late SD phase (Czeh et al.,
1993; Zhou et al., 2010a). It is possible that different experimental methods
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(including age of animals, and the use of local microinjection of KCl rather than
bath applications to generate SD) might have made it easier to detect excitation
during the late-SD phase in the present study. In addition, the lower recording
temperatures required for these whole-cell recordings (31-33oC) may have made
SD less intense, and thus facilitated recording of the late excitatory phase.
Spiking activity in the late-SD period has been observed in previous
recordings using either extracellular or intracellular sharp microelectrode
recordings from brain slices (e.g. Pomper et al., 2006), and also in vivo. Indeed,
in his initial description of spreading depression of cortical activity, Leao (1944)
noted a “burst of spikes following a slow negative wave” and a burst of high
frequency electrical activity was also illustrated during the decay of extracellular
potential in an study of cortical spreading depression in rodents (Takano et al.,
2007). Bursting activity during the late-SD phase was also reported in a recent
clinical study, detected as epileptic discharges occurring on the slow extracellular
potential shift (Dreier et al., 2011). Residual postsynaptic depolarization alone
could facilitate conversion of subthreshold postsynaptic potentials into spikes in
the late-SD phase, however coincident increases in presynaptic release
probability could be a significant contributor in these other studies.

2.5.3 Prolonged NMDAR receptor activation during the late- SD phase
NMDAR activation is well-established to contribute to the initiation and/or
spread of SD (see Introduction), however, it has not previously been clarified
whether ongoing NMDAR activation can also contribute significantly to
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consequences of SD. This was investigated in the present study by using two
approaches; 1) bath applications of a low concentration of NMDAR antagonist,
that itself had no effect on SD initiation and propagation (see Aiba et al., 2012),
and 2) focal delivery of NMDA antagonists, applied by pressure pulses only after
the passage of SD past the recording site. These present studies revealed a
brief (~2 min), but important, period of NMDAR activation during the late-SD
phase.
A persistent phase of NMDAR activation was also demonstrated during
anoxic depolarizations generated by simulated ischemia in hippocampal slices,
although in that case reverse transport of glutamate under anoxic conditions
appeared to be a major contributor (Rossi et al., 2000), rather than the increased
synaptic glutamate release observed here with normoxic SD.
Recent work has shown that extended duration of DC shifts correlates
with poor outcomes of brain trauma patients (Hartings et al., 2011b). The present
studies raise the possibility that NMDAR activation during the late SD phase
could contribute to these long events, based on the sensitivity to delayed
antagonist application of secondary extracellular potential shifts Interestingly, in
the clinical recordings, it was noted that long duration events were often
accompanied by saddle-like waveforms, (Hartings et al., 2011b).

The present

results are consistent with the idea that activation of NMDARs during the late-SD
phase could underlie saddle-like waveforms (see also Introduction).

The

simultaneous measurements of extracellular potential shifts and membrane
potential (see Figure 4A) suggest that the secondary phase of slow potential
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changes occurs during the repolarization phase of neuronal membrane
potentials.

Due to its nonselective-cationic nature and voltage-dependent

magnesium block (Spruston et al., 1995), charge transfer through NMDARs is
expected to be minimal during complete depolarizations immediately following
the arrival of SD, and then increase as neurons begin to repolarize (see Figure
4A).
Extracellular potential shifts of SD are larger and are also more sensitive
to NMDAR antagonists when recorded in hippocampal dendritic fields, when
compared with recordings from the cell body layer (Herreras and Somjen,
1993a).

Thus NMDAR contributions to DC recordings in neocortex may be

complicated by the complexity of signal sources. Further studies are therefore
needed to address the association of injurious NMDAR activation with
extracellular potential durations and waveforms in clinical recordings.

2.5.4 Cellular Mechanisms of Injury
Large intracellular Ca2+ elevations during SD have been inferred from
extracellular measurements of Ca2+ decreases following SD (Somjen, 2001), and
are confirmed by more recent intracellular measurements (Kunkler and Kraig,
2004; Dietz et al., 2008; Gniel and Martin, 2010). Using the low affinity indicator
Fura-6F, it was shown that under normoxic conditions, recovery of intracellular
Ca2+ elevations in CA1 neurons took substantially longer in dendritic
compartments than in somata (Dietz et al., 2008). In the present work, it is
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shown that these sustained Ca2+ elevations are due to persistent NMDAR
activation in the late SD period.
Excessive cytosolic Ca2+ elevations are well established to lead to some
forms of neuronal death, and small dendritic compartments may be important
injury initiation sites (Connor et al., 1988, Shuttleworth & Connor 2001). Brief
intensive glutamate receptor activation has been shown to trigger dendritic Ca 2+
deregulation that propagates from dendrites, even in the absence of continued
agonist stimulation (Wadman and Connor, 1992; Shuttleworth and Connor,
2001). A dendritic initiation site for excitotoxic injury was also observed with
continuous NMDA exposures (Vander Jagt et al., 2008) and in that case
propagation of dendritic Ca2+ overload was due to depletion of metabolic
reserves and reversed by delayed NMDA receptor block (Vander Jagt et al.,
2008).

In other studies with glutamate microstimulation, a transition was

observed between rapid recovery of dendritic Ca2+ elevations with single stimuli,
and very prolonged or irrecoverable increases following repetitive stimulation
(Connor and Cormier, 2000).

SD shares some similarities with these prior

excitotoxicity studies, as there was substantial glutamate release during the late
SD period, resulting in NMDAR activation and sustained dendritic Ca2+
elevations. These sustained dendritic Ca2+ elevations peaked ~1 min following
the onset of SD (Figure 1A-C), during the period of neuronal repolarization.
When metabolic capacity was selectively reduced in a single cell (while
permitting normal SD propagation), dendritic Ca2+ and somatic Ca2+ levels
remained very high following SD, and neurons showed signs of acute neuronal
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injury (Figure 6&7). Severe increases in membrane permeability were verified by
loss of the fluorophore Lucifer yellow, and were almost completely prevented by
selective application of an NMDA receptor antagonist during the late-SD phase.
At least part of the effect is likely due to extended depolarization and additional
Ca2+ influx, since metabolic inhibition also prolonged depolarization in an NMDAdependent manner (Figure 8). However it is noteworthy that the durations of
Ca2+ elevations were more severely prolonged than were the neuronal and
extracellular depolarizations (compare Figures 6&8).

Part of the reason for this

mismatch could be a technical limitation, since it was not possible to achieve the
same level of metabolic inhibition in the experiments in Figure 8 (see Results).
However the duration of sustained Ca2+ elevations is also determined by Ca2+
extrusion rates.

Reduction of extrusion rates is expected in metabolically

compromised tissues, and this may contribute significantly to the duration of Ca 2+
deregulation and neuronal injury demonstrated in Figures 6&7. These results
suggest that consequences of NMDAR activation during the late-SD period could
be a significant contributor to conversion of normally irrecoverable SD to
irrecoverable injury observed in metabolically compromised tissue.

2.5.5 Conclusions
The present study provides a link between SD and cellular mechanisms of
excitotoxic neuronal injury.

Characterization of enhanced glutamate release

during a period of postsynaptic vulnerability suggests temporal NMDAR targeting
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and/or approaches other than NMDAR antagonists (e.g. targeting presynaptic
release) may be considered to limit deleterious effects of SD in the injured brain.

2.6 FIGURE LEGENDS:
Figure 2.1:

NMDAR activation contributes to prolonged dendritic Ca2+

loading after SD.
A-C: Intracellular Ca2+ dynamics during SD monitored in single neurons loaded
with Fura-6F in control conditions (n=8).

SD was generated by local

microinjection of KCl (>200 µm from recorded neurons) and Fura-6F ratios were
determined at 1 Hz. A: Raw image of Fura-6F fluorescence (380 nm excitation,
left panel, scale bar: 20 µm) and selected pseudocolored images representing
intracellular Ca2+ levels at times indicated in minutes.

Calculated Ca2+

concentrations from this neuron are shown in B (soma values in blue, dendrite
values determined from region indicated by arrows are in red).

C: Mean data

from 8 such control experiments. D-F: As described above, except that slices
were pre-exposed to 20 µM DL-AP5 for 10 min prior to SD (n=7 for panel F).
Note the rapid recovery of dendritic Ca2+ levels in AP5, despite the similar initial
Ca2+ loading in soma and dendritic compartments.

Figure 2.2: Increased spontaneous EPSP frequency following the initial
depolarization of SD.

A: Representative traces of simultaneous whole-cell

current (Im: voltage clamped at -50 mV) and extracellular DC potential recordings.
SD was generated by local microinjection of KCl (>200 µm from recording site,
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application time indicated by *) and was recorded from single pyramidal neuron
and corresponding dendritic field. The image shows locations of the whole-cell
patch pipette, extracellular DC recording electrode and KCl ejection pipette
(highlighted by dashed lines). Traces in a-c show recordings from baseline (a),
prodromal (b) and late-SD (c) phases of the whole-cell current at an expanded
time base to show increases in sEPSC frequency associated with SD.
Membrane responses to test pulses are marked by #. B: Plot showing mean
increases in sEPSC frequency associated with SD.

In control conditions

(diamonds, n=6), sEPSC frequency to >30 Hz, and slowly recovered over the
subsequent minute. Time was adjusted to the onset of SD (t=0, indicated by
arrow head) and mean sEPSC frequency is shown in 10 second bins. sEPSC
frequencies during the first 20 seconds after SD onset were excluded, because
the quality of voltage-clamp could not be verified during the initial phase of the
large SD current. Tetrodotoxin (TTX, open squares, n=12) significantly reduced
sEPSC frequency at time points indicated by asterisks (p<0.05 compared with
controls), but co-application of with DL-AP5 did not further affect sEPSC
frequency (triangles, n=6, p>0.20).

C. sEPSC mean amplitudes were not

significantly altered, when tested at the first time point shown after SD (asterisk in
Figure 2B).

Figure 2.3:

Increased release probability during the late-SD phase as

assessed from paired-pulse ratios (PPR). A: Representative trace of voltageclamp recording during SD. Whole-cell current was recorded at -50 mV with
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bipolar stimulation of Shaffer-collaterals. Paired stimulation (100 ms interpulse
interval) was delivered at 0.2 Hz, and evoked EPSCs appear as sharp vertical
lines and are expanded in the insets (a-c). Note the reversed PPR and slow
EPSC kinetics during the late-SD phase (b). B: Quantitative analysis of PPR
changes in control conditions (n=8) and in the presence of DL-AP5 (20 µM, 10
min, n=8). Data during the late-SD phase were collected from the initial 3-5
responses. DL-AP5 did not show any significant effects on PPR throughout the
recordings.

C:

Representative traces showing membrane responses to test

pulses (-10 mV, 200 ms) and the waveform of single evoked EPSCs during
baseline and in the late-SD phase. Note that the membrane response to the test
pulse shows almost full recovery.

On the other hand, kinetics of evoked EPSC

was significantly slowed in the late-SD phase (see Results).

Spontaneous

EPSCs occurring during the late-SD phase are indicated by arrow heads.

Figure 2.4:

NMDAR antagonism accelerated repolarization and current

decay of SD.

A: Simultaneous recording of membrane potential (Vm) and

extracellular DC potential changes associated with SD, demonstrating the
extended neuronal depolarization during the late SD phase. Test current pulses
(-200 pA, 500 ms, downward deflections in Vm) were applied periodically
throughout the recordings to monitor seal quality and assess input resistance
changes.

B: Example traces from a single neuron, showing membrane

depolarizations during a control SD and then during a second SD generated in
DL-AP5 (20 µM, 10 min exposure, 20 min interval between SDs).
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DL-AP5

significantly decreased the duration of depolarization and this effect was
completely reversed following DL-AP5 washout in recordings from this neuron.
C: Mean data from similar experiments where the effects of DL-AP5 were tested
in separate populations of control and AP5-treated preparations. Mean durations
of 10-90% repolarization are presented (data pooled to give total of 7 recordings
for each bar; 2 where repetitive SDs could be recorded from single neurons, and
5 from single SDs in each condition, *p<0.05). D: Example traces from a single
slice, showing extracellular DC potential changes during a control SD and then
during a second SD generated in DL-AP5 (20 µM, 10 min exposure, 20 min
interval between SDs).

E: Mean data from 5 such experiments and showing

reversibility after DL-AP5 washout. Duration was determined from the time to
70% recovery from the initial peak. * p<0.05.

F: DL-AP5 (20 µM, 10 min) also

decreased duration of large inward current during SD.

SD currents were

normalized to peak responses, and average waveforms from control (solid line,
n=6) and DL-AP5 (dashed line, n=6) are shown. Data pooled to give a total of 6
recordings for each trace; 3 where repetitive SDs could be recorded from single
neurons, and 3 from single SDs in each condition). G: Mean data showing the
time to 50% recovery from peak currents, in the population of neurons shown in
F. *p<0.05

Figure 2.5:

NMDAR activation during the late-SD period underlies

prolonged ionic loads. A-C: Delayed pressure application of DL-AP5 (after the
passage of SD) significantly decreased the duration of extracellular DC
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potentials.

A: Time control showing that the duration of DC shifts was

reproducible when repetitive SDs were generated in a single slice. Localized
pressure application of vehicle (0.1% DMSO, during time indicated by horizontal
bar) during the second SD (gray trace) did not cause any reduction on DC
response compared with the initial SD (black trace). B: In contrast, delayed DLAP5 application significantly decreased the duration of the DC shift (gray trace),
compared with the initial control response in the same slice (black trace).
Mean data from 5 such vehicle and AP5 studies (**p<0.01) D-F:

C:

Delayed

NMDAR block prevented prolonged dendritic Ca2+ loading after SD. D: Raw
image of Fura-6F fluorescence (380 nm excitation, left panel, scale bar: 20 µm)
and selected pseudocolored images representing intracellular Ca2+ levels at
times indicated in minutes. Calculated Ca2+ concentrations from this neuron are
shown in E (soma values in blue, dendrite values determined from region
indicated by arrows are in red).

F:

Mean data from 5 such experiments.

Horizontal bars indicate the duration of localized DL-AP5 applications.

Figure 2.6: Prolonged NMDAR activation contributes to neuronal injury in
metabolically compromised neurons. Energy metabolism of single neurons
was partially inhibited by brief dialysis with sodium azide-containing internal
solution and Ca2+ responses during SD were then evaluated. A: Raw image of
Fura-6F fluorescence (380 nm excitation, left panel, scale bar: 20 µm) and
selected pseudocolored images representing intracellular Ca2+ levels at times
indicated in minutes. Calculated Ca2+ concentrations from this neuron are shown
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in B (soma values in blue, dendrite values determined from region indicated by
arrows are in red). Note that even though there was an initial transient recovery
of somatic Ca2+ responses after the initial peak, sustained Ca2+ deregulation
rapidly developed throughout the neuron after SD.

C&D: Same as described

above for A&B, with the exception that DL-AP5 was applied locally to this
selectively vulnerable neuron after the passage of SD. Note the prompt recovery
of Ca2+ levels throughout the neuron. E: Population data from control (Gray
traces, n=5) and DL-AP5-treated preparations (red traces, n=5), showing
effectiveness of delayed DL-AP5 applications on neuronal Ca2+ overload,
measured in somatic compartments of sodium azide-loaded neurons.

Arrow

head indicates SD onset and the horizontal bar indicates the duration of vehicle
(ACSF) or DL-AP5 pressure pulse applications.
Figure 2.7: Prolonged NMDAR activation triggered significant membrane
compromise in metabolically stressed neurons. Single neurons were loaded
with 0.2% Lucifer yellow (LY) in sodium azide-containing internal solution, prior to
SD challenge. These neurons showed profound loss of intracellular LY following
SD (A), but such loss was almost completely prevented by delayed DL-AP5
application (B).
Figures 5&6.

Localized DL-AP5 applications were as described above in
A&B show representative fluorescence images from single

neurons. C shows mean indicator loss measured 10 min after SD. Responses
of 4 control neurons (white bar) are compared with 4 neurons which were
protected with delayed DL-AP5 pulses, and then subjected to a second SD after
DL-AP5 washout (gray bars, **p<0.01 vs. control).
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Figure 2.8: NMDAR activation contributes to extended depolarization of SD
in energy-depleted preparations A-B: Effects on extracellular DC potential
shifts. A: In each panel, a pair of SDs was generated in a single slice. The first
SD was without drug applications (black trace) and the second was in the
presence of sodium azide (1 mM, 5 min pre-exposure, gray trace) and also
included localized pressure application of either saline or DL-AP5 (indicated by
the horizontal bar). B: Summary data of DC durations (70% recovery) from 5 sets
of each experiment shown in A. ***p<0.005, paired t-test between control SD
and second SD with NaN3 and pressure applications. C-D: Effects on single cell
depolarizations. C: Representative traces under control conditions (top), in a
neuron dialyzed with sodium azide (middle; 300 µM, NaN 3 in intracellular solution
lacking ATP) and in an azide-loaded neuron with DL-AP5 bath application
(bottom; 20 µM, 10 min exposure). Responses in each panel are from different
preparations, recorded in consecutive experiments.

D: Mean durations of

neuronal depolarization (10-90% repolarization) from experiments shown in C.
The duration of neuronal depolarization was significantly extended by sodium
azide-dialysis (n=5) compared with control (n=4), and the effect was reversed by
DL-AP5 (n=4).

**p<0.01, *p<0.05, one way ANOVA with post hoc Turkey’s

multiple comparison test.
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3.1 ABSTRACT
Cortical spreading depression (CSD) is a consequence of a slowly-propagating
wave of neuronal and glial depolarization (spreading depolarization; SD).
Massive release of glutamate contributes to SD propagation, and it was recently
shown that Zn2+ is also released from synaptic vesicles during SD. The present
study examined consequences of extracellular Zn2+ accumulation on the
propagation of SD. SD mechanisms were studied first in murine brain slices,
using focal KCl applications as stimuli and making electrical and optical
recordings in hippocampal area CA1. Elevating extracellular Zn2+ concentrations
with exogenous ZnCl2 reduced SD propagation rates.

Selective chelation of

endogenous Zn2+ (using TPEN or CaEDTA) increased SD propagation rates, and
these effects appeared due to chelation of Zn 2+ derived from synaptic vesicles.
Thus in tissues where synaptic Zn2+ release was absent (knockout of vesicular
Zn2+ transporter ZnT-3), SD propagation rates were increased, and no additional
increase was observed following chelation of endogenous Zn 2+ in these tissues.
The role of synaptic Zn2+ was then examined on CSD in vivo. ZnT-3 KO animals
had higher susceptibility to CSD than wild-type controls as evidenced by
significantly higher propagation rates and frequencies. Candidate mechanisms
were explored in brain slices and suggested a potential role of Zn 2+ inhibition of
NMDA-Rs. These results suggest the extracellular accumulation of synapticallyreleased Zn2+ can serve as an intrinsic inhibitor to limits SD event. The inhibitory
action of extracellular Zn2+ on SD may counteract to some extent the neurotoxic
effects of intracellular Zn2+ accumulation in acute brain injury models.

83

3.2 INTRODUCTION
Cortical spreading depression (CSD) was discovered as a slowly
propagating suppression of electrocorticographic (ECoG) activity (Leao, 1944)
and subsequently characterized as a regenerative, severe depolarization of
neurons and glia (Somjen, 2001). CSD is thought to underlie aspects of migraine
and events very similar to CSD have recently been recorded with relatively high
frequencies in patients with ischemic stroke, subarachnoid hemorrhage,
traumatic brain injury and intracerebral hemorrhage (Dreier, 2011; Lauritzen et
al., 2011). Because suppression of ECoG activity may not be readily apparent
during propagation of these events in injured brain, the general term spreading
depolarization (SD) has been used to emphasize the important underlying
mechanism.

Recovery from SD places a substantial metabolic burden on

tissues, and it is very likely that failure of ionic homeostasis caused by repetitive
SD events contributes to infarct enlargement in injured brain. Thus prevention of
SD is considered a promising target for reducing the progression of acute brain
injuries (Dreier, 2011; Hartings et al., 2011a; Lauritzen et al., 2011).
The propagation of SD is associated with increased extracellular
glutamate concentrations (Fabricius et al., 1993) and activation of NMDA-type
glutamate receptors (NMDA-Rs) contributes to SD progression in many
experimental situations.

Thus NMDA-R antagonists inhibit SD and related

events both in vitro and in vivo (Gill et al., 1992; Anderson and Andrew, 2002;
Hartings et al., 2003; Faria and Mody, 2004; Peeters et al., 2007). The divalent
cation Zn2+ is enriched in synaptic vesicles at many glutamatergic synapses, due
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to the activity of a specific transporter termed ZnT-3 (Cole et al., 1999). A range
of studies have concluded that Zn2+ can be co-released with glutamate following
vesicle fusion at some synapses (Assaf and Chung, 1984; Howell et al., 1984;
Qian and Noebels, 2005), and can potentially modify synaptic function by altering
the activity of ion channels, receptors and transporters (Frederickson et al.,
2005).

NMDA-Rs are among the most well studied molecular targets for

extracellular Zn2+ actions. Structural studies have identified high and low affinity
Zn2+ binding sites in the amino-terminals of NR2A and NR2B subunits, and
interaction with Zn2+ causes suppression of channel activity in an allosteric
manner (Gielen et al., 2009). In addition to allosteric inhibition, lower sensitivity
(IC50>20μM) voltage-dependent inhibition by Zn2+ has also been described
(Paoletti et al., 1997).

Because Zn2+ and glutamate are expected to be co-

released at synapses where NMDA-R are present, Zn2+ could potentially serve to
limit excessive activation of NMDA-R in many forms of brain pathology (Paoletti
et al., 2009).

In addition to NMDA-Rs, Zn2+ has been shown to attenuate

inhibitory synaptic transmission mediated by ionotropic GABA receptors, with
substantially different sensitivities depending on subunit composition (Smart et
al., 2004). These interactions could potentially lead to complex effects of Zn 2+ on
SD.
We recently reported that intracellular accumulation of Zn2+ contributed to
initiation of some forms of SD in brain slices, including events generated by
ischemia-like conditions (Dietz et al., 2008). In addition, SD propagation was
shown to involve substantial release of vesicular Zn2+ into the extracellular
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space, in a wavelike manner that accompanied the SD wavefront (Carter et al.,
2011b). We found that Zn2+ from this source accumulated post-synaptically, and
speculated that this intracellular accumulation may contribute to further SD
initiation, or possibly injury.

However, in the current study we tested whether

extracellular Zn2+ accumulation during SD could also have a self-limiting effect on
SD propagation. The current results show that extracellular Zn2+ does serve to
limit SD propagation, and suggest dual roles for Zn 2+ in SD and injury
progression.

3.3 MATERIALS and METHODS

3.3.1 1. Animals
All experimental procedures using animals were reviewed and approved
by the Institutional Animal Care and Use Committee (IACUC) of the University of
New Mexico. For in vitro characterization of ZnCl2, inhibitor and chelator effects,
4-10week old mice (FVBN or C57Bl/6) animals of either sex were used, and drug
effects compared with control SD responses generated in the same slices.

For

in vitro studies of effects of ZnT-3 deletion, tissues from age-matched wild type
C57BL/6 animals and ZnT-3 KO animals were compared. The ZnT-3 KO mice
were originally generated as described previously (Cole et al., 1999), and were
backcrossed onto C57BL/6 for more than 13 generations. Experiments between
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genotypes were alternated.

For in vivo CSD studies, 11-16 week old male

animals were used, alternating between age-matched C57BL/6 and ZnT-3 KO.

3.3.2 Drugs
Unless otherwise stated, reagents were obtained from Sigma Aldrich (St
Louis. MO).

Histidine (200μM) was included in all solutions used for ZnCl2

studies (including for studies of control responses) in order to increase Zn 2+
solubility in the phosphate containing recording solutions (Rumschik et al., 2009).

3.3.3 Statistical analysis
All results are presented as mean ± SEM, and were analyzed by Student’s
t-tests or one-way ANOVA with appropriate post hoc t-tests, unless otherwise
mentioned. Throughout the study, events >2 standard deviations from the mean
were excluded as outliers.

3.3.4 In vitro SD recordings
Murine brain slices were prepared as previously described (Carter et al.,
2011b).

Briefly, mice were deeply anesthetized, decapitated and brains

extracted into ice cold cutting solution. 350μm coronal slices were prepared with
a vibratome and transferred to ACSF. Brain slices were allowed to recover at
35°C for one hour, and then maintained in ACSF at room temperature until
transferred to the recording chamber (RC27-L, Warner Instruments). Slices were
continuously superfused with artificial cerebrospinal fluid (ACSF, containing (in
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mM) 126 NaCl, 3 KCl, 1.25 NaH2PO4, 1 MgSO4, 26 NaHCO3, 2 CaCl2, and 10
glucose, equilibrated with 95% O2/5% CO2) at 32°C.
SD was generated in the hippocampal CA1 region by localized
microinjection of 1M KCl from a conventional patch micropipette (tip diameter 1020μm), by using a pressure ejection controller (Parker Picospritzer III, General
Valve Corp, 40psi). The stimulus threshold was determined by incrementally
increasing pulse duration (10-100ms), and all experiments were conducted using
pulse durations 50-100% longer than the threshold (typically 50-150ms). Drug
challenges were compared with control responses generated in the same slices.
As a control for osmotic effects of KCl microinjection, we confirmed that
local injection of equimolar NaCl (1M) did not mimic the responses to localized
KCl microinjections, when tested in the same slices. Thus NaCl pulses did not
generate propagating SD-like events, as determined from propagating light
transmission increases, or DC potential shifts at the recording site (n=3).
SD propagation through the CA1 region was detected electrically and
optically. DC potential shifts were recorded with extracellular electrodes (0.5-1
MΩ) placed in stratum radiatum, 50µm below the slice surface. Signals were
amplified with a MultiClamp 700A amplifier, and acquired using pClamp 9.2
software (Axon Instruments) Intrinsic optical signals were assessed from
transmitted light from a halogen source (>575nm) and collected by a CCD
camera (Till Imago, controlled by TillVision v4.0 software, Till Photonics). SD
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propagation rates were determined by tracking the wavefront of intrinsic optical
signals, following image acquisition at 0.33Hz (Fig. 1A).

3.3.5 Slice electrophysiology
Single cell recordings were obtained from hippocampal CA1 pyramidal
neurons. Neurons were visually identified and whole cell clamp was made with 12MΩ glass pipettes.

Intrinsic excitability and EPSCs were recorded with

potassium-gluconate based internal solution (10mM Hepes, 135mM potassiumgluconate, 8mM NaCl, 1mM MgCl2, 2mM ATP-Na2 and 0.3mM GTP-Na3) in
ACSF.

Intrinsic excitability was examined by voltage responses to ±200pA

current pulses with no holding current applied. Prolonged recording (>10min)
often resulted in rundown of action potential frequency and therefore intrinsic
excitability was measured 2-3min after establishment of whole-cell configuration
from neurons pre-exposed to ZnCl2 for at least 10min.
Field excitatory postsynaptic potentials (fEPSPs) were evoked by
stimulation of Schaffer collateral inputs using a concentric bipolar electrode and
detected using glass electrodes in the CA1 subfield. After input output curves
were determined, stimulation intensity was set at ~50% of maximal for
subsequent pharmacological analysis. For isolation of NMDA-R components of
fEPSP, slices were first incubated in low magnesium ACSF (50µM Mg2+
balanced with increased Ca2+ (3mM)) for 20min, and then 10µM DNQX and
10µM bicuculline were added.
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3.3.6 Intracellular and Extracellular Imaging of FluoZin-3 fluorescence
Intracellular Zn2+ was measured from single CA1 neurons loaded with
FluoZin-3 as described previously (Vander Jagt et al., 2009). Patch pipettes
contained 10mM Hepes, 135mM potassium-gluconate, 8mM NaCl, 1mM MgCl2,
2mM ATP-Na2 and 0.3mM GTP-Na3, 500µM FluoZin3.

Dialysis was strictly

limited to 3min, which limited final intracellular indicator concentration to levels
<100µM. Electrodes were then slowly removed and neurons allowed to recover
for 15min.

FluoZin3 fluorescence was excited at 495nm (80ms, 0.2Hz) and

band-pass filtered (535±25nm) emission fluorescence was collected with the
CCD system.

Neurons were exposed with either ZnPyr (1µM Zn 2+, 100nM

pyrithione) or ZnCl2 (100µM) for 10min and then were washed with ACSF.
FluoZin3 signals were background corrected using regions of interest from
adjacent non-loaded neurons, and expressed as ΔF/F0.
Extracellular Zn2+ accumulation was imaged as described previously
(Carter et al., 2011b). Slices were superfused with 1µM FluoZin3 containing
ACSF. In order to enhance signal to noise ratio, 1mM CaEDTA was included
(Qian and Noebels, 2005; Carter et al., 2011b).
monitored with the CCD system at 1Hz.

FluoZin-3 signals were

To correct for autofluorescence

changes, signals were background subtracted using recordings made in the
same slices, but without FluoZin3 addition.
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3.3.7 In vivo cortical spreading depression (CSD)
Mice were anesthetized with isofluorane (3% induction, 1-1.25%
maintenance) and nitrous oxide (70%) in oxygen (30%), and positioned in a
stereotaxic frame.

The depth of anesthesia was monitored throughout the

experiments and the isofluorane concentration was adjusted to maintain depth
sufficient to prevent reflex responses. The scalp was opened and anterior and
posterior burr holes were made approximately 1mm apart bilaterally in the
parietal bone, and the distance between them measured for calculation of CSD
propagation rates. Craniotomies anterior to the burr holes were made for either
electrical or KCl stimulation (see Fig. 4A). When windows were not used for
experiments, saline filled cotton pads were set on the brain surface.

In all

experiments, glass electrodes were placed through ipsilateral burr holes,
~300µm below the cortical surface, and electrical activity was amplified by using
an Axoprobe 1A amplifier (Axon Instruments) and digitized by using a Powerlab
8/16 system (AD Instruments). The digital data was segregated and filtered via
AC coupling and DC coupling for ECoG and extracellular DC recording,
respectively. CSD propagation rates were calculated from the latency of CSD
and the measured distance between the recording electrodes.
Durations of ECoG suppression were calculated after CSD elicited by
bipolar electrical stimulation.

CSD propagation rates and frequencies were

calculated from repetitive CSDs generated by KCl applications. A gelatin sponge
(Gelfoam®, Ethicon 360) soaked with 0.3M KCl was used to apply KCl on the
anterior cranial widow and electrical responses were recorded for 30min. During
91

the 30min trial, KCl was reapplied to prevent drying, either immediately after
detection of each SD event, or after 10min in the absence of significant electrical
responses. To be included in the analysis, events must have propagated in an
anterior to posterior direction, with less than 50% decreased in amplitude
between electrodes. Repetitive SDs were tested in both hemispheres and the
data from each animal were averaged.
After completion of the study, mice were euthanized by intraperitoneal
injection of a barbiturate overdose.
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3.4 RESULTS

3.4.1 Extracellular Zn2+ inhibits SD propagation
We first examined the effects of elevating extracellular Zn 2+ on the
propagation of SD events generated in brain slice preparations.

SD was

triggered by brief microinjection of KCl into stratum radiatum of area CA1, and
SD was detected by a combination of optical (intrinsic optical signals, IOS) and
extracellular DC recording (see Methods).

The experimental setup and

representative recordings are shown in Figures 1A&B. Under control conditions,
SD was visualized as a wave of increased light transmittance that propagated at
~2.5 mm/min, in both directions from the site of KCl application. Opposite to
optical responses to KCl, local microinjection of NaCl caused localized nonpropagating decrease of light transmission, likely due to tissue constriction
following increased osmolarity (data not shown). A biphasic DC potential shift
characteristic of SD was recorded coincident with arrival of the optical signal at
the extracellular recording electrode site (Fig. 1B). These baseline responses
are consistent with a large body of prior literature of SD in hippocampal slices
(Somjen, 2001).
The effects of elevating extracellular Zn2+ concentrations were tested
following bath application of ZnCl2. For all experiments testing effects of
exogenous ZnCl2, 200µM histidine was included in recording solutions in order to
increase its solubility in phosphate-containing solutions (Rumschik et al., 2009).
Histidine alone had no significant effect on SD propagation (Fig. 1D, discussed
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below), and was included in control and test recording solutions for all studies
involving ZnCl2.

ZnCl2 exposures were kept brief (10 min), to maximize the

contribution of effects on extracellular sites, and reduce possible intracellular
accumulation. Under these conditions, the propagation rates of SD were
concentration-dependently decreased by Zn2+, with significant inhibitory effects at
50 and 100μM (Fig. 1C). The observed Zn2+ effect was completely reversed by
brief co-incubation with the membrane impermeable Zn2+ chelator CaEDTA
(1mM, 10min, n=5).
The suitability of this approach with histidine supplementation to increase
availability of Zn2+ in ACSF was confirmed in a set of pilot studies comparing
ZnCl2 additions in 1) normal ACSF, 2) ACSF supplemented with histidine, and 3)
modified ACSF lacking added phosphates.

Without ZnCl2 additions, SD

propagation in all three solutions was identical (p>0.05). When 100µM ZnCl2
was applied in normal ACSF, there was an obvious visible precipitate likely due
to formation of zinc phosphate complexes. This was not observed in histidine or
phosphate-free solutions. Further comparisons between the three solutions were
therefore made using 50µM ZnCl2.

Figure 1D shows that this concentration

caused similar inhibition of SD propagation rate effective in both Pi free and
histidine (Pi-free 33.6±0.01%, histidine 42.0±0.05%), but significantly less
effective in ACSF, (17.3 ±0.09%, p<0.01 compared with Pi-free and histidine,
n=5) consistent with greater extracellular availability (Fig. 1D). Superfusion in
phosphate-free solution often led to significant tissue swelling (as assessed by
light transmission increases) and thus in order to avoid potential effect of
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phosphate removal on cellular metabolism, we chose histidine supplementation
rather than phosphate-free ACSF for the remaining studies (Rumschik et al.,
2009).
Single cell Zn2+ imaging (following intracellular FluoZin-3 loading, see
Methods) revealed relatively slow, but significant intracellular Zn 2+ accumulation
following brief exposures to ZnCl2 (100µM ZnCl2, 48.7 ±10.0% ΔF/F0 increase
after 10 min exposure, n=3, Fig. 1E). Because intracellular Zn 2+ accumulation is
known to modulate neuronal excitability (Frederickson et al., 2005), we next
tested whether intracellular accumulation of Zn2+ could contribute to inhibition of
SD propagation. An approach to selectively increase intracellular Zn 2+ loading
was carried out by exposure of slices to a low concentration of a Zn 2+-ionophore
complex (1µM ZnCl2 together with 100nM sodium pyrithione for 10min, hereafter
referred to as Znpyr) and followed by brief wash (3 min) to minimize extracellular
Zn2+ levels.

This Zn2+ loading protocol resulted in rapid intracellular Zn2+

accumulation, that reached significantly higher levels than observed with the
ZnCl2 exposures (Fig 1E; 1µM Znpyr: 123.8±12.5% after 10 min loading and 3
min wash, p<0.01 vs. 100µM ZnCl2 10min, t-test n=3). Figure 1F shows that
preferentially increasing intracellular Zn2+ loading with ZnPyr did not have any
effect on SD propagation rate.
As a control, we evaluated other effects of pyrithione. Pyrithione itself is a
membrane permeable chelator and it is possible that presence of pyrithione
depleted synaptic vesicle Zn2+ pools and thereby modulated SD propagation.
The content of the available synaptic vesicle Zn2+ pool was analyzed by
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recording extracellular Zn2+ accumulation during SD, utilizing extracellular
FluoZin3 (Carter et al., 2011b).

Exposure to Napyr (100nM, 15min) did not

significantly reduce extracellular Zn2+ transients attributed to release from
synaptic vesicles (control 111.4±23.9% vs. Napyr 105.1±15.7%, peak ΔF/F0,
p=0.84, n=3). Consistent with these results, Napyr did not affect SD propagation
rate (Fig. 1F, Napyr).
Taken together, these results imply that extracellular, rather than
intracellular actions of Zn2+ most likely explain the inhibitory effects of ZnCl2 on
SD shown in Figure 1C.

3.4.2 Vesicular Zn2+ limits SD propagation
We next tested whether basal levels of Zn2+ present in the slices or Zn2+
released endogenously during SD may serve to inhibit SD propagation. Zn 2+
levels in the extracellular space could be contributed to by multiple sources,
including contamination of recording solutions (Kay, 2004), or release from
synaptic vesicles (Frederickson et al., 2005) and other endogenous sources
(Frederickson et al., 2005; Sensi et al., 2009).

Figure 2A shows that pre-

exposure to a membrane permeable Zn2+ chelator (TPEN, 50µM, 10 min preexposure), significantly increased SD propagation rate. In a second different set
of preparations, slices were pre-exposed to CaEDTA (1mM), a Zn2+ chelator with
poor membrane permeability. CaEDTA exposures were kept short (10 min), to
minimize potential depletion of intracellular Zn2+ pools (Frederickson et al., 2002).
Under these conditions, CaEDTA also significantly increased rate of SD
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propagation (Fig. 2B). These results suggest that extracellular Zn2+ that is
present within slices inhibits SD propagation rate.
Zn2+ is highly enriched in glutamergic synaptic vesicles and is released at
high levels during SD at the propagating wavefront (Carter et al., 2011b). To
evaluate a possible contribution of this source of endogenous Zn 2+ to inhibition of
SD propagation, we compared SD propagation rates in brain slices from WT and
ZnT-3 KO animals.

ZnT-3 is a vesicular Zn2+ transporter and thus genetic

deletion of ZnT-3 results in loss of synaptic Zn2+ (Cole et al., 1999) and abolished
extracellular accumulation of Zn2+ following SD (Carter et al., 2011b). As shown
in Fig. 2C, ZnT-3 KO preparations showed significantly faster SD propagation
rates than those in WT preparations (WT: 2.78±0.15 mm/min, ZnT-3 KO:
4.12±0.47 mm/min, p<0.001, n=5). In addition, unlike WT preparations,
pretreatment with the Zn2+ chelator CaEDTA did not increase propagation rates
in ZnT-3 KO slices.
In a different set of experiments, the effects of exogenous ZnCl 2
applications were also compared between WT and ZnT-3 KO slices. As shown
in Fig. 2D, ZnCl2 (100µM) decreased SD propagation rates in both WT and ZnT3 KO preparations to a similar degree. These data support the idea that higher
propagation rates in ZnT-3 KO is likely due to lack of vesicular Zn2+ release and
action, rather than changes in Zn2+ sensitivity.
Together, these results suggest that Zn2+ released from synaptic vesicles
during SD inhibits propagation of the advancing SD wavefront.
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3.4.3 Vesicular Zn2+ inhibits CSD propagation in vivo
We next tested the significance of the in vitro results for cortical spreading
depression (CSD) in vivo. Electrical recordings were made from the parietal
cortex of anesthetized mice, and CSD was generated by stimulation of the
cortical surface in an anterior cranial window, by using either a bipolar stimulating
electrode or repetitive KCl applications (see Methods, Fig. 3A). Fig. 3B shows a
representative CSD generated by electrical stimulation in a WT animal. The top
panel shows a characteristic DC deflection that lasts for ~1min.

This was

accompanied by a longer-lasting (~5min) depression of electrocorticographic
(ECoG) activity (Fig. 3B middle and bottom).
CSD was reliably generated by both electrical and KCl stimuli in all WT
and ZnT-3 KO animals studied, with no differences in electrical properties of
single CSD episodes. Figs 3C&D compare the amplitudes and durations of DC
deflections in both genotypes, generated by electrical stimuli. No differences
were observed in any of these parameters. The durations of ECoG depression
were analyzed from the recovery of the power of band-passed ECoG activity
(Fig. 3B middle). We did not observe any significant difference in the depression
period (50% recovery) of ECoG following CSD (Fig. 3E).
Fig. 4A shows representative CSDs generated by repetitive KCl
applications. CSD propagation rates were significantly faster in ZnT-3 KO
animals compared with WT controls (Fig. 5B. WT and ZnT-3 KO, 2.38±0.21
mm/min and 3.08±0.22 mm/min, respectively, p=0.045, n=6). In addition, ZnT-3
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KO animals showed markedly higher CSD frequencies than WT animals (Fig.
4C). Thus ZnT-3 KO animals showed significantly higher numbers of CSDs in a
30 min recording period (WT and ZnT-3 KO, 3.3±0.28 and 4.2±0.33, respectively,
p=0.011, n=6), associated with shorter inter SD intervals (Fig. 4C, WT and ZnT-3
KO, 9.5±1.4 min and 6.9±0.5 min, respectively, p=0.0053, n=6). In normal brain,
ECoG suppression is usually significantly shorter than the duration of the interSD interval, and thus CSDs rarely invade at-risk tissue where ECoG is still
suppressed. However in ZnT3-KO animals, the significant decrease in inter-SD
interval (without a concomitant decrease in ECoG suppression duration
(compare 4C, & 3E)) increased the incidence of CSD propagating into ECoGsuppressed brain. This observation suggests that extracellular Zn 2+ could play a
role in preventing CSD propagation into the unrecovered brain tissue (see
Discussion). These results are consistent with the hypothesis that synaptic Zn2+
release inhibits CSD propagation rate and frequency in vivo.

3.4.4 Potential extracellular Zn2+ targets that could contribute to modulation of
SD propagation
As described above (Introduction), NMDA-Rs are a candidate target to
explain the inhibitory effect of extracellular Zn2+ on SD propagation. Previous
work has shown that ZnCl2 inhibits NMDA-R at the hippocampal CA1 synapse
(Vogt et al., 2000; Izumi et al., 2006) and Figures 5A&B confirm that ZnCl2
concentration-dependently decreased isolated NMDA-R components of evoked
fEPSPs evoked by single stimuli (see Methods). Comparing Figures 1C and 5B
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shows that ZnCl2 was more effective against fEPSPNMDA than against SD
propagation. These mismatches could be due to the different pools of NMDA-R
(subunit compositions or synaptic/extrasynaptic localization) were activated in
these different tests (see Discussion). Figures 5C-E demonstrates that a similar
mismatch in effectiveness was also observed with the synthetic NMDAR
antagonist D-AP5. Thus low concentrations of D-AP5 (2-20µM) readily inhibit or
block fEPSPNMDA (Fig 5C&D), while higher concentrations are required to either
slow SD propagation (20-50µM) or block the response completely (100µM, n=4).
Mismatch in sensitivity to NMDAR antagonism could be due to much higher
levels of extracellular glutamate accumulating during SD, compared with EPSPs
generated by single electrical stimuli.
The similarity between effects of D-AP5 and ZnCl2 on fEPSPNMDA and SD
inhibition is consistent with a role for NMDA-R in the actions of Zn2+ to inhibit SD
propagation, but does not provide a direct test of the hypothesis. One approach
would be to fully block NMDA-Rs involved in SD with D-AP5, and then determine
whether ZnCl2 lost the ability to slow the event.

However, because high

concentrations of D-AP5 completely prevented initiation and propagation of SD
(Fig. 5E), this type of test was not possible. Figure 5F shows a different study,
where inhibitory effects of endogenous Zn2+ were removed by using the ZnT3KO, and then the effectiveness of AP-5 was tested. In this case baseline SD
propagation rates were elevated by synaptic Zn2+ removal (as in Figure 2C), but
D-AP5 retained the same degree of block as was observed in WT tissues (WT
vs. Control: 22.9±0.04% vs. 23.9±0.02% inhibition with
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25µM D-AP5;

40.9±0.05% vs. 39.5±0.04% for 50µM D-AP5). This suggests that there was no
significant cooperativity between Zn2+ and D-AP5 in inhibiting SD, and this could
be due to either to different sites of action of these inhibitors on the NMDA
receptor (Paoletti and Neyton, 2007) and/or because Zn2+ interacts with other
extracellular targets to reduce excitability and inhibit SD.
Figure 6 shows that incubation with ZnCl2 (100µM) did not result in
significant changes in resting potential, action potential number or input
resistance of single CA1 pyramidal neurons (Fig. 6A-D). Furthermore, consistent
with a previous report (Izumi et al., 2006) ZnCl2 had no significant effect on a
measure of presynaptic release probability - paired pulse ratio (PPR) of evoked
field excitatory postsynaptic potentials (fEPSP; Fig. 6E&F, p>0.5, n=4). ZnCl2
also had no effect the amplitudes of evoked fEPSPs (100 µM ZnCl 2: 98.5 ±13%
of control, p>0.1, n=4,). Similarly, no obvious difference in the evoked responses
between WT and ZnT-3 KO preparations were observed (input-output curve
(range: 0.2-0.6mA), PPR (interpulse interval: 20, 50 and 100ms), p>0.1 in both
tests, n=5). These data imply that there was no significant Zn2+ inhibition of
evoked presynaptic Ca2+ influx and glutamate release, or of AMPA receptors that
might contribute to decreased SD propagation rates (Kunkler and Kraig, 2004;
Pietrobon, 2010).
Figure 6G shows that GABAA-R activation contributes significantly to
limiting the rate of SD, since full block of these channels with gabazine
significantly enhanced SD propagation rate. Since GABAA–Rs are known to be
inhibited by Zn2+ (Weiss et al., 2000; Frederickson et al., 2005; Sensi et al.,
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2009), actions on these channels cannot be directly responsible for inhibitory
effects of SD on propagation rate. Furthermore, when GABAA-Rs were fully
blocked with gabazine, ZnCl2 was not more effective than in control conditions
(mean inhibitory effect of ZnCl2; control 28.9%, gabazine 29.3% Fig 6G,
*p<0.01).
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3.5 DISCUSSION

3.5.1 General
The current study demonstrates that Zn2+ released during SD can serve to
limit progression of the event. This conclusion is supported by consequences of
exogenous Zn2+ applications, increased SD propagation rates following
extracellular Zn2+ chelation and higher SD propagation rates in ZnT-3 KO
preparations. The significance of results in brain slices was confirmed in an in
vivo CSD model, in which ZnT-3 KO animals had higher CSD propagation rates
and frequencies than WT animals. Previous work has emphasized a neurotoxic
role of intracellular Zn2+ accumulation (Weiss et al., 2000; Sensi et al., 2009).
However, our current study raises the possibility that the synaptic Zn 2+ released
during SD may be beneficial in some contexts by limiting SD.

3.5.2 Zn2+ released from synaptic vesicles inhibits SD propagation
Zn2+ is capable of interacting with a large number of ion channels,
receptors and intracellular signaling pathways (Weiss et al., 2000; Frederickson
et al., 2005; Sensi et al., 2009), however the inhibitory actions of Zn2+ on SD
propagation appear to be due to extracellular actions rather than intracellular
accumulation. Thus, approaches to selectively increase intracellular Zn2+ (with
zinc pyrithione) did not retard SD, and the inhibitory effects of brief ZnCl2
exposures were readily reversible. Both these observations are compatible with
interaction of an extracellular target.
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The fact that brief exposures to Zn2+-selective chelators significantly
increased SD propagation rates implies that there is sufficient extracellular Zn 2+
within the slice to inhibit SD propagation. Two main sources of Zn 2+ need to be
considered; contamination of Zn2+ from a variety of exogenous sources (Kay,
2004), and endogenous sources including synaptic vesicles.

Results from

tissues lacking Zn2+ in synaptic vesicles (ZnT-3 KO) show that release from
vesicles underlies these effects. Thus SD generated in ZnT-3 KO preparations
was significantly faster than in wild type tissues, both measured in vitro in
hippocampal slices and in vivo during CSD. Importantly, the potentiating effects
of CaEDTA were abolished in ZnT-3 KO slices, demonstrating no additional
effect of contaminating Zn2+.
We recently showed that a large release of Zn2+ from synaptic vesicles
accompanies the advancing SD wave front (Carter et al. 2011), and it seems
likely that such release is responsible for retarding progression of the event. If
this is the case, then release should occur just prior to the complete
depolarization that characterizes SD. It is noted that SD propagation is preceded
by a episodic transient hyperexcitation (Herreras et al. 1994; Larrosa et al. 2006)
which is associated with increase of spontaneous EPSC frequencies
(unpublished observations).

The exact extracellular Zn2+ concentrations

achieved during and after SD are not yet clear. However, extracellular Zn 2+
transients generated by SD were ~10-times higher than those produced by trains
of electrical stimulation, and from comparison with prior work (Assaf and Chung
1984; Howell et al. 1984), it seems likely that Zn2+ concentrations can reach at
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least 100 μM in synaptic clefts following SD. However estimates of extracellular
Zn2+ concentrations are controversial and need to be consolidated (Frederickson
et al. 2005; Kay 2003).

3.5.3 Potential mechanisms contributing to Zn2+ inhibition of SD
We did not observe effects of ZnCl2 on intrinsic excitability or synaptic
function that could explain the decrease in SD propagation rate.

A marked

increase in extracellular GABA concentration has been reported during SD
(Molchanova et al., 2004) and Zn2+ can inhibit GABAA receptors (Smart et al.,
2004), but based on the effects of GABAA-receptors block with gabazine (Fig 6),
such an action of Zn2+ would be expected to accelerate (rather than inhibit) SD
propagation.
One candidate for decreases in SD propagation is inhibition of NMDA-Rs.
As described above (Introduction) and demonstrated in the present work, NMDAR antagonists can completely abolish some forms of SD, presumably by
substantially increased threshold for initiation.

Activation of NMDA-R at the

advancing wave front also appears to contribute significantly to setting the SD
propagation rate. Previous work showed that CPP slowed SD propagation in
brain slice (Larrosa et al., 2006) and the present study extends these
observations by showing that with partial inhibition of NMDA-R, SD could still be
generated, but propagated substantially more slowly than in control conditions.
In the present study, we confirmed effective inhibition of NMDA-R by
exogenous application of ZnCl2, but it was not possible to completely inhibit
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evoked NMDA potentials with ZnCl2.

A similar partial block of NMDA-R

components of fEPSPs was reported previously (Izumi et al., 2006). At least two
factors could contribute to the partial nature of this block.

First, Zn 2+

preferentially inhibits NMDA receptors containing NR2A subunits and significantly
higher concentrations are required to inhibit NR2B containing receptors (Paoletti
and Neyton, 2007; Gielen et al., 2009). It is important to note that Zn2+ sensitive
NR2A containing receptors appear more predominantly localized to synaptic
sites, whereas extrasynaptic regions express more NR2B-containing receptors
(Hardingham and Bading, 2010).

Thus a potentially greater involvement of

extrasynaptic receptors during massive glutamate at the SD wavefront might
explain the weaker inhibitory effects of Zn2+ on SD, as compared with evoked
synaptic potentials.

Second, the effective concentration of Zn 2+ that can be

achieved in brain slice studies is limited by solubility in the ACSF-based
recording solutions. Zn2+ interacts with and precipitate with phosphate and thus
decrease activity of Zn2+, and for this reason histidine was included in recording
solutions to increase availability (Rumschik et al., 2009). However it is likely that
the effects were still underestimated. Some combination of these two factors is
expected to explain why SD was slowed, but not abolished by the concentrations
of ZnCl2 we could test in this study.
The similarity between effects of D-AP5 and ZnCl2 on fEPSPNMDA and SD
inhibition is consistent with a role for NMDA-R in the actions of Zn2+ to inhibit SD
propagation but (as noted above in Results), direct tests of this hypothesis were
not possible due to the essential requirement of NMDAR for generation of the SD
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event. Thus it is not yet known whether inhibition of NMDAR might be sufficient
to explain decreased SD propagation rate, and/or whether other targets of Zn 2+,
including the recently described Zn sensing metabotropic receptor (Chorin et al.,
2011) could also contribute.

3.5.4 Implications for Zn2+-based interventions to limit brain injury
Important studies have shown that Zn2+ chelation can be neuroprotective
in rodent stroke models and a large body of work has identified multiple
intracellular pathways linking intracellular Zn2+ accumulation to injury (Koh et al.,
1996; Sheline et al., 2000; Weiss et al., 2000; Sensi et al., 2009). However on
the other hand, several studies have suggested opposite (neuroprotective) roles
of Zn2+ in ischemic injury (Galasso and Dyck, 2007). Thus administration of
exogenous Zn2+ decreased ischemic lesion size (Zhao et al., 1996) and
pretreatment with CaEDTA has been shown to accelerate early ischemic infarct
formation in a rat stroke model (Kitamura et al., 2006). In addition, ZnT-3 KO
animals have been shown to have higher susceptibility to some other forms of
brain injury (Cole et al., 2000; Doering et al., 2010).
Recent work has consolidated the idea that SD can contribute significantly
to the expansion of ischemic injuries (Dreier, 2011; Lauritzen et al., 2011), and it
is possible that divergent effects of Zn2+ on SD explains the apparently
contradictory effects of Zn2+ chelation in different injury models.

Thus we

recently provided evidence that Zn2+ chelation increased the threshold for
initiation of some forms of SD in brain slices. This was attributed to intracellular
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Zn2+ accumulation, which likely contributed to metabolic failure in an in vitro
ischemia model (Dietz et al. 2008).

Substantial synaptic Zn 2+ release also

accompanies SD and leads to postsynaptic uptake (Carter et al. 2011) raising the
possibility that Zn2+ released during repetitive SDs in ischemia can prime injured
tissues by lowering SD threshold and/or activating other intracellular cell death
pathways.

However Zn2+ chelation did not prevent initiation of SD under

normoxic conditions (Dietz et al., 2008, and present study), presumably because
the initiation of these events was determined by localized accumulation of K +,
rather than progressive depletion of metabolites.
The current study reveals an additional important complexity to the actions
of Zn2+ in SD, by describing significant extracellular actions. By slowing the
progression of recurrent SD events through peri-infarct regions, synaptic release
of Zn2+ could limit the deleterious invasion of SDs into tissue that has not fully
recovered from previous depolarizations. It will be of interest to determine the
relationship between extracellular Zn2+ accumulation and the durations of DC
shifts and ECoG recovery in rodent models of focal ischemia, to evaluate this
possibility.
The idea of opposing intracellular and extracellular actions of Zn2+ may
emerge as a common theme in Zn2+ pathophysiology, as a recent report showed
that while intracellular Zn2+ accumulation contributes to neuronal excitability due
to KCC2 downregulation, binding of Zn2+ to an extracellular receptor leads to
activation of KCC2 (Chorin et al., 2011). These considerations further strengthen
the idea that strategies that specifically target intracellular Zn 2+ accumulation
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(while maintaining potentially beneficial effects of extracellular Zn 2+) could be
more effective interventions for ischemic stroke.
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3.6 FiGURE LEGENDS
Figure 3.1: Extracellular Zn2+ inhibits SD propagation. A: Images showing
electrode placement and propagation of SD through the hippocampal CA1
subregion. SD was generated by local microinjection of KCl (10ms pulse) from a
stimulation pipette (Stim), and was detected using an extracellular recording
electrode (Rec). SD was also tracked from propagating intrinsic optical signal
increases (>575nm transmission, arrows).

Scale bar = 250μm.

B:

Time

courses of intrinsic optical (IOS) and electrical signals (DC) generated from the
preparation illustrated in A. C: Brief ZnCl2 pre-exposures (10 min in histidinesupplemented ACSF) resulted in concentration-dependent reductions in SD
propagation rate (*p<0.05, **p<0.01, n=5). D: Comparison of buffer composition
on effectiveness of ZnCl2 applications. ZnCl2 (50µM; 10min) was more effective
in phosphate free ACSF (Pi free) and histidine supplemented ACSF (200µM
histidine) than in control ACSF (* p<0.05, n=5).

E: Intracellular Zn2+

accumulation assessed in single neurons loaded with FluoZin3. ZnCl2 exposures
(100µM) resulted in slow intracellular accumulation, and more rapid increases
were observed with Znpyr (1µM ZnCl2 with 100nM pyrithione). F: Preferentially
loading intracellular Zn2+ had no effect on SD propagation rate. Exposure to
Znpyr (as in 1E, followed by brief wash) did not reduce SD propagation rate, and
no effects were observed with a control for non-specific effects of pyrithione
(sodium pyrithione, Napyr 100nM) influenced SD propagation rate (n=5).
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Figure 3.2: SD propagation rate in WT and ZnT-3 KO animals in vitro. A&B:
Effects of Zn2+ chelation on SD propagation rate. Slices were pre-incubated with
one of two Zn2+ chelators prior to SD initiation; TPEN (50μM, A) or CaEDTA
(1mM, B). Both chelators significantly increased SD propagation rates (*p<0.01
n=5). C: In slices from ZnT-3 KO animals (filled bars), control SD propagation
rates were significantly higher than those observed in WT slices. In addition,
Zn2+ chelation with CaEDTA did not further increase SD propagation rates in
ZnT3-KO slices (*p<0.01, **p<0.05, n=5). D: ZnCl2 (100µM 10min) effectively
decreased SD propagation rate in both WT and ZnT-3 KO preparation.
Experiments were interleaved between WT and ZnT-3 KO (*p<0.01, n=5).
Figure 3.3: CSD threshold and propagation rate in WT and ZnT-3 KO
animals. A: Arrangement of craniotomies and burr holes for CSD recording. B:
Representative responses showing extracellular DC recording (top), ECoG
(middle) and relative ECoG power (bottom, 10sec bins) following a single CSD
generated by electrical stimulation. CSD was recorded as large, long-lasting
negative DC potential shift, coupled with transient suppression of ECoG activity.
C-E: Lack of difference in the DC shift duration (C), DC shift amplitude (D), or
duration of ECoG suppression (E, measured as 50% recovery time). n=6 for
each.
Figure 3.4: ZnT-3 KO animals showed higher CSD incidence. Increased
CSD propagation rates and frequencies in ZnT-3 KO animals.

A:

Representative traces of repetitive CSD generated by topical KCl applications in
WT and ZnT-3 KO. Arrowheads indicate onset of CSD and recording artifacts
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generated by re-application of KCl are denoted by asterisks. B: Propagation
rates of CSD in WT and ZnT-3 KO. Mean SD propagation rates were determined
for each animal, from the time-offset between CSDs detected with a pair of
electrodes. (* p<0.05 n=6).

C: Inter-CSD intervals were significantly lower of

ZnT-3 KO animals. (* p<0.001, n=6)
Figure 3.5: Partial inhibition of NMDA-R could contribute to effects of ZnCl2
on SD propagation rate.

A&B: ZnCl2 partially inhibits NMDA-R.

Isolated

NMDA-R components of evoked fEPSP (see Methods) were reduced by ZnCl2 in
a concentration-dependent manner (10-100µM, 10min).

C-F: NMDAR block

with D-AP-5 concentration dependently inhibits SD propagation. C&D show
concentration dependent inhibition of fEPSPNMDA (**p<0.01, n=3).

E shows that

D-AP5 at 100µM reversibly prevented SD generation. SD incidences are shown
in the numbers in bar graphs.

Intermediate concentration of D-AP5 shows

decreased SD propagation rates in both WT and ZnT-3 KO preparations (F).
Recovery was evaluated after at least 30min washout of D-AP5 (** P<0.01 vs.
WT control, ##p<0.01 vs. ZnT-3 KO control, n=5).
Figure 3.6: Lack of effect on intrinsic excitability, presynaptic release or
GABAA-R mechanisms.

A-D: Lack of effect on intrinsic excitability of CA1

pyramidal neurons tested by recording responses to intracellular current injection
(representative traces in A). ZnCl2 (100µM, 10-30min, n=8 each) had no effect on
resting potential (B), action potential frequency (C) or input resistance (D). E&F:
No significant effect of ZnCl2 (100µM, 10min) on paired pulse ratios determined
from fEPSP recordings (p=0.50, n=4). G. GABAA-R block by gabazine (10µM)
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significantly increased SD propagation rate. The degree of SD acceleration by
gabazine was unaffected by ZnCl2 (100µM, 10min; *p<0.01, n=4)
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4.1 ABSTRACT
Spreading depolarizations (SDs) are coordinated depolarizations of brain
tissue that are implicated in the progression of stroke injury. We have recently
shown that extracellular Zn2+ accumulation can inhibit the propagation of SD
events. In that prior work, Zn2+ was tested in normoxic conditions, where SD was
generated by localized KCl pulses in oxygenated tissue.

The current study

examined the extent to which Zn2+ effects are modified by hypoxia, to assess
potential implications for stroke studies. All studies examined SD generated in
brain slices acutely prepared from mice and recordings were made from the
hippocampal CA1 region.

SDs were generated by either local potassium

injection (K-SD), exposure to the Na+/K+ -ATPase inhibitor ouabain (ouabain-SD)
or superfusion with modified ACSF with reduced oxygen and glucose (oxygen
glucose deprivation: OGD-SD).

Extracellular Zn2+ exposures (100µM ZnCl2)

effectively decreased SD propagation rate and significantly increased the
initiation threshold for K-SD generated in oxygenated ACSF (95% O2).

In

contrast, when SD was generated by either OGD, or ouabain in hypoxic
conditions (0% 02), ZnCl2 no longer inhibited SD propagation. In both these
conditions, Zn2+ sensitivity was restored by exposure to the protein oxidizer
DTNB, suggesting that redox modulation may contribute to resistance to Zn 2+ in
hypoxic conditions.

DTNB pretreatment also significantly potentiated inhibitory

efficacies of competitive (D-AP5) or allosteric (Ro25-6981) NMDA receptor
antagonists on OGD-SD. Finally, Zn2+ inhibition of isolated NMDAR currents
were greatly potentiated by DTNB.

Together, these results demonstrate that
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hypoxia-induced redox modulation can modulate sensitivity of SD to Zn 2+ as well
as other NMDAR antagonists, and this feature may limit the protective effects of
endogenous Zn2+ accumulation in hypoxic regions close to ischemic infarcts.
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4.2 INTRODUCTION
Many preclinical studies have accumulated evidence suggesting that
slowly-propagating waves of coordinated neuronal and glial depolarization can
contribute to expansion of stroke injury (Dreier, 2011; Lauritzen et al., 2011).
The events initiate from depolarization of a volume of tissue and consequent
elevations of extracellular potassium and glutamate concentration drive near
complete depolarization of surrounding tissue, generate a slowly propagating (24 mm/min) feed-forward event (Somjen, 2001).

These events are termed

spreading depolarizations (SD), and underlie the well-recognized phenomenon of
spreading depression of cortical activity (Leao, 1944), as well as spreading
ischemia and other related consequences that depend on the physiological state
of the brain tissue (Dreier, 2011). The cumulative metabolic burden of repetitive
SDs that occur in the hours and days following injury appears to increase the
volume of tissue involved in an infarct, and there is considerable interest in
finding effective approaches to limit the spread of SDs (Marrannes et al., 1988;
Lauritzen et al., 2011).
Antagonists of NMDA subtype glutamate receptors (NMDARs) are
amongst the most well-studied inhibitors of SD. While NMDAR antagonists are
very effective at blocking SDs under some conditions, in other SD models, the
same agents can be completely ineffective. Thus SDs triggered by localized KCl
pulses in well-oxygenated brain slices can reliably be blocked by NMDAR
antagonists (Mody et al., 1987; Avoli et al., 1991; Kruger et al., 1999), and similar
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effectiveness has been observed with NMDARs tested against SDs generated in
vivo, in otherwise healthy brain (Marrannes et al., 1988).

In contrast, SDs

triggered by simulated ischemia (oxygen glucose deprivation) in brain slices were
quite resistant to NMDAR blockers (Jarvis et al., 2001). Likewise the SDs
generated by global ischemia in vivo (or anoxic depolarization) were not
prevented by NMDAR antagonists and contribute to significant damage
(Hernandez-Caceres et al., 1987; Lauritzen and Hansen, 1992; Murphy et al.,
2008).

In contrast, SD (or periinfarct depolarization) generated with focal

ischemia by middle cerebral artery occlusion models showed significant
sensitivity to NMDAR antagonists and decreased numbers of SD associated with
infarct volume (Gill et al., 1992; Hartings et al., 2003). It is possible that part of
the lack of antagonist efficacy in some circumstances is due to a lack of
contribution of NMDARs in carrying SDs under ischemic conditions, and a larger
role for K+ or other mediators (Somjen, 2001). However, it is also known that the
effectiveness of NMDAR block can be influenced by oxygen-dependent redox
modulation (Pringle et al., 2000b), raising the possibility that similar mechanism
could contribute to differential pharmacosensitivity of SD.
We have recently shown that Zn2+ can limit the progression of some
forms of SD (Aiba et al., 2012). Thus for SDs generated by microinjection of KCl
in brain slices, exogenous applications of ZnCl2 significantly slowed the
progression rate of SD. These actions were likely due to an extracellular action
of Zn2+. Large amounts of vesicular Zn2+ release also occurs during SD (Carter
et al., 2011a), and release of endogenous Zn2+ from this source appeared to
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contribute significantly to setting the rate and threshold of SD generated by KCl
in vivo (Aiba et al., 2012). These observations may be significant for
understanding the complex roles of Zn2+ in ischemic injury, since intracellular
Zn2+ accumulation is implicated in the progression of stroke injury (Koh et al.,
1996; Sensi et al., 2009), but appears to provide a protective effect under some
circumstances (Zhao et al., 1996; Kitamura et al., 2006). A potentially protective
role of vesicular Zn2+ is also consistent with reports on seizure and brain trauma
where removal of an endogenous Zn2+ source facilitated injurious events or
consequences (Cole et al., 2000; Dominguez et al., 2003; Doering et al., 2010; ,
but see also Qian et al., 2011).

It is possible that inhibitory actions of Zn2+ on

SD and/or other NMDA dependent injury could contribute to these complex
results.
In the present study, we examined whether inhibitory effects of Zn 2+ on SD
were influenced by hypoxia, similar to the effects that have been described
previously for synthetic NMDA receptor antagonists (described above). Such
information should be helpful for determining the potential protective inhibitory
effects of extracellular Zn2+ on SD in the stroke-injured brain. The results show
a dependence of Zn2+ inhibition on oxygen availability, attributed to redox
modulation. These effects were paralleled by effects on isolated NMDA receptor
currents. In addition, the sensitivity of OGD-SD to some synthetic NMDA receptor
antagonists was sensitized by redox modulation with some degree, suggesting a
contribution of similar or identical mechanism to pharmacoresistance of SD.
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4.3 EXPERIMENTAL PROCEURES

4.3.1 Animals and slice preparation
All experimental procedures were approved by the Institutional Animal
Care and Use Committee (IACUC) at the University of New Mexico. Bain slices
were prepared from 4-10 week old C57BL/6 or FVB/N mice of both sexes. In
order to minimize experimental variables resulting from the variability of animals,
effects of inhibitors were tested only on interleaved slices obtained from the
same experimental animals.
Brain slices were prepared as previously described (Aiba et al. 2012).
Briefly, mice were deeply anesthetized with subcutaneous injection of a
ketamine/xylazine mixture (85 mg/ml and 15 mg/ml, respectively, total 150 µl)
and decapitated. Brains were then extracted into ice cold cutting solution (mM:
220 Sucrose, 6 MgSO4, 3 KCl, 1.25 Na2HPO4, 25 NaHCO3, 10 glucose, 0.2
CaCl2) and sliced with a vibratome at 350 µm thickness.

Slices were then

allowed for recover in ACSF (mM: 130 NaCl, 1 MgSO4, 3 KCl, 1.25 Na2HPO4, 25
NaHCO3, 10 glucose, 2 CaCl2, equilibrated with 95% O2/5% CO2) at 35oC for 1
hour, and then transferred to room temperature ACSF and held until transfer to
the recording chamber.

4.3.2 SD generation and detection
SD was detected simultaneously with extracellular DC recording
electrodes and optical detection of intrinsic optical signals. In order to decrease
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variability, the condition of slices was visually inspected based on morphology of
soma, and slices with local damage were not used.

Electrical signals were

recorded with a low resistance glass electrode (0.5-1 MΩ, filled with ACSF)
placed in the CA1 dendritic subfield. Signals were amplified with a Multiclamp
700A amplifier, digitized (Digidata 1322A) and analyzed with pClamp9.2 software
(Molecular Devices, CA).

Changes in transmittance of light through slices

(hereafter termed intrinsic optical signals; IOS) were also used to visualize the
propagation of SD events. Light transmission (>575 nm high-pass filtered light)
was acquired at 0.5-1 Hz using a charge-coupled device controlled by Till Vision
software (Version 4.0) which allowed the velocity of traveling waves of IOS to be
calculated. The region of interest (ROI) for IOS measurements was placed at the
electrical recording site and optical data were expressed as light transmission
changes with respect to basal levels (ΔT/T0).
SD was generated by one of three stimuli: 1) local injection of 1 M KCl (KSD), 2) exposure of slices to a moderate concentration of the Na +/K+/ATPase
inhibitor ouabain (ouabain-SD), 3) exposure of slices to oxygen-glucose
deprivation (OGD-SD). All SDs were recorded with low resistance electrodes
(0.5-1 MΩ) placed in the CA1 dendritic subfield. K-SD was induced by local
ejection of 1 M KCl via glass micropipette (~1 µm tip diameter, 40 psi). The
ejection volume was estimated to be ~10nl, based on the comparison between
the diameter of droplet from 10-20 ejection and a reference volume (see Aiba et
al., 2012).

KCl ejection pipettes were placed in hippocampal CA1 dendritic

subfield >300 µm distant from the recording sites at 50 µm from the slice surface.
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The threshold for K-SD was determined with escalating duration of KCl
microinjections. Threshold testing began with a 10 ms pulse, and then doubling
of stimulus duration every 5 minutes, until a propagating event was generated.
Ouabain SD was generated by superfusion of 30 µM ouabain containing ACSF,
equilibrated with varying concentrations of O2, as indicated in the text. OGD-SD
was generated by superfusion with a modified ACSF, prepared by substitution of
95% O2 with 95% N2, and 10 mM glucose with 1.5mM glucose and 8.5mM
sucrose.
Figure 1 shows representative SDs generated by the three test stimuli in
this study (KCl microinjection, ouabain exposure or OGD). In each case, SD was
demonstrated as spreading wave of intrinsic optical signal (IOS) increases,
accompanied by a characteristic biphasic DC potential change recorded with the
extracellular recording electrode.

K-SD was generated from a local KCl

microinjection site and propagating through CA1 region. This propagation was
electrically detected as a characteristic biphasic extracellular DC shift (Fig. 1A).
Following the passage of SD, IOS showed a long lasting (~10 min) increase,
which returned to baseline level without any evidence of tissue damage.
K-SD was generated from a local KCl microinjection site and propagating
through CA1 region.

This propagation was electrically detected as a

characteristic biphasic extracellular DC shift (Fig. 1A). Following the passage of
SD, IOS showed a long lasting (~10 min) increase, which returned to baseline
level without any evidence of tissue damage. Similar to K-SD, ouabain- and
OGD exposures resulted in the propagating SD waves were detected as IOS
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increases (Joshi and Andrew, 2001). Unlike K-SD, ouabain- and OGD exposures
spontaneously generated SD. passage of SDs were followed by irrecoverable
IOS decreases in dendritic fields (Fig. 1C-F), attributable to the formation of
granular structure in dendrites (dendritic beading) that inhibits passage of visible
light through the tissue (Jarvis et al., 1999). Electrical responses of ouabain- and
OGD-SD were typically monophasic, likely reflecting a lack of transmembrane ion
flux in the irrecoverably damaged tissue.
As presented in Figures 1B&C, initiation and propagation phases of
ouabain- and OGD-SD could be reliably resolved with these imaging methods.
Thus SD usually initiated on either side of the CA1 subfield with gradual increase
of IOS signal, followed by a stable propagation phase. SD propagation rates
were analyzed at least 8 s after SD, and rates were averaged from at least 3
consecutive images.

4.3.3 Drugs
D-AP5, MK801 and Ro256981 were obtained from Sigma. D-AP5 was
dissolved in water at a stock concentration of 10 mM. MK801 and Ro25-6981
were dissolved in DMSO at 100 mM and 10 mM, respectively. Matched final
DMSO concentrations were used in vehicle control experiments.

In the

experiments that included ZnCl2, 200 µM histidine was always included in the
ACSF.

This method can effectively limit Zn2+ precipitation in phosphate

containing solutions (Rumschik et al., 2009).

Histidine supplementation was

preferred for the present studies over phosphate removal, to avoid potential
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negative effects on metabolism. As reported previously, (Aiba et al., 2012) no
confounding effects of histidine alone on SD characteristics were detected.

4.3.4 NMDAR current recording
Whole-cell NMDAR currents were recorded from single CA1 pyramidal
neurons. Whole-cell clamp was obtained with patch pipettes (2-3 MΩ) filled with
internal solution containing (in mM): 130 Cs-methanesulfonate, 10 Hepes, 0.5
CaCl2, 8 NaCl, 10 EGTA, 5 QX314, 2 Na2ATP, 0.3 Na3GTP, pH adjusted to 7.2.
Neurons were dialyzed for at least 10 minutes prior to recordings. Excitatory
postsynaptic NMDAR currents (EPSCNMDA) were evoked by iontophoretic
stimulations with high resistance electrodes (20-30 MΩ) filled with 1 M sodium
glutamate.

Glutamate electrodes were placed <30 µm from the putative

locations of apical dendritic trees of whole-cell patched neurons. Recordings
were made in the presence of 20 µM DNQX and 5 µM bicuculline, and evoked
glutamate currents were initiated after stepping membrane voltage to +30 mV for
1 - 2 seconds, depending on the latency of the response. The duration and
intensity of glutamate stimulation was adjusted for each recording in order to
obtain evoked currents less than 1 nA in amplitude and 1 sec duration (typical
stimuli: 10-30 µA, 0.5-3 ms). Control experiments utilizing the same parameters
with 1 M NaCl-filled stimulation electrodes did not evoke postsynaptic currents
(n=2). The Zn2+ sensitivity of NMDAR currents was measured by superfusing
slices with ACSF containing 100 µM ZnCl2. The effect of hypoxia and ZnCl2 was
evaluated by comparing the amplitudes of baseline responses (average of 9
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traces) with the average of 4-6 responses obtained after 10-15 min exposure to
the hypoxic solution containing ZnCl2. Input resistance and series resistance
was estimated ~500 ms prior to testing NMDA currents.

Recordings in which

series resistance changed by >20% were excluded from the analysis.

4.3.5 Statistics
Student t-tests or ANOVA with post hoc Turkey analysis were used for
statistical analysis unless otherwise described. P<0.05 was considered to be
statistically significant.

4.4 RESULTS

4.4.1 Differential sensitivity of K-SD and OGD-SD to extracellular Zn2+
Figure 1 shows the general features of SD generated by the three stimuli
used in the study: KCl microinjection, exposure of slices to the Na +/K+-ATPase
inhibitor ouabain, or superfusion with modified ACSF with reduced oxygen and
glucose. The sensitivity of these three types of SD to extracellular Zn 2+ was
examined by bath application of 100 µM ZnCl2 (Figure 2), and experimental
slices were interleaved with control slices throughout.
ZnCl2 reliably inhibited the rate of propagation of K-SD, as reported previously
and which

was attributed to extracellular intracellular actions of Zn 2+ in this

model (Aiba et al., 2012). In addition, ZnCl2 significantly increased the threshold

131

for K-SD initiation (Fig. 2A).

This increased threshold is consistent with

extracellular Zn2+ inhibition of SD frequency seen in an in vivo CSD model (Aiba
et al., 2012).
Similar to K-SD, propagation of ouabain-SD (Fig. 2B) also showed a
significant sensitivity to extracellular Zn2+. The concentration of ouabain (30 µM)
was determined to have significant sensitivity to NMDAR antagonists, and under
these condition ouabain SD was reliably blocked with MK801 (n=5). In these
experiments, slices were preincubated with 100 µM ZnCl2 for 10 min and SD was
then generated by further incubation with ouabain solution containing 100 µM
ZnCl2. ZnCl2 showed significant inhibition of the SD propagation in this model
(Fig. 2C). However except for propagation rate, SD was reliably generated in the
presence of ZnCl2, and SD threshold as evaluated by SD onset time was
unaffected (Fig. 2D).
We next tested the sensitivity of OGD-SD to ZnCl2. In the present study, the
OGD solution lacked any added O2, but a small amount of glucose (1.5mM) was
maintained in the modified ACSF, as these conditions proved effective for testing
pharmacosensitivity of OGD-SD (see Methods, Figure 5 and Discussion). Similar
to the test of ouabain SD, slices were preincubated with ZnCl2 (100µM, 10min)
and SD was then generated by OGD solution containing ZnCl 2.

ZnCl2 was

without effect on propagation rate or onset of OGD-SD (Fig. 2C). Because of the
poor solubility of ZnCl2 in ACSF (see Methods), we could not did not test higher
ZnCl2 concentrations to determine whether resistance to Zn 2+ was absolute.
However these results reveal a large difference in Zn2+ sensitivities of OGD-SD,
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compared with SD generated under conditions of abundant oxygen (K-SD and
ouabain SD).

4.4.2 2. Oxygen concentration strongly influences Zn2+ sensitivity of SD
propagation
We next examined whether the selective removal of oxygen and/or
glucose could be sufficient to render KSD insensitive to Zn 2+. Ouabain was a
suitable SD stimulus to test these possibilities, because ouabain exposure
reliably generates SD in the absence of oxygen/glucose. We first examined the
effects of different oxygen concentrations by equilibrating ACSF with either 0% or
21% O2 with 5% CO2. Unlike 95% O2 condition and similar to OGD-SD, (see Fig
1C) significant tissue swelling (increased IOS) was observed prior to the onset of
SD, when slices were exposed to hypoxic ouabain solutions (Fig. 3A&B). In
addition, the propagation rate of ouabain-SD was significantly slower in 21% and
0% O2, when compared with 95% O2 (n=5, p<0.05). However, except for these
differences, SD was reliably generated in these hypoxic conditions, and no
differences in propagation rate or onset were observed between 21% and 0% O 2.
In contrast to these similarities, the ZnCl2 sensitivities of ouabain SD
generated with these lower O2 concentrations SDs were quite different. Thus SD
propagation in 21% O2 was significantly inhibited by ZnCl2 (Fig. 3A, similar to the
95% O2 condition). However, no inhibitory effect of ZnCl2 on the propagation of
ouabain-SD was observed in 0% O2 (Fig. 3B). These results suggest that O2
concentration alone can significantly modify the sensitivity of SD to Zn 2+.
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As shown in Fig 3C, both hypoxia solutions similarly inhibited synaptic
transmission as measured by prompt inhibition fEPSP amplitude, likely via A 1
receptor dependent mechanism (Sebastiao et al., 2001).

Mitochondrial

respiration was also demonstrated to be effectively inhibited by these hypoxia
solutions as evidenced by significant elevation of NAD(P)H autofluorescence
(Fig. 3D). Since there was some trend towards a stronger synaptic depression
under 0% O2 than in 21% O2, we considered the possibility that increased
suppression of synaptic transmission could contribute to greater resistance of
responses in 0% O2 to ZnCl2.

This possibility was tested by blocking fully

synaptic activity with the potent A1-R agonist, N6-cyclopentyladenosine (hereafter
CPA, 300 nM in 95% O2 superfusate).

Exposure to CPA in 95% O2 solution

significantly decreased propagation rate, to a similar level as observed in 21%
and 0% O2. However CPA had no effect on the ZnCl2 sensitivity (propagation
rate, Control: 3.28 ± 0.20 mm/min, ZnCl2: 2.09 ± 0.19 mm/min, n=5, p<0.01),
indicating that basal synaptic strength did not influence the Zn 2+ sensitivity.
In addition to testing effects on oxygen availability, we also examined the
influence of glucose deprivation in the ouabain-SD model.

SD was reliably

generated by ouabain solutions that lacked all added glucose (in ACSF 95% O 2
and glucose substitution with sucrose). Under these conditions, SD propagation
almost identical to control experiments (Figure 2C), and sensitivity to ZnCl 2 was
unchanged (SD propagation rate, Control: 4.50 ± 0.44 mm/min, ZnCl2: 2.71 ±
0.13 mm/min, n=5, p<0.01).

These results argue against a potential role of

glucose availability in the lack of ZnCl2 sensitivities of OGD-SD.
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4.4.3 Zn2+ sensitivity of OGD-SD reversed by the protein oxidizer DTNB
The results above suggested that O2 concentration can be sufficient to
affect the sensitivity of SD to extracellular Zn2+. One potential mechanism that
could explain these results is that severe hypoxia modulates Zn 2+ sensitivities of
target proteins by directly modifying extracellular redox potential. This possibility
was tested by pre-exposure to the protein oxidizer DTNB. DTNB is a protein
oxidizer with poor membrane permeability (Wagner et al., 1996) and has been
used to modify redox modulation of many proteins, including extracellular
domains of NMDAR (Pringle et al., 2000a; Choi et al., 2001; Herin et al., 2001).
A previous study has shown that a high concentration of DTNB (2 mM)
significantly inhibited SD triggered by hypoxia (Hepp et al., 2005), and consistent
with this, 2 mM DTNB blocked OGD-SD in our recording conditions (data not
shown). A lower concentration of DTNB (0.5mM) was found more appropriate for
the current studies, since it did not prevent SD initiation, but likely retains an
ability to prevent anoxia induced redox modulation (e.g. Gozlan et al., 1994).
OGD-SD generated in control and the slices preincubated with DTNB (0.5 mM,
10 min, 95% O2) showed similar propagation rates and onset times (Figure 4A).
However DTNB pre-treatment significantly increased the sensitivity of OGD-SD
to ZnCl2.

Unlike control OGD-SD (Figure 2C), ZnCl2 significantly decreased

propagation rate and also delayed onset of OGD-SD DTNB preexposed slices
(Figure 4B). Similarly, propagation of ouabain SD generated in 0% O 2 (which
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was previously insensitive to ZnCl2; see Figure 4G), became sensitive to ZnCl2 in
DTNB preexposed slices (Figure 4C). In addition to DTNB, oxidized glutathione
(0.5mM 10min pre-exposure) also significantly reversed ZnCl2 sensitivity of OGDSD (propagation rate, Control: 2.26 ± 0.11 mm/min ZnCl2: 1.55 ± 0.10 mm/min,
n=5, p<0.01 ), supporting a role of redox modulation in the Zn 2+ sensitivity of
OGD-SD.
In contrast to significant effect on SD generated in anoxia, DTNB was
without effect on the Zn2+ sensitivity of K-SD in normoxic conditions, in which
little redox modulation was expected (Figure 5D). DTNB did not show any effect
on Zn2+ sensitivity of threshold in these experiments (p>0.50, n=5). Therefore
these results suggest that extracellular redox modulation under severe hypoxia
is, at least in part, likely responsible for the lack of Zn2+ sensitivity of SD.
As an additional control, we examined whether intracellular Zn2+
accumulation could contribute to inhibitory effects of ZnCl2 exposures, specifically
in the conditions where a ZnCl2 effect was revealed by DTNB. We examined this
possibility by loading Zn2+ intracellularly by exposure to Zn2+-ionophore complex
(ZnPyr: 100 µM ZnCl2 and 1 µM Pyrithione) for 10min. In order to exclude the
effects of residual extracellular Zn2+ effect, slices were briefly washed with ACSF
(3 min) and SD was generated with nomimnally Zn2+ free OGD solution.
Intracellular Zn2+ loading did not affect propagation rate or onset of OGD-SD in
DTNB (propagation rate, Control: 2.42 ± 0.15 mm/min, ZnPyr: 2.60 ± 0.24
mm/min, SD onset, Control: 7.24 ± 0.39 min, ZnPyr: 7.71 ± 0.44 min, n=5,
p>0.5).

These results argue against a possibility of intracellular Zn2+
136

accumulation contributing to these effects, and support the idea that Zn 2+ may
inhibit OGD-SD in an anoxic redox modulation of an extracellular site.

4.4.4 Redox modulation in anoxic condition (0% O2) can modulate Zn2+ sensitivity
of NMDAR
We next tested whether the sensitivity of one potential target for Zn 2+
(NMDAR) was modified by redox modulation by hypoxia and DTNB. For these
analyses, NMDAR dependent whole-cell currents were evoked by local
iontophoretic glutamate application at +30 mV in the presence of GABA A and
AMPA receptor antagonists (see Methods). Under these conditions, the evoked
whole-cell currents were detected as slow outward current (Figure 5A), and DAP5 almost completely occluded these responses (10 µM AP5, 95.7 ± 5.0%
inhibition, n=3).
We examined inhibitory effects of Zn2+ on these NMDAR currents in different
O2 concentration. After baseline responses were obtained, slices were exposed
to 100 µM ZnCl2 in various O2 concentrations for 10 min and glutamate
iontophoresis repeated.

In contrast to synaptically-evoked responses (see

Figure 3A above), glutamate iontophoresis reliably evoked NMDAR currents in
21% and 0% O2 (NMDAR current in 95% O2 vs. 21% or 0% O2, p>0.10, paired ttest, Fig. 6A&B).
Effects of ZnCl2 exposures were compared with time-control experiments. In
95% O2, these NMDAR currents were strongly inhibited by Zn2+ (100 µM ZnCl2,
79.7 ± 4.1%, n=3). Similarly, 100 µM ZnCl2 significantly decreased the NMDAR
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currents in 21% O2, and similar inhibition was observed in DTNB pre-exposed
slices (Fig. 6B).

The current inhibition by ZnCl2 in 21% O2 was somewhat

smaller than in 95% O2, which may be due to modification of extracellular redox
potential and/or due to other modification under hypoxia (see Discussion).

In

contrast to 95% or 21% O2, addition of ZnCl2 alone was almost without effect in
0% O2, however significant Zn2+ inhibition was revealed when tested in 0% O2
and DTNB preexposed slices. These results indicate that similar to SD, the Zn2+
sensitivity of NMDAR was attenuated by a mechanism involving hypoxia
dependent redox modulation.

4.4.5 DTNB potentiated competitive NMDAR antagonist to inhibit SD
Finally, we examined whether the redox sensitivity of ZnCl2 effects were
matched by differences in sensitivity to synthetic NMDAR antagonists.

This

possibility was examined by testing effects of DTNB effect on the NMDAR
antagonist sensitivities of OGD-SD, under the conditions as used above for
probing differences in Zn2+ sensitivity (Figure 6). At high concentrations of these
antagonists, no propagating SD wave was observed optically, and no sharp DC
shift was recorded to indicate SD propagation. Slices degenerated progressively
following ~15-20 minutes depletion of energy substrates under these conditions.
Thus in order to evaluate additive effects of DTNB to the antagonist inhibition of
OGD-SD,

antagonist concentrations were chosen to obtain partial inhibitory

effect (i.e. slower propagation rate or delayed SD onset) under control conditions,
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before evaluating additive effects of DTNB. For the experiments below, slices
were pre-incubated with either MK801 (20 µM), D-AP5 (25 µM) or Ro25-6981 (10
µM) for 10 min and then challenged with OGD.
Exposure to MK801 consistently delayed SD onset and decreased
propagation rate of OGD-SD in control slices (Figure 6A) and the inhibitory
effects were not significantly different in the DTNB pretreated slices. Similar to
MK801, D-AP5 delayed the onset of OGD-SD, but was without effect on SD
propagation rate. In DTNB pretreated slices, D-AP5 further delayed SD onset
time and prevented SD generation in 1 of 5 DTNB slices. D-AP5 also decreased
SD propagation rate in DTNB pretreated, but not in control slices. Ro25-6981
also delayed SD onset in control slices, and SD onset was further delayed in 4
out of 6 slices and in 2 DTNB pretreated slices SD was not generated. Unlike
other antagonists, Ro25-6981 was without effect on the propagation rate of SD in
both control and DTNB treated slices.

These results imply that anoxic redox

modulation can significantly affect efficacies of some NMDAR antagonists on
OGD-SD.

4.5 DISCUSSION

4.5.1 General
We have previously shown that SD generated by local KCl application was
inhibited by extracellular Zn2+, and the present study extended the findings to
other forms of SDs that may be relevant for acute brain injury.
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The initial

comparison revealed quite different ZnCl2 sensitivities between normoxic SD (KSD and ouabain SD in 21% and 0%) and anoxic SD (OGD-SD, ouabain SD in
0% O2). The subsequent analysis suggested that the hypoxia effect was, at least
in part, mediated by oxygen dependent redox modulation, and could potentially
involve modification of targets such as NMDA receptors. These findings were
extended to inhibitory effects of synthetic NMDAR antagonists and collectively
indicate that anoxia induced redox modulation can significantly reduce efficacy of
a range of pharmacological inhibitors of SD.

4.5.2 Zn2+ sensitivity of SD propagation and initiation
The present study evaluated the possibility that extracellular Zn 2+ can act
as an inhibitor of SD under conditions relevant to ischemia. The results showed
that Zn2+ inhibition of SD seems to be abolished by anoxic redox modulation.
Thus extracellular Zn2+ accumulation is likely no longer protective by limiting the
numbers of SDs propagating through vulnerable ischemic tissues, and in
contrast, may contribute to toxicity by increasing intracellular Zn 2+ accumulation
after transporter-mediated uptake (Qian et al., 2011).
The present study indicated that Zn2+ is not universally inhibitory to SD
and that inhibitory effects are limited to SD propagating in oxygenated tissue.
Mechanistic studies revealed that this is due to hypoxia dependent redox
modulation and reversal of redox reduction by DTNB revealed Zn 2+ sensitivity of
SD propagating in hypoxic (0% O2) tissue. Thus Zn2+ is intrinsically inhibitory for
SD, but the efficacy is significantly modified by local tissue oxygenation. This
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suggests that a SD generated at a single site can propagate differently
depending on the degree of tissue oxygenation. The significance of extracellular
Zn2+ accumulation and inhibition of SD propagation for stroke damage is not yet
known.

While a number of influential studies suggest a toxic role for

intracellular Zn2+ accumulation in ischemic brain injury (Koh et al., 1996;
Calderone et al., 2004), some studies have suggested protective roles of Zn2+ in
similar focal ischemia models (Zhao et al., 1996; Kitamura et al., 2006). These
protective effects raise the possibility that extracellular sites of Zn 2+ action could
provide some neuroprotection during ischemic brain injury.

Some of the

controversial roles of Zn2+ in ischemic brain injury could be due to variability in
the volume of ischemia, reperfusion rate and effectiveness of recurrent supply
which may modulate protective role of extracellular Zn 2+ by affecting local tissue
oxygenation.

A recent study has demonstrated that SD generated following

focal stroke in rodents can circularly propagate around the infarct core
(Nakamura et al., 2010). Extracellular actions of Zn2+ released during SD (Carter
et al., 2011a) may partly contribute to such a propagation pattern.

Thus by

preventing SD propagation in healthy tissue, elevation of extracellular Zn2+
concentration may confine SD propagation in the metabolically compromised
vulnerable tissue.

4.5.3 Pharmacoresistance of SD
In general, acute ischemia first generates anoxic depolarization (AD), which is
followed by recurrent periinfarct depolarizations (PIDs) that propagate around
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hypoperfused penumbral tissue and contribute to damage of vulnerable neurons
(Dreier, 2011; Lauritzen et al., 2011). Because of the extended time window in
which PIDs are seen, it is likely that these events are primarily involved in the
progression of delayed neuronal death.

Complete oxygen and glucose

deprivation has commonly been used to generate SD in brain slice models, but
these events resemble to AD rather than PIDs, due to the complete lack of
energy supply during these SD events, and their high resistance to NMDAR
antagonists (see Introduction). As described in the Introduction, PIDs generated
by focal ischemia models show significant sensitivities to NMDAR antagonists
(Gill et al., 1992; Iijima et al., 1992; Hartings et al., 2003). However an in vitro
PID model with similar NMDAR sensitivity has not previously been established.
The present studies utilized an OGD model with a reduced metabolic stress by
using only 85% glucose deprivation. While this model will not reproduce many
aspects of PIDs occurring in vivo, OGD-SD in our study showed significant
sensitivity to NMDAR antagonists (see Introduction, Figure 5) and allowed us to
identify a redox dependent mechanism that reduced phrmacosensitivity to SD
under anoxic condition. Similarly, the concentration of ouabain used here (30uM)
generated an event that was reliably prevented by NMDAR antagonists, whereas
NMDAR antagonist did not prevent SD when generated with 100 µM ouabain
(Balestrino et al., 1999). Thus the data obtained here are not directly comparable
to previous studies that showed insensitivity to NMDAR antagonist in similar
brain slice preparations (Balestrino et al., 1999; Jarvis et al., 2001; Joshi and
Andrew, 2001). SD propagation is contributed to by NMDAR activation and other
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factors, such as extracellular potassium concentration

While the increased

NMDAR antagonist sensitivity by reduced stimuli was not a main subject of the
present study, extracellular potassium clearance by residual Na +/K+-ATPase
activity could contribute to reduced potassium concentration (Xiong and Stringer,
2000; D'Ambrosio et al., 2002) and enhanced reliance of SD propagation on
NMDAR-dependent mechanisms.

4.5.4 Redox modulation of ion channel activities by anoxia
In the present study, we have shown that the oxidizer DTNB can significantly
sensitize NMDAR to the Zn2+ in 0% O2.

Because only a single high ZnCl2

concentration was tested in the present study, the mechanism(s) underlying the
inhibitory effect of Zn2+ are not fully delineated. However recordings of NMDAR
current at +30 mV suggest that the inhibition is not mediated by voltage
dependent block, but is rather based on allosteric modulation (Paoletti et al.,
1997). Redox modulation of NMDARs has been long been known, and it was
concluded that reducing conditions potentiates NMDAR currents in neuronal
cultures (Aizenman et al., 1989). The relevance for pathological conditions was
subsequently examined, and found a deleterious role of NMDAR redox
modulation in seizures and ischemic damage (Gozlan et al., 1994; Sanchez et
al., 2000). Owing to the high oxygen consumption rates of acute brain slices
(Galeffi et al., 2011; Hall et al., 2012), the brain tissue could have experienced
severe tissue hypoxia and resulted in anoxia dependent redox modification.
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Such a mechanism could contribute to some controversial results associated with
roles of Zn2+ in seizures (e.g. Cole et al., 2000; Qian et al., 2011). On the other
hand, effects of oxidation are controversial, since the protein oxidizer DTNB
decreased NMDAR currents in isolated neurons (Aizenman et al., 1989),
whereas it was without effect on NMDAR currents in brain slices (Sanchez et al.,
2000).

It was suggested in the latter study that NMDARs in brain slice

preparation are mostly present as oxidized status. The high content of oxidized
conformation in brain slice might have facilitated detection of reduced
conformational change in 0% O2.
Previous studies have suggested the presence of oxygen sensor sites in
NMDAR at the N-terminal region (Takahashi et al., 2007). The presence of Zn2+
binding sites in the N-terminal domain suggest that structural changes in this
region affected Zn2+ binding or subsequent conformation changes. Thus our
results likely suggest that decreased oxygen concentration modulated NMDAR
structure and significantly decreased Zn2+ sensitivity of NMDAR current.

A

previous study has also suggested significantly higher Zn 2+ sensitivity of the
oxidized NMDAR (Tang and Aizenman, 1993). The reported change in Zn2+
sensitivity was smaller compared with the present study. This could be explained
by differences in the redox modulation method used (alkylation vs. anoxia) and
different GluN2 subunit contents between brain tissues from adults vs. embryos.
Similar to Zn2+, redox modulation has been shown to decrease the efficacy of
competitive NMDAR antagonist to prevent excitotoxicity and ischemia-induced
neuronal death (Pringle et al., 2000b).
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The mechanism(s) underlying redox

modulation of NMDAR antagonist sensitivity is not understood. However in both
the present and the previous study,the open channel blocker MK801 was shown
to be insensitive to the redox modulation (Pringle et al., 2000b). Open channel
blockers such as memantine and ketamine are already used in clinical settings
and could be useful for targeting SD occurring near the ischemic core where
oxygen concentration is severely decreased and NMDARs may be significantly
modified to their reduced structure.
Although the NMDAR was the primary interest in the present study, other ion
channels are also susceptible to hypoxia dependent redox modulations.

For

example, one study showed that DTNB can postpone hypoxic SD onset by
activation of BK channels (Hepp et al., 2005). Activation of BK channels may
decrease rate of discharge prior to large depolarization of SD and may reduce
potassium accumulation ahead of SD wave.

The resultant decreased

extracellular potassium accumulation may increase demand on NMDAR
activation for generation of propagating wave and made SD propagation more
sensitive to the Zn2+ inhibition of NMDAR.

4.5.5 Conclusion
The present study shows that inhibitory effect of Zn 2+ on SD and NMDAR
are significantly decreased by severe hypoxia.

This effect likely hinders

protective functions of Zn2+ to limit SD- dependent injurious mechanisms in
ischemic brain injury. Because of the high oxygen consumption of mammalian
brain, severe excitatory injury may also capable of inducing such redox
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modification of NMDAR and affect Zn2+ sensitivity. These findings should be
important for design of targeting SD and NMDAR dependent brain injury.
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4.6 FIGURE LEGENDS
Figure 4.1: Representative SD responses generated by the three different
stimuli.
A: SD generated by KCl microinjection. Left panels show a series of 6 images (2
second intervals) of intrinsic optical signals (ΔT/T 0) following KCl microinjection
ejected via a micropipette (location indicated by “KCl”). Intensity increases in
these ratio images are indicated by brightening of the image, and the advancing
wavefront of SD is marked by the arrowheads. Traces at right show IOS and
electrical signals recorded from the same preparation.

IOS signals were

recorded from a region of interest indicated by the box, and simultaneously
recorded field potential changes recorded with a microelectrode place at position
“rec”. The dotted vertical line shows the alignment between the large DC shift
and the initial IOS signal that accompanies the spread of SD. Scale bar: 400 µm
B:

SD generated by exposure of slice to the Na+/K+/ATPase inhibitor ouabain

(30 µM). Details of the figure are as described for A, with large DC shift being
and propagating wavefront of SD being generated ~5 min after the onset of
ouabain exposure. C: SD generated by exposure of slice to OGD. Similar to
ouabain-SD, OGD-SD was initiated after a significantly delay and rates of SD
propagation could be calculated by advancing wavefront of IOS signals.

Figure 4.2: Differential sensitivities of K-SD, ouabain-SD and OGD-SD to
ZnCl2.
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Slices were pre-exposed to ZnCl2 (100 µM, 10 min) before application of one of
the three SD stimuli.

A: Propagation rates of K-SD were significantly reduced,

and the threshold for SD onset (see Methods) was significantly increased in the
same preparations (n=6, **p<0.01, ***p<0.005).

B: ZnCl2 significantly reduced

propagation rates of outbain-SD, with no significant decrease in the time to SD
onset (n=5, **p<0.01).

C: In contrast to the two other stimuli, ZnCl2 exposures

were without effect on the propagation rates of OGD-SD (n=5).
Figure 4.3: Changing O2 availability dictates sensitivity to ZnCl2.
A&B:

Evidence for effectiveness of experimental hypoxia.

Slices were first

exposed to ACSF equilibrated with 95% O2, and then challenged with modified
ACSF equilibrated with either 21% or 0% O2 (replaced with N2, see Methods).
Consequences of tissue hypoxia were evaluated based on reductions in field
excitatory postsynaptic potentials (fEPSP) (A) and increases in tissue NAD(P)H
autofluorescence (B in the same preparations). C&D: Zn2+ sensitivity of ouabain
SD generated under these reduced oxygen conditions.

Left panels show

representative traces of ouabain-SD and right panels show effects on
propagation rate and SD onset.

A significant decrease in SD propagation was

observed in 21% by ZnCl2 application but inhibitory effects of ZnCl2 were
abolished in 0% O2 (n=5 each, **p<0.01).
Figure 4.4:

The protein oxidizer DTNB was sufficient to confer ZnCl2

sensitivities to SDs in anoxic conditions.
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A: DTNB pre-exposure (0.5 mM, 10 min) by itself had no effect on OGD-SD
propagation rate (left) or onset (right).

B:

In the presence of DNTB, ZnCl2

effectively inhibited OGD-SD propagation rate, and delayed OGD-SD onset (n=5,
*p<0.05, **p<0.01).

C: Similarly, ouabain-SD generated in 0% O2 was also

inhibited by ZnCl2 in DTNB pre-treated slices. D: Under conditions where ZnCl2
was already effective, DTNB did not further enhance ZnCl 2 sensitivity. Illustrated
here is a lack of effect of DTNB alone on K-SD, and a lack of effect on the
inhibition of K-SD by ZnCl2 (n=5).
Figure 4.5:

Zn2+ inhibition of NMDAR current was sensitive to hypoxic

redox modulation.
A: Whole-cell NMDAR currents were evoked by local glutamate iontophoresis
pulses and examined in hypoxic conditions (0% O2 ACSF).

The top pair of

traces shows a response in 95% O2 (solid trace) and a small amount of rundown
of the response in the same neuron obtained after 10min exposure to 0% O2
(dashed trace). The middle pair of traces show that ZnCl2 exposure caused little
additional run-down of evoked NMDAR current, when tested in 0% O2. However
when slices were exposed to DTNB in 0% O2, ZnCl2 caused a large decrease in
current amplitude. B: Summary data from sets of data illustrated in A, and also
similar experiments conducted in 21%O2 ACSF (**p<0.01).

Figure 4.6: Augmentation of NMDA receptor antagonist efficacy by DTNB.
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OGD-SD was generated in control (vehicle: 0.1% DMSO), in the presence of
antagonist and with antagonist in DTNB treated slice. A: The NMDAR open
channel blocker MK801 (20 µM) significantly delayed SD onset and inhibited
propagation rate, but the inhibitory effect was not modified in DTNB pretreated
slices. B: The competitive NMDAR antagonist D-AP5 (25 µM) also significantly
delayed SD onset and inhibited propagation, and the inhibitory effect was
significantly larger in the DTNB pretreated slices. In one experiment with D-AP5
and DTNB, SD was not detected. C: The GluN2B subunit selective allosteric
inhibitor Ro25-6981 (10 µM) significantly delayed SD onset and the inhibitory
effect was larger in the DTNB treated slices. Unlike other NMDA antagonists,
Ro25-6981 was without effect on SD propagation in control and DTNSB treated
slices. In two experiments with Ro25-6981 and DTNB, SD was not detected.
Numbers in the bars indicate incidences of SD. Statistical tests were conducted
by using values obtained from successfully generated SD. * p<0.05, ** p<0.01
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5.1 ABSTRACT
Intracellular Zn2+ accumulation has been implicated in regulation of
neuronal excitability and neuronal injury, and multiple sources of Zn 2+ can
contribute to this signaling. In addition to release from synaptic vesicles and
transmembrane flux, significant amounts of Zn2+ can be sequestered by diffusible
intracellular binding proteins and released following cytosolic acidification or
change in redox state. Neuronal excitability is often recorded using whole-cell
methods, that involve significant dialysis of intracellular contents. The present
study evaluated whether intracellular dialysis significantly disrupts neuronal Zn 2+
dynamics, by depleting intracellular buffering mechanisms. Intracellular Zn 2+ was
assessed in CA1 neurons in acutely-prepared brain slices. Single neurons were
loaded with the Zn2+ indicator FluoZin3, using intracellular dialysis with
conventional patch pipettes. Comparison between standard intracellular dialysis
(20 minutes) and very brief dialysis (2 minutes) revealed large differences in
intracellular FluoZin3 signals. Thus low concentrations of Zinc Pyrithione (ZnPyr)
generated robust responses in neurons with standard dialysis, but signals were
virtually absent in neurons with short dialysis. Supplementation with recombinant
metallothionein 3 was sufficient to abolish ZnPyr responses in neurons with
standard dialysis. Release from oxidation-sensitive Zn2+ pools also appeared
reduced with standard dialysis, based on the lack of response to the oxidizer
DTDP, when compared with large responses in neurons with brief dialysis.
Different dialysis conditions were then used to probe responses to synaptic
stimulation. Under standard dialysis conditions, trains of synaptic stimuli (20 Hz,
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10 s) generated slow FluorZin3 signals which lasted for 2-3 minutes in wild-type
(WT) preparations and such responses were not observed in the preparations
lacking vesicular Zn2+ (ZnT3 KO). In contrast, under brief dialysis conditions,
intracellular Zn2+ transients were very similar in WT and ZnT3 KO preparations.
These results indicate that intracellular dialysis can be an important confound for
studying intracellular Zn2+ signaling.

However these effects may also be

exploited for discriminating between contributions from different Zn2+ sources (i.e.

5.2 INTRODUCTION
Zn2+ is an essential heavy metal ion required for a wide range of functions
in mammalian cells. While total intracellular Zn2+ content is quite high (>200 µM),
cytoplasmic free Zn2+ concentrations are maintained at extremely low levels (<1
nM), due to the fact that much is bound in structural proteins and also the high
activities of intracellular buffer and transporter systems (Colvin et al., 2008; Sensi
et al., 2011). Recent Zn2+ studies have revealed diverse roles for cytosolic Zn2+
transients in physiological and pathophysiological.

For example, elevated

cytoplasmic free Zn2+ levels in neurons have been implicated to modulation of
neuronal circuit activity (Manzerra et al., 2001; Hershfinkel et al., 2009; Huang
and McNamara, 2010), and activation of neurotoxic pathways when intracellular
Zn2+ levels become excessively high (Sensi et al., 2011).
In the mammalian brain, Zn2+ is highly concentrated in synaptic vesicles of
glutamergic neurons, due to the activity of vesicular Zn 2+ transporter ZnT3 (Cole
et al., 1999).

Vesicular Zn2+ can be released as a neuromodulator and can
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directly modify the function of ion channels and receptors via direct interactions.
In addition to extracellular actions, released Zn2+ can also translocate into
postsynaptic neurons and potentially contribute to plasticity of some synapses (Li
et al., 2001a; Huang et al., 2008). Glutamate exposures have been widely used
to study neuronal intracellular Zn2+ homeostasis (Sensi et al., 2002; Colvin et al.,
2008; Dineley et al., 2008; Kiedrowski, 2011).

In these cases, activation of

NMDA-type glutamate receptors (NMDARs) have been shown to release Zn 2+
from intracellular pools. Therefore it seems likely that synaptic Zn2+ release and
influx can contribute to postsynaptic Zn2+ concentration, in some combination
with intracellular liberation from intracellular stores. The relative contributions of
these two pathways remain to be clarified, as does the impact of standard
electrophysiological recording methods on these Zn2+ signals.
Whole-cell clamp recording in acute brain slice preparation is a very
widely used method for studying pre- and postsynaptic activities of single
neurons.

Whole-cell clamp technique involves substantial dialysis of the

intracellular compartment due to the small intracellular volume (10 -10~12 litter)
compared with the pipette solution volume (>10 -6 litter). Due to effective washout
of some intracellular components, intracellular dialysis can mask important
neurophysiological responses such as long term potentiation (Malinow and
Tsien, 1990), some Ca2+ currents (Belles et al., 1988) and intracellular signalingdependent channel modifications (Manzerra et al., 2001). On the other hand,
intracellular dialysis has been also exploited as a valuable method to manipulate
intracellular constituents (Blatow et al., 2003; Eggermann and Jonas, 2012).
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Whether or not whole-cell recording depletes neurons of important Zn2+ buffers
and/or otherwise modifies detection of intracellular Zn 2+ responses has not been
explicitly tested.
In the present study, we demonstrate a significant vulnerability of
intracellular Zn2+ buffers and/or pools to intracellular dialysis.

While these

dialysis methods may be a significant technical confound, we also demonstrate
that they can be exploited to evaluate contributions of both synaptic and
intracellular Zn2+ release, following synaptic stimulation.
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5.3 METHODS

5.3.1 Slice preparation
All procedures using experimental animals were approved by the
Institutional Animal Care and Use Committee of the University of New Mexico.
Brain slices were prepared from 4-10 week old WT and ZnT3 KO C57BL/6
animals of both sexes. Data in each specific experiment were collected from
matched numbers of each sex, within an age range of 2 weeks.

ZnT3 KO

animals were originally developed by (Cole et al., 1999) and backcrossed onto
the C57BL/6 line for at least 13 generations. Both WT and ZnT3 KO homozygote
colonies were established and maintained at the University of New Mexico.
Mice were deeply anesthetized with a subcutaneous injection (0.2 ml) of
ketamine/xylazine mix (85 mg/ml and 15 mg/ml, respectively) and decapitated.
Brains were carefully extracted into ice-cold cutting solution (in mM: 220 sucrose,
1.25 Na3PO4, 25 NaHCO3, 3 KCl, 10 glucose equilibrated with 95% O2/5% CO2
gas), hemisected and sliced at 350 µm thickness with a vibratome. Slices were
allowed to recovered in ACSF (in mM: 130 NaCl, 1.25 NaH2PO4, 25 NaHCO3, 3
KCl, 10 glucose equilibrated with 95% O2/5% CO2 mix-gas) for 1 hour at 35oC,
and were subsequently maintained at room temperature in ACSF. Slices were
transferred to a recording chamber (RC-27, Warner Instruments) and superfused
with ACSF at 2 mm/min and 32oC.
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5.3.2 Zn2+ indicator loading into single CA1 neurons
Intracellular Zn2+ dynamics were evaluated by using the high affinity
indicator Fluo-Zin3, loaded via whole cell dialysis into single CA1 pyramidal
neurons.

Neurons were visually identified, and patch pipettes (3-5 MΩ)

contained (in mM): 135 potassium gluconate, 8 NaCl, 1 MgCl2, 2 Na2ATP, 0.3
NaGTP, 10 Hepes, 0.05 EGTA. pH was adjusted to 7.2 with KOH and Fluo-Zin3
added to the pipette solution.
A central issue in this study was the influence that whole-cell dialysis had
on intracellular Zn2+ dynamics. Therefore the duration of dialysis was carefully
monitored, and the electrode withdrawn from the neuron at specified times after
the initial establishment of the whole-cell configuration. Thus membrane rupture
was determined as the time when initial access resistances dropped below 30
MΩ, and if this was not completed within 10 seconds of initial attempts, the
neuron was discarded.

During intracellular dialysis, neurons were voltage

clamped at -65 mV (holding current range between -50 and +50 pA), and the
quality of whole-cell configuration was monitored based on the holding current
and membrane response to test pulse (-5 mV, 100 ms). Neurons were discarded
when holding current exceeded -100 pA for more than 20 s without any sign of
recovery, or when series resistance exceeded 30MΩ.

Following intracellular

dialysis, the loading pipette was carefully withdrawn. Successful electrode
withdrawal was determined by formation of an out-side-out recording
configuration, and could be achieved within 20 seconds. After successful
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electrode withdrawal, neurons were allowed 20 minutes recovery, prior to onset
of any stimulation.
The concentration of FluoZin-3 added to the pipette solution depended on
the duration of dialysis, in order to approximately match the final FluoZin-3
concentration achieved in neurons (see Figure 1).

The tested concentration

ranged from 40-500 µM (see Results).
In some experiments, recombinant human metallothionein-3 (MT3) was
added to the intracellular solution.

This was supplied as lyophilized purified

recombinant human MT3 in various Zn2+ binding forms (approximately 80%
Zn7MT3, 10% of Zn6MT3 and 10% Zn8MT3 (Bestenbalt LLC, Tallinn, Estonia)). 5
µM MT3 stock solution was prepared in 10-times concentrated pipette solution
lacking ATP/GTP, and containing 10% chelex resin, and stored at -80 ◦C. MT3
and ATP/GTP were then added to the pipette solution immediately prior to
experiments

5.3.3 Fluorescence imaging
FluoZin-3 fluorescence was excited with 495 nm light (120 ms) delivered
from monochromator via a dichoric mirror (505 nm long pass). Emission signals
were band-passed filtered (535/50 nm) and acquired using a CCD camera (Till
Imago) controlled by Till Vision software (version 4.04).

Intracellular

fluorescence signals were calculated after subtracting background neuronal
autofluorescence within the same images.
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Because of the high signal to noise ratio achieved by single-cell loading
with FluoZin-3, intracellular fluorescence values could be approximated by the
maximum fluorescence values obtained from low-pass filtered images. In each
set of experiments, both analysis methods yielded similar values when ROI was
carefully adjusted on neurons in every frame, except that analyses with
maximum fluorescence always resulted in less noise. The kinetics of responses
were analyzed as changes relative to the basal fluorescence intensities.

In

some experiments (e.g. Figure 1 100µM ZnPyr exposure), significant tissue
swelling occurred and focus adjustment was required.

5.3.4 Synaptic stimulation
Synaptic responses were evoked with a concentric bipolar stimulating
electrode placed >100 µm from the imaging site. Glass recording electrodes
filled with ACSF (0.5-1 MΩ) were placed adjacent to neurons being imaged in
order to verify activation of postsynaptic neurons near the recording sites. In
each experiment, input-output curve were generated based on field excitatory
postsynaptic potentials (fEPSP) evoked with single current pulses (70 µs, 0.1
Hz). 70% maximum stimulation was used for test stimuli. In all experiments,
input-output curves were determined at least 10 minutes after recovery of
neurons from indicator loading, and subsequently no stimulation was applied until
a train of electrical stimulation (20 Hz, 10sec) was applied to evoke intracellular
Zn2+ responses.
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5.3.5 Reagents
Unless otherwise noted, all chemicals were from Sigma Aldrich (St Louis MO).
FluoZin3,

Alexa

633

and

TPEN

(N,N,N′,N′-Tetrakis(2-

pyridylmethyl)ethylenediamine) were obtained from Life Technologies (Carlsbad,
CA)

5.3.6 Statistics
All statistical tests were performed by using Graph Pad Prism software
(GraphPad Software, Inc., version 4.03).

One-way ANOVA with post hoc

Newman-Keuls multiple comparison tests were used throughout. Values are
presented as mean +/- SEM. n values indicate numbers of slices tested. A pvalue <0.05 was considered to be statistically significant.
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5.4 RESULTS

5.4.1 Intracellular dialysis increased detection of intracellular Zn2+ increases.
We first examined the hypothesis that intracellular dialysis could reduce
intracellular Zn2+ buffering capacity, and make cytosolic Zn2+ increases more
readily detectable. The general experimental approach is shown in Figure 1,
where single pyramidal neurons were dialyzed via a conventional whole-cell
patch pipette containing the membrane-impermeable Zn2+ indicator FluoZin-3.
Two different durations of dialysis were compared (2 minutes and 20 minutes),
and the concentration of indicator added to the pipette solution adjusted (500 µM
and 40 µM, respectively) so that the final neuronal indicator concentrations were
approximately matched. This was confirmed by exposing the indicator-loaded
neurons with saturating concentration of ZnPyr (100 µM ZnCl2, 5 µM sodium
pyrithione, 20 minutes exposure) and obtaining maximum fluorescence signals
(Figure 1A&B).

The approximate intracellular Zn 2+ concentrations were

estimated by using an equation described in (Grynkiewicz et al., 1985), and the
calculation confirmed extremely resting intracellular Zn2+ concentrations. These
initial experiments verified that initial FluoZin3 concentrations were closely
matched in the neuronal populations, despite very different dialysis durations.
Figure 2 shows that the duration of dialysis had a substantial effect on the
amplitude of Zn2+ increases detected by FluoZin-3, when neurons were
challenged with a low concentration of zinc pyrithione (ZnPyr: 1 µM ZnCl 2 and 1
µM sodium pyrithione). Pyrithione serves to facilitate Zn2+ passage across the
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plasma membrane, and thereby increase intracellular Zn 2+ levels independent of
active transport mechanisms. As shown in Figure 2A, the FluoZin3 response in
the briefly dialyzed neurons was barely detectable, whereas large FluoZin-3
increases were detected in all neurons that were first subjected to standard (20
minutes) dialysis (Figure 2B). The increased signals with standard dialysis could
be due to washout of an endogenous Zn 2+ buffer into the dialysis pipette, and/or
changes in transport mechanisms involved in accumulation and clearance.
Experiments in Figure 2C show that supplementation of the pipette
solution with recombinant MT3 (0.5 µM) was sufficient to abolish the large Zn 2+
signals seen with standard dialysis.

We estimated relevant intracellular MT

concentrations from previous publications (Hidalgo et al., 1994; Colvin et al.,
2008) and examined effects of a range of MT3 concentrations (0.1-5 µM) in an
initial set of pilot studies.

0.5 µM MT3 was then chosen for subsequent

experiments, as this concentration showed significant effects on intracellular Zn 2+
responses while having little deleterious effect on the quality of whole-cell
recordings.
Although the difference in the amplitudes of response could be affect by
initial fluorescence or

Zn2+

concentration,

our

estimates of

maximum

fluorescence values as well as near zero minimum fluorescence values (after
TPEN exposure) suggested it was not the case (see Figure 1B&C).

These

observations indicate a large increase in the net accumulation of Zn2+ that was
detectable by FluoZin-3, was caused by intracellular dialysis.

Supplementation

with recombinant MT3 is consistent with the possibility that washout of
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endogenous Zn2+ buffering proteins could underlie the effect, however it is
emphasized that addition of excess endogenous buffer in these studies could
mask other contributing mechanisms (see Discussion).

5.4.2 Intracellular dialysis also reduced oxidation dependent intracellular Zn 2+
release
Previous work has shown that addition of a membrane-permeable oxidant
effectively mobilizes Zn2+ from intracellular stores/binding proteins, and leads to
increases in Zn2+ that can be detected by cytosolic indicators (Aizenman et al.,
2000). We therefore examined whether dialysis leads to depletion of the size of
the oxidation-sensitive intracellular Zn2+ pool. After a stable baseline was
collected, neurons were exposed to 200 µM DTDP for 20 minutes. As shown in
Figure 3, briefly dialyzed neurons showed a robust increase in FluoZin3 signals.
In contrast, FluoZin-3 signal responses were very small in neurons with standard
dialysis, suggesting much smaller oxidation sensitive Zn 2+ pools in these
preparations. Intermediate Fluozin-3 responses were observed in neurons with
standard dialysis supplemented with recombinant MT3. These results suggest
that intracellular dialysis may deplete oxidation-sensitive Zn2+ pools, which may
be contributed in part by differences in availability of MT3 or other redox-sensitive
Zn2+ binding stores.
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5.4.3 Dialysis allows dissection of multiple sources of Zn2+ following synaptic
stimulation.
The results above suggest that differences in dialysis conditions could be
used

experimentally

to

manipulate

the

ability

to

preferentially

detect

transmembrane Zn2+ influx (with standard dialysis) and liberation from
intracellular binding sites (with short dialysis). We next examined whether these
experimental approaches could be exploited to assess the contributions of
different Zn2+ sources to intracellular Zn2+ accumulation following synaptic
stimulation.
This was done using trains of synaptic stimulation (20 Hz for 10 s), as this
was suggested to be a physiologically relevant stimulation intensity in a recent
study of tissue metabolism in a similar preparation (Hall et al., 2012). As shown
in Figure 4, these stimuli provided reliable detection of post-synaptic Zn2+
accumulation. For these experiments, the slow Zn 2+ chelator CaEDTA (1 mM)
was included in recording bath solution in order to prevent detection of
contaminating Zn2+ (see (Qian and Noebels, 2005) and Discussion). Based on
previous studies, exposure to 1 mM CaEDTA should have little effect on basal
intracellular Zn2+ concentration (Lavoie et al., 2007), and leaves a significant
fraction of rapidly released Zn2+ available at synaptic clefts (Vogt et al., 2000;
Pan et al., 2011).
Figure 4 shows a summary of intracellular Zn2+ responses of postsynaptic
neurons, indicator loaded with standard dialysis, brief dialysis and standard
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dialysis with MT3. In order to evaluate contributions of synaptic Zn2+ release,
experiments were compared between WT and ZnT3 KO preparations. Strong
genotypic differences were seen in the standard dialysis preparations (Fig
4A&B). Thus WT preparations showed a robust FluoZin3 signal increase peaked
during 1-2 minutes after stimulation and slowly decayed over next 5 minutes,
while responses was virtually absent in ZnT3 KO preparation (Fig 4A&B). These
data suggesting that the response observed in dialyzed WT preparations were
largely contributed to by presynaptic Zn2+ release, and are consistent with the
possibility that significant depletion of intracellular Zn 2+ buffering by standard
dialysis facilitated detection of the response.
A strong difference between WT and ZnT3 KO preparations was not seen
in briefly dialyzed neurons. Thus both WT and ZnT3 KO preparation showed
intracellular Zn2+ responses in these cells, following synaptic stimulation (Fig
4C&D). The responses in ZnT3 KO preparations raised the possibility that these
responses were generated by liberation from intracellular sources.
Figures 4E&F show experiments to test whether artificial provision of an
intracellular Zn2+ source, by inclusion of MT3 in the pipette solution, could reveal
additional Zn2+ release signals in neurons that had been extensively dialyzed.
MT3 addition had no additional effect in WT neurons, but did significantly
increase detection of Zn2+ increases in ZnT3 KO neurons.
Taken together, these results suggest that synaptic stimulation leads to
postsynaptic Zn2+ accumulation from at least two sources, which can be
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preferentially demonstrated with different dialysis methods. Synaptic release can
be readily demonstrated after standard dialysis, where a large portion of the Zn 2+
buffering system is lost. In contrast, briefly-dialyzed neurons appear to retain a
significant source of intracellular Zn2+, which can generate postsynaptic FluoZin-3
signals, even in the absence of synaptically-released Zn2+.

5.5 Discussion

5.5.1 General
The present study examined effects of intracellular dialysis on Zn2+
measurements in neurons whole-cell clamped in acute slice preparations.

A

major finding is that dialysis appears to effectively deplete intracellular Zn 2+
buffering and decrease the size of oxidation-sensitive intracellular Zn2+ pools.
Such disruption of intracellular Zn2+ homeostasis was shown to significantly
modify detection of intracellular Zn2+ responses to a train of synaptic stimulation.
Thus standard whole-cell dialysis facilitated detection of synaptic Zn2+
translocation,

whereas

in

briefly-dialyzed

preparations

intracellular

Zn2+

responses seem to be mediated mainly by intracellular Zn 2+ liberation. Together,
these findings indicate a high vulnerability of intracellular Zn 2+ homeostasis to
whole-cell dialysis, and demonstrate its potential use for selective detection of
intracellular Zn2+ signals arising from different mechanisms.
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5.5.2 Dialysis effects
The present study compared effects of two different durations of
intracellular dialysis; one standard (20 minutes) and one intentionally very brief (2
minutes). It is generally understood that intracellular dialysis is one of the most
profound confounds of whole-cell clamp recordings.

Washout of intracellular

constituents and the imposition of a homogenous intracellular ionic composition
improves the resolution of electrophysiological recordings, however dialysis of
channel subunits or signaling molecules can prevent recording of significant
physiological responses (see Introduction).

The present demonstration of

significant disruption of intracellular Zn2+ homeostasis is another example of the
significant impact of dialysis. The 20 minutes dialysis conditions tested here are
relatively common for studies of synaptic physiology or pathophysiology. The
current results suggest that loss of Zn2+ buffering and/or intracellular release
could be a significant variable in a range of whole-cell studies.
One of the most striking dialysis effects was the response to low
concentrations of the Zn2+ carrier ZnPyrithione.

As noted above, pyrithione

serves to facilitate Zn2+ passage across the plasma membrane, and thereby
increases intracellular Zn2+ levels independent of active transport mechanisms.
The fact that standard intracellular dialysis significantly increased intracellular
accumulation following ZnPyrithione could be due to washout of intracellular
buffers, or possibly due to some other factors that decrease Zn 2+ extrusion rates.
Reversal of the dialysis effect with recombinant MT3 is consistent with the
possibility that washout of endogenous Zn2+ buffering proteins could underlie the
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effect, however as noted above (Results) addition of excess endogenous buffer
in these studies could mask other contributing mechanisms. Likewise, the loss of
intracellular Zn2+ accumulation following exposure of the oxidant DTDP is
consistent with the hypothesis that dialysis washes out an oxidation-sensitive,
diffusible Zn2+-binding source, such as MT3. A similar role for metallothionein in
intracellular Zn2+ buffering and regulating the oxidation sensitive pool size have
previously been demonstrated with overexpression of metallothionein in
astrocytes (Malaiyandi et al., 2004).
It is noted that even extensively dialyzed neurons maintained extremely
low resting intracellular Zn2+ concentrations (estimated ~500pM) which were not
different from cells loaded with brief dialysis (see Figure 1). This suggests that
mechanisms required for maintaining resting Zn2+ concentrations are different
from those that prevent excessive intracellular Zn2+ accumulation. Thus while
Zn2+ binding molecules such as thionein and metallothioneins) are likely
important defense molecules against severe Zn2+ influx (Hourez et al., 2005)
resting Zn2+ concentrations may not be under control of these molecules. It was
previously suggested that function of the membrane Zn 2+ transporters ZIP1and
ZIP3 and mitochondrial membrane potential seem to be resistant to intracellular
dialysis (Zhou et al., 2010a; Qian et al., 2011). Thus mechanisms such as Zn2+
extrusion or sequestration into organelle alone could be sufficient for maintaining
extremely low Zn2+ concentrations at rest (Sensi et al., 2011).
In addition to depletion of buffer molecules, the concentrations of small
signaling molecules such as inositol phosphate can be modified by intracellular
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dialysis (Hourez et al., 2005).

Because we did not replenish these small

molecules, intracellular dialysis could have significantly impaired intracellular
signaling pathways. These effects certainly could have contributed to reduced
detection of intracellular Zn2+ release in the dialyzed neurons, and facilitated
selective detection of synaptic Zn2+ translocation in the dialyzed neurons.
Even though the mechanisms underlying dialysis effects are not yet
definitively identified, the results from Figures 2&3, together imply that dialyzed
neurons have higher sensitivities to the detection of Zn 2+ influx, whereas in briefly
dialyzed neurons FluoZin3 responses more strongly reflect intracellular Zn 2+
release.

5.5.3 Other neuronal intracellular Zn2+ buffer systems
While the present study revealed that inclusion of MT alone was sufficient
to restore a large portion of intracellular Zn2+ homeostasis, it does not necessarily
rule out important contributions of other Zn2+ buffers to intracellular Zn2+
homeostasis.

In an early studies it was shown that Zn 2+-GSH provides an

additional major cytoplasmic Zn2+ buffer in hippocampus (Sato et al., 1984).
While GSH is contained in all cell types, GSH is less abundant in neurons (1 mM)
compared with the glia (10 mM) (Rice and Russo-Menna, 1998).

The GSH

concentration in recorded neurons may be even lower because of the fact that
intracellular GSH can be severely depleted during brain slice preparation (Rice,
1999). This factor might have made contributions of MT3 dialysis relatively more
detectable in the brain slice preparations studied here.
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5.5.4 Intracellular Zn2+ responses during synaptic stimulation
Previous studies have suggested that synaptic stimulation can elevate
intracellular Zn2+ levels by two mechanisms; intracellular Zn2+ release and
synaptic Zn2+ translocation (Frederickson et al., 2005; Sensi et al., 2011). Bulk
loading of populations of CA1 neurons with a low affinity Zn 2+ indicator Newport
Green (KD = 1~3 µM) (Li et al., 2001b; Suh, 2009) has shown intracellular Zn2+
increases in postsynaptic neurons (Li et al., 2001b; Suh, 2009) and the latter
study showed that accumulation was abolished in ZnT3 KO tissues. While this
argues for a role of synaptic Zn2+ release and translocation, the results of the
present study suggest that both synaptic release and intracellular release can
contribute to postsynaptic Zn2+ accumulation.

Thus in briefly dialyzed

preparations, postsynaptic Zn2+ responses were observed in both WT and ZnT3
KO preparations. The presence of responses in ZnT3 KO preparations suggest
that, in our recording conditions, intracellular Zn2+ release can significantly
contribute to the FluoZin3 signal changes following synaptic stimulation
Conversely, with standard dialysis, FluoZin-3 signals were abolished in ZnT3 KO
tissues, implying preferential detection of Zn2+ that is released and taken up by
postsynaptic neurons. Taken together, the preferential detection of intracellular
Zn2+ release in the briefly dialyzed neurons is likely contributed to by the
presence of intracellular buffers, which bind with Zn2+ with significantly higher
affinity and masked a large part of fluxed Zn2+ from detection by FluoZin3. While
it has been previously shown that glutamate can evoke intracellular Zn 2+ release
in neuronal culture models (Dineley et al., 2008; Kiedrowski, 2011), the present
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study appears to be the first to suggest intracellular Zn 2+ release during
physiological synaptic activity.

5.5.5 Kinetics of Zn2+ responses
One of the remarkable features of intracellular Zn 2+ responses following
synaptic stimulation was their very slow kinetics. Both in standard dialysis and
briefly dialyzed preparations, similar slow monophasic responses were detected.
Such responses were much slower than intracellular Ca2+ transients observed
with the same stimuli (data not shown). Previous single cell Zn 2+ imaging during
different stimuli (exposures to ouabain, oxygen glucose deprivation and NMDA)
have also shown relatively slow changes in intracellular FluoZIn3 signals (Dietz
et al., 2008; Medvedeva et al., 2009; Vander Jagt et al., 2009).

One possibility

is that high affinity endogenous intracellular Zn2+ buffers limit mobility of Zn2+ ions
and contributed to sluggish responses. However our dialysis studies suggest this
may not the case. In fact, similarly slow responses were also observed in the
dialyzed neurons in which large fraction of intracellular Zn 2+ buffer is likely to be
significantly depleted. Instead of large buffer molecules, these slow responses
could be contributed by interactions with organic anions (e.g. HCO 3-, PO43-)
which are abundantly present in the cytoplasm with high affinity (Rumschik et al.,
2009). An interesting question is whether the observed responses may reflect
true intracellular Zn2+ dynamics, or whether signals are distorted due to presence
of fluorescence probes. Thus a high affinity Zn2+ binding molecule such as
FluoZin-3 could have significant impact on the mobility of Zn 2+.
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Because of

extremely low intracellular Zn2+ concentrations at rest and even after stimulation,
such a confound may be inevitable for imaging studies of intracellular Zn 2+.

5.5.6 Conclusion
The present study revealed significant effects on intracellular Zn 2+
homeostasis by conditions used in standard electrophysiological experiments.
The present results also show that modifying whole cell indicator loading
conditions can be valuable tool to help discriminate between different sources of
Zn2+ that contribute to

intracellular neuronal Zn2+ signals in adult brain slice

preparations.
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5.6 Figure Legends
Figure 5.1 Experimental approach for FluoZin-3 loading. The high affinity
Zn2+ indicator FluoZin3 was loaded in hippocampal CA1 pyramidal neurons in
acute brain slices via patch-pipettes.

A: Three different intracellular dialyses

effects were compared; short dialysis (top), standard dialysis (middle) and
standard dialysis supplemented with 0.5 µM MT3 (bottom). In order to achieve
similar intracellular indicator concentrations, different concentration of indicator
concentrations were used. Detailed methods are provided described in Method
and Results. B: Initial intracellular Zn2+ concentrations were compared based on
their maximum fluorescence obtained by exposure to saturating concentration of
ZnPyr (100 µM ZnCl2 and 5 µM pyrithione, 20 minutes).

A briefly dialyzed

neuron is shown, after recovery (basal level) and then following ZnPyr exposure.
C: Comparisons of maximum fluorescence obtained from 5 neurons differently
indicator loaded in each condition. Results are transformed to the estimated
FluoZin3-Zn2+ concentration (see Methods). No significant differences were in
estimated resting levels (p<0.5). n=5 each.

Figure 5.2 Intracellular Zn2+ concentration changes following exposure to 1
µM ZnPyr. FluoZin-3-loaded neurons were exposed to 1 µM ZnPyr (1 µM ZnCl 2
and 1 µM sodium pyrithione, 20 minutes), followed by 20 µM TPEN. A-C Plots of
responses from 5 individual neurons. D. Quantitative analysis of peak FluoZin3
responses. ***p<0.005,
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Figure 5.3 Intracellular dialysis effect on oxidation dependent intracellular
Zn2+ release.

FluoZin-3-loaded loaded neurons were challenged with ACSF

containing 200 µM DTDP.

After significant Zn2+ responses were obtained,

neurons were exposed to 20 µM TPEN. A-C shows responses from 5 individual
neurons and D shows a quantitative analysis of peak responses. ***p<0.005

Figure 5.4 Intracellular dialysis effects on intracellular Zn2+ accumulation
following synaptic stimulation. FluoZin3-loaded neurons from WT and ZnT3
KO slices are shown, with three different intracellular dialysis methods.
Following recovery slices were challenged with Schaffer collateral synaptic
stimulation (20 Hz, 10 s). Panels A-F shows individual responses obtained from
5 neurons in each preparation. Peak responses were obtained following data
reduced traces and are compared in G. ***p<0.005
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6. Discussion

6.1 Summary of the present studies
The present dissertation studies addressed how tissue metabolism can
influence consequences of SD and synaptic Zn2+ release.

Experiments in

Chapter 2 suggested a critical role of an excitatory phase during the late-SD
phase in determining recoverability of SD when energy metabolism was limited.
Injurious consequences of SD were reliably reversed by an NMDAR antagonist,
applied specifically in the late-SD phase. These results suggest a significant
contribution of glutamate toxicity to SD-dependent injury.
Studies in Chapters 3&4 evaluated inhibitory effects of Zn2+ on SD
propagation and initiation. These studies revealed different Zn 2+ sensitivities of
SD, depending on local oxygen concentrations. Mechanistic studies suggested
that this was due in part to redox modulation of extracellular sites under
conditions of severe hypoxia.

In fact redox modulation alone significantly

reversed the Zn2+ sensitivity of NMDARs and SD under hypoxia. These studies
not only provided new insights into the roles of synaptic Zn 2+ release in SD
regulation, but also revealed an important influence of local tissue metabolism on
NMDAR pharmacology.
Experiments in Chapter 4 did not directly test roles of Zn 2+, but provided a
technical advance to evaluation of neuronal intracellular Zn 2+ homeostasis. The
experiments revealed a vulnerability of intracellular Zn2+ homeostasis to

185

intracellular dialysis, and demonstrated the use of different recording conditions
to selectively detect synaptic Zn2+ influx in acute brain slice preparations. This
recording technique should provide a useful approach for evaluating intracellular
Zn2+ buffering capacity and contributions of synaptic influx in ischemia relevant
conditions.

6.2 Excitotoxicity

6.2.1 Contributions of SD to delayed ischemic neuronal death
One of the important conclusions of the present work is that NMDAR
activation during SD can trigger excitotoxic neuronal death.

The result in

Chapter 2 revealed that KCl-induced SD, which is normally fully recoverable in
healthy tissues, became highly injurious when it involved metabolically
compromised neurons. This was due to a brief period of NMDAR activation
during the late phase of SD, as demonstrated by the finding that preventing
NMDAR activation specifically during the late-SD period was sufficient to prevent
neuronal injury. The presence of injurious NMDAR activation during the late-SD
phase is consistent with the clinical observations that prolonged DC potential
shifts were observed during SD in compromised tissue (Oliveira-Ferreira et al.,
2010; Hartings et al., 2011b). Thus the duration of extracellular potential shifts
could be an important clinical parameter to indicate the intensity of injurious
NMDAR activation. This hypothesis deserves further validation in experimental
stroke models as well as in clinical observations.
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As described earlier, the term “excitotoxicity” was originally defined by Olney,
who revealed that excessive excitatory neurotransmitter can cause neuronal
degeneration (Olney, 1969; Olney and Sharpe, 1969). The increased glutamate
release, NMDAR activation and NMDAR-dependent Ca2+ overload seen in the
present work suggest that SD-dependent neuronal injury can be categorized as
excitotoxicity. The similarity between SD-induced injury and excitotoxicity may
provide a significant new insight to motivate selectively targeting of NMDAR
dependent injury during SD and may help explain previous clinical failures in
NMDAR antagonists. While there appear to be many similarities between SDinduced injury and excitotoxicity induced by glutamate applications, because of
unique features of SD, the intensity of stimulation during SD may be much more
profound, and it is important to further understand SD dependent injury
processes to help identify relevant therapeutic targets.
SD-induced neuronal injury was characterized by Ca2+ deregulation and
membrane dysfunction and in this respect was similar to necrotic cell death seen
following intense NMDAR activation. Thus acute cell death induced by acute
glutamate exposure (500 µM glutamate for 5 minutes) was characterized by Ca2+
overload, significant cell swelling and subsequent membrane rupture (Choi et al.,
1987).

Excitotoxicity is often considered to be an event contributing to only

during the early phase of ischemic injury (Dirnagl et al., 1999).

However

because of the persistence of SD for long periods (even days) after initial stroke
injury (Dohmen et al., 2008), the present study significantly extends the
contribution of excitotoxic necrotic neuronal death following acute stroke injury.
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6.2.2 Aberrantly increased presynaptic activity in metabolically compromised
tissue
The studies in Chapter 2 revealed an important contribution of a brief
period of excitation during SD, and provided evidence that this involved
increased glutamate release.

Thus presynaptic activity was significantly

enhanced during the late SD phase and concomitant NMDAR activation was
critical for determining injurious consequences of SD. While the contribution of
glutamate release to injurious NMDAR activation was not directly confirmed, the
aberrant release during the late SD phase could be a potential target to prevent
SD induced injury in metabolically compromised tissue. Some of the potential
mechanisms underlying increased presynaptic activity during SD were already
speculated upon in Chapter 2 and will not be repeated here. Instead, the general
discussion here will focus mainly on potential links between aberrant glutamate
release and tissue metabolism.
In severe hypoxia, action potential-dependent presynaptic glutamate
release is suppressed by an adenosine-dependent mechanism (Rudolphi et al.,
1992; Tanaka et al., 2001). Such a mechanism may underlie the rapid loss of
consciousness observed following cerebral arterial occlusion in humans
mentioned in the Introduction (Rossen et al., 1943). However under extreme
metabolic stress, such as produced by oxygen and glucose deprivation in vitro,
the frequency of spontaneous glutamate release was significantly increased
(Hershkowitz et al., 1993; Katchman and Hershkowitz, 1993; Andrade and Rossi,
2010; Ye et al., 2010). This aberrant excitatory synaptic activity may underlie the
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important discovery made by Rothman concerning the basis of excitotoxicity in
ischemic brain injury (see Introduction 1.4.2). An increase of synaptic activity
can also be seen following oxygen glucose deprivation in the preparations used
in the present studies (Supplementary Figures A1&2).

Recording of

spontaneous EPSCs reliably revealed high frequency EPSCs prior to the onset
of OGD-SD (Appendix Figure A1).

A similar observation was made when

recording evoked fEPSPs (Appendix Figure A2).

While action potential

dependent release was suppressed following OGD, sustained exposure to OGD
resulted in a transient recovery of action potential-dependent evoked response ~
1minute before SD onset. During this phase, the paired pulse ratio was always
reduced, indicating that action potential dependent release recovered and was
actually enhanced just before the arrival of OGD-SD. The enhanced sEPSC and
action potential-dependent release are quite similar to the excitatory phase seen
during the late phase of SDs generated by localized KCl microinjections (K-SD,
Chapter 2). In both situations, increased release was observed when tissue
energy metabolism was expected to be severely compromised (i.e. continuous
depletion of energy substrate in OGD, and increased energy demand during the
late phase of K-SD).

Thus it is possible that severe metabolic stress generally

elevates presynaptic release probability and contributes to the excitatory phases
with both stimuli.

A prior study has examined underlying mechanisms of OGD-

induced increased synaptic release (Andrade and Rossi, 2010). The increase is
not Ca2+ dependent, as removal of extracellular Ca2+ did not prevent EPSC
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frequency increases.

Instead, presynaptic actin depolymerization has been

suggested as a potential contributor (Andrade and Rossi, 2010).
An excitatory phase characterized by increased presynaptic release
probability seems to be important for both K-SD and OGD-SD models.

As

discussed in Chapter 2, this excitatory phase seems to be critical for determining
consequences of K-SD in metabolically compromised neurons. In the OGD-SD
model, such an excitatory phase occurs prior to the wavefront of SD and
increased discharge may contribute to elevation of extracellular potassium
concentrations ahead of SD.

Based on Grafstein’s potassium hypothesis

(Grafstein, 1956), such an increased potassium concentration may allow SD to
propagate independently of NMDAR activation and thus reduce the therapeutic
values of NMDAR antagonists.

Thus understanding and block of aberrant

glutamate release in K-SD may significantly ameliorate injurious consequences
of SD, and in the OGD model, block of prodromal excitation could significantly
enhance NMDAR antagonist to block SD propagation.
The studies presented in Chapter 2 concentrated on excitatory
transmission, but additional studies were conducted to also evaluate inhibitory
synaptic activity (IPSC) during SD generated by KCl microinjection (Appendix
Figure A3).

These experiments highlight different effects on transmission,

comparing glutamate and GABA during SD.

Isolated IPSCs showed a rapid

increase in frequency prior to SD onset, followed by a large outward current.
Unlike EPSCs, IPSC frequency did not change following SD. The increased
IPSC frequency prior to SD also correlated with the discharge pattern of
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interneurons (Figure A4). Thus interneurons showed extremely high frequency
action potential trains ahead of SD onset, which were likely responsible for GABA
release prior to SD onset. These results highlight different regulation of excitatory
and inhibitory neurotransmitter release during K-SD. During the late-SD phase,
glutamate release was enhanced however GABA release was not. Thus in the
late SD phase there seems to be significant imbalance in glutamate-GABA
balance, which may contribute to the sustained dendritic Ca 2+ elevations
described in Chapter 2.

6.3 Pharmacological intervention of SD

6.3.1 Subpopulations of NMDARs and their activation during in SD
The studies in Chapters 3&4 determined the NMDAR antagonist
sensitivity of different forms of SDs. The results generally confirmed the efficacy
of NMDAR antagonist to prevent SD.

As described in Introduction, NMDAR

antagonism is currently one of the most attractive approaches being considered
to limit the incidence of SD.

In addition to complete prevention of SD, the

present work also suggests that NMDAR activation is critical for determining
injurious consequences of SD, including following stroke.

However the well-

recognized failures of NMDAR antagonists in clinical trials have indicated that
simple administration of NMDAR antagonists is not effective for stroke
(Introduction 1.3.2). These failures may be due in part to the fact that NMDAR
activation during SD may have unique features, and require targeting of selective
receptor subtypes and/or timing of antagonist application.
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The following

discussion will examine different NMDAR populations identified previously and
their potential contribution to SD and SD induced injury.
The simplest distinction between NMDAR subtypes can be made based
on their composition, or different GluN1 splicing variants and GluN2 subunit
content.

Such subunit composition can strongly modulate the biophysical

properties of NMDAR channels.

GluN1 mRNA can be spliced in at least 8

variants and the presence of exon-5 can influence the deactivation kinetics of
some NMDAR currents by as much as 300% (Vance et al., 2012). The GluN2
subunit also affects the desensitization kinetics of NMDARs such that GluN2A
containing receptors deactivate faster than GluN2B containing receptors (Erreger
et al., 2005). In addition to different biophysical properties, the cytoplasmic tails
of GluN2 subunits significantly differ in their interaction with postsynaptic density
proteins, and the GluN2 subunit composition significantly influences the degree
of excitotoxic insult following NMDAR activation (Martel et al., 2012). It was
suggested that selectively targeting different GluN2 subunits, may be beneficial
for blocking excitotoxicity (Nikam and Meltzer, 2002; Liu et al., 2004). The
sensitivities of OGD-SD to NMDAR antagonists were tested in Chapter 4 and
revealed that most of antagonists had some inhibitory effect on OGD-SD. Of the
antagonists used, Zn2+ and Ro25-6981 had some subunit selectivity. Thus Zn2+
preferentially inhibits GluN2A while Ro25-6981 blocks GluN2B containing
receptors (Paoletti and Neyton, 2007).

The results indicated that Zn2+ could

inhibit both SD propagation and initiation, while Ro25-6981 only inhibited SD
onset and did not affect propagation rate. While Zn 2+ at this concentration likely
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inhibited some of GluN2B containing receptors (Paoletti and Neyton, 2007), the
data suggest that activation of both GluN2A and GluN2B containing receptors
are important for SD initiation, while SD propagation can be conducted mainly by
GluN2A containing receptors. A similar conclusion was obtained in an additional
experiment, testing the sensitivity of ouabain SD to Zn 2+ and ifenprodil, another
GluN2B selective antagonist (Appendix Figure A5). The results was similar to
OGD-SD, thus SD propagation was more sensitive to Zn 2+, whereas ifenprodil
was without effect on ouabain-SD. The onset of ouabain-SD was not influenced
by either antagonist alone, but was significantly delayed when both Zn2+ and
ouabain were co-applied.

GluN2A containing receptors have relatively faster

activation kinetics compared with GluN2B containing receptors and it is possible
that at the propagating SD wavefront, GluN2A containing receptors may be more
important for driving depolarization in adjacent tissue. In contrast to propagation,
the initiation of SD appears more insensitive to receptor kinetics, and the amount
of charge transfer mediated by NMDARs may be more important. However Zn 2+
at 100 µM should have inhibited some fraction of GluN2B as well as GluN2A
receptor populations (Paoletti and Neyton, 2007). In addition, results from
Chapter 4 indicate that the efficacies of antagonists can be significantly
modulated by the extracellular environment. Thus it is possible that efficacy of
the NR2B blockers was been reduced by pH, redox or local ionic strength.

At

this point, the present study cannot make a strong conclusion to support or reject
the benefit of targeting specific GluN2 populations for SD. In the absence of
receptor antagonists with higher subunit specificity, future tests for GluN2 subunit
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selectivity could be conducted using preparations where specific GluN2 subunits
have been genetically ablated.
NMDARs can also be classified into different populations based on their
cellular localization. One major and potentially relevant classification is based on
synaptic and extrasynaptic sites. While synaptic NMDARs are coupled tightly
with signaling molecules present at postsynaptic densities, extrasynaptic NMDAR
are not, and Ca2+ influx from these different populations can activate different or
sometimes opposing signaling pathways (Hardingham and Bading, 2010).
Because of the high glutamate concentrations in ischemic brain regions,
activation of extrasynaptic receptors can occur in ischemic brain tissue.
Activation of specific downstream signaling pathways linked to extrasynaptic
receptors has therefore been considered an important neurodegenerative signal
(Stark and Bazan, 2011) (but see also Wroge et al., 2012). In addition to cellular
signaling pathways, extrasynaptic receptors may be less inhibited by synaptically
released Zn2+ and thus may contribute more to charge transfer and Ca 2+ influx
during SD. Selectively targeting extrasynaptic NMDARs has therefore long been
considered for selectively targeting neurodegenerative signaling. Memantine is
an NMDAR open channel blocker with a high off rate (Lipton, 2006). Some
studies claim that memantine is more selective for extrasynaptic receptors at
specific test concentrations (Lipton, 2006; Hardingham and Bading, 2010).
However there seems very little rationale for this conclusion and recent paper
has challenged claims of selectivity (Wroge et al., 2012).

Thus there are

currently limited approaches for selectively targeting extrasynaptic receptors. In
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this context, it is interesting that a very recent study demonstrated that synaptic
NMDAR utilize D-serine as a coagonist while extrasynaptic NMDARs appear to
use glycine for their activation (Papouin et al., 2012). While it is not known
whether such selectively may persist during SD, this study raises the possibility
of selectively inhibiting synaptic and extrasynaptic NMDAR population, to modify
SD.
There is a study suggesting that different pools of NMDARs are present
even at synaptic sites (Atasoy et al., 2008). This study showed that spontaneous
glutamate release (contributing to sEPSCs) and evoked glutamate release
activates distinct pools of NMDARs.

In addition, NMDARs are expressed at

silent synapses (Kerchner and Nicoll, 2008). Silent synapses either do not have
sufficient glutamate release, or do not express sufficient AMPA receptors to
generate significant postsynaptic current. Thus even in the presence of NMDAR
surface expression they do not yield NMDAR currents.

During SD, massive

glutamate waves and depolarization throughout entire postsynaptic neurons
could be sufficient to generate additional NMDAR current, which would then
seem to be difficult to target with an open channel blocker. Because of the
massive NMDAR activation during SD, the heterogeneity in synaptic NMDARs
may not be significant for determining SD initiation or propagation. However
these different populations of NMDAR may be important when considering
cellular signaling pathways.
In addition to postsynaptic NMDARs several studies have proposed the
presence of NMDARs at presynaptic terminals in cerebellar interneurons (e.g.
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Glitsch and Marty, 1999) and recently in hippocampal pyramidal neurons
(McGuinness et al., 2010; Larsen et al., 2011). In the latter studies, presynaptic
NMDARs are expected to be activated by glutamate release from the same
terminals and amplify Ca2+-dependent glutamate release processes.

Such a

mechanism may amplify postsynaptic ionic loading in ischemia (Zhou et al.,
2010b). However the contribution of presynaptic NMDARs seems to be very
difficult to unequivocally prove.

The NMDAR antagonist ifenprodil has been

shown to decrease presynaptic release probability by inhibiting P/Q type Ca 2+
channels in the basolateral amygdala (Delaney et al., 2012). In addition NMDAR
currents in dendrites can propagate and directly activate axonal Ca 2+ channels
(Christie and Jahr, 2008). As described in the Chapter 2, significant NMDAR
activation occurs after SD. Such dendritic NMDAR activation may increase
presynaptic glutamate release and contribute to the glutamate release in the
tissue where SD is propagating.

However the massive NMDAR activation

throughout SD makes it difficult to selectively determine a contribution of
presynaptic NMDARs to SD propagation.

6.3.2 Pharmacology of NMDAR antagonists during SD
The present study mainly used the competitive NMDAR antagonist AP5 to
evaluate contributions of NMDAR to SD and SD dependent injury. However as
will be discussed later, this compound is not ideal for therapeutic purposes. The
following discussion in this section will examine advantages and disadvantages
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of different NMDAR antagonists for targeting SD initiation/propagation as well as
SD dependent excitotoxic injury.
NMDAR channel blockers are often considered to be most potent
antagonists because of their slow dissociation kinetics.

In addition, use

dependent inhibition may be useful to preferentially target brain tissue where
NMDARs are severely over activated.

This class of antagonists includes

chemical analogues of PCP and includes MK801, memantine and ketamine.
Because of current clinical use of memantine and ketamine, open channel
blockers are likely the most feasible antagonist to be tested for SD in clinical
settings. A confound to the use of open-channel blockers is the fact that most
NMDAR open channel blockers (except for memantine) have significant
psychotomimetic activity. Thus PCP is used experimentally to induce
schizophrenia (Murray, 2002). One hypothesis for this effect is that open channel
NMDAR blockers shift the excitatory–inhibitory balance in the neocortex. This
effect is partly due to the fact that MK801 preferentially inhibits NMDAR
expressed in interneurons in vivo (Homayoun and Moghaddam, 2007; Wang and
Gao, 2012), and thus systemic injection of MK801 decreases the activity of
inhibitory neurons and increases the firing rate of pyramidal neurons.

This

preferential block is likely due to a high discharge rate of interneurons which
increases the probability of channel block.

In injured brain, GABA tone is

elevated (Clarkson et al., 2010) and NMDAR block rate by MK801 in
interneurons could be even higher.

Thus the acute effect of open channel

NMDAR blocker in the neocortex may be a disinhibition of glutamergic neurons

197

and the resultant increased excitability could decrease threshold for SD, an effect
that would obviously be undesirable in the injured brain.
Binding and dissociation kinetics of open channel blockers are often
measured at resting potential, however these kinetics are significantly reduced
when measured at severely depolarized membranes (MacDonald et al., 1991).
This is likely because actions of channel blockers are partly based on the cation
current, as is seen with voltage dependent Mg2+ block of NMDAR. Appendix
Figure A6, adapted from previous literature (MacDonald et al., 1991) and
presented in the appendix, shows an example of this phenomenon. At resting
potential (-60 mV) the open channel blocker PCP moves into the channel and
inhibits NMDAR current. However at +40mV, NMDAR current recovered from
channel block by PCP in a use-dependent manner, due to loss of charge
attraction of the blocker to the channel domain.

Binding properties of open

channel blockers can be quite variable and use-dependent recovery seen in this
reference paper utilized unphysiological recording conditions (+40 mV). However
these findings raise the possibility that even when NMDAR channels are
preblocked by MK801, some NMDARs recover during depolarization and a
significant amount of NMDAR may be available during the post-SD excitation
phase. Thus open channel blockers may be useful for preventing SD, but may
not be effective at preventing the excitatory phase critical for determining
injurious consequence of SD described in Chapter 2.
As noted above, NMDAR antagonist competitive for glutamate sites (e.g.
AP5) were used in the most of the present studies. This choice was made
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mainly because of the high selectivity of this agent, and the fact that AP5 could
be effectively washed out, thereby providing a useful for test for the specificity of
the drug effect. However in most experiments, high AP5 concentrations were
required to obtain reliable inhibitory effects on SD. Synaptically-evoked NMDAR
currents were usually blocked with 1-2 µM AP5, however full block of SD
required >100 µM and inhibition of post-SD excitation also required ~20 µM AP5.
Based on mechanisms of competitive action, these differences in concentration
could be simply be a reflection of the much higher glutamate concentrations
achieved during SD, compared with synaptic stimulation. This also suggests that
high concentrations of competitive antagonists will be required for prevention of
SD in various clinical settings. Competitive antagonists (both at glutamate and
glycine binding sites) generally do not have selectivity for different NMDAR
subpopulations (Paoletti and Neyton, 2007). Nonselective inhibition of NMDAR
activation required for block of SD would hinder physiological NMDAR activities
as well as NMDAR dependent regeneration process (Lo, 2008; Murphy and
Corbett, 2009). Thus the use of competitive antagonists could have significant
unfavorable side effects in clinical setting.
Another class of NMDAR antagonists includes allosteric modulators.
Ifenprodil, Ro25-6981 and Zn2+ belong to this category. Recent clinical studies
showed that a member of this class (Ro25-6981) is potentially useful as a novel
class of antidepressant (Pittenger et al., 2007) and some clinical studies have
confirmed this is safe to administer to human patients (Pittenger et al., 2007).
One of the characteristic features of this class is that most agents do not fully
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block NMDAR currents. Zn2+ inhibition of NMDAR (GluN1/GluN2A) produces
~70% block of maximum currents and ifenprodil-like compounds inhibit ~90%
(Paoletti and Neyton, 2007). In addition, the experiments in Chapter 3 suggest
that the binding sites of these antagonists could be sensitive to the extracellular
redox environment and protective effects may be limited in the context of severe
brain injury. Ifenprodil and Ro25-6981 were shown to reduce SD (Faria and
Mody, 2004; Peeters et al., 2007), and these compounds are potentially useful
for preventing SD, in such cases as brain trauma and subarachnoid hemorrhage.

6.3.3 Strategies to enhance efficacy of NMDAR antagonists
The studies in Chapter 4 revealed that hypoxia-dependent redox
modulation can be a confound for targeting NMDAR activation. In fact addition of
DTNB significantly increased pharmacosensitivities of OGD-SD to zinc, D-AP5
and Ro25-6981.

In addition to oxygen concentration, SD involves massive

changes in other extracellular environment such as pH and ionic strength. It is
not known whether these factors can modulate pharmacological compounds as
well as their targets.

Evaluation of these extracellular modifications on

pharmacosensitivity should be important for designing pharmacologically
targeting of SD occurring in severely injured brain.
In addition to modulation of the extracellular environment, studies in
Chapter 4 briefly discussed the observation that decreasing the intensity of SD
stimuli can significantly increase sensitivity of SD to NMDAR antagonists. For
example, the use of modified oxygen glucose deprivation (OGD) which retained
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15% glucose was necessary for revealing NMDAR sensitivity of OGD-SD.
Because of significant sensitivity of periinfarct depolarizations to NMDAR
antagonists, it is likely that such reduced SD stimuli are useful for evaluating
pharmacosensitivity of SD occurring in periinfarct tissue.
The increased NMDAR antagonist sensitivity seen with more moderate
stimuli could be explained by a reduced contribution of potassium ion
concentration to SD initiation/propagation. While speculative, it seems possible
that if SD initiation and propagation are regulated by additive contributions from
potassium and glutamate, decreasing potassium contribution should thereby
enhance the relative efficacy of NMDAR antagonists to prevent SD propagation.
Extracellular potassium clearance is regulated by the activities of Na +/K+ ATPase
activity and inward rectifier potassium channels, and support for cellular energy
metabolism may help these processes. This issue was addressed in additional
experiments (Appendix Figures A7, 8). OGD-SD is known to be highly resistant
to NMDAR antagonists however experiments in Figure A7 showed that addition
of glucose dramatically increased the sensitivity to NMDAR antagonist MK801.
Thus when the glucose concentration was elevated to 1.5 mM in OGD solutions,
the onset and propagation rates of OGD-SD did not change but became
significantly more sensitive to MK801.

In order to test whether increased

capacity for glycolysis decreased potassium and sensitized SD to NMDAR
antagonists, additional experiments were also conducted.

Contributions of

potassium were tested by adding additional KCl in OGD-solution. Under this
condition MK801 was ineffective at inhibiting SD. Similarly when glycolysis was
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inhibited by supplementation of iodoacetate (an inhibitor of glycolysis) MK801
sensitivity was also lost. While further experiments will be needed to verify
mechanisms, these results suggest that approaches to enhance tissue
metabolism could enhance efficacy of NMDAR antagonists.

6.3.4 Targets downstream of NMDAR activation in ischemic brain injury
The excitotoxic pathways revealed in the present study involve Ca 2+
deregulation and associated membrane compromise. As described earlier, these
are common features of excitoxic neuronal injury and the underlying mechanisms
have been extensively studied in prior work. Because of the diverse function of
NMDARs, NMDAR antagonists may not be ideal therapeutic compounds to limit
excitotoxicity. However the toxic downstream pathways of NMDAR activation are
very well studied in in vitro excitotoxicity models and several studies suggest the
value of targeting downstream of NMDAR activation, without targeting NMDARs
themselves. Direct evidence for a contribution of NMDAR-dependent signaling
pathways to neuronal death came from the neuroprotection produced by
disruption of NMDAR interaction with targets in rodent cortical neurons (Aarts et
al., 2002) and very recently in non-human primates (Cook et al., 2012).

As

discussed earlier, cellular signaling pathways activated by SD could be unique
and identification and selective block of these pathways may identify therapeutic
approaches to prevent acute brain injury with less unwanted off-target effects.
One of the most interesting classes of compounds is protein kinase
inhibitors.

As seen in the present study, NMDAR activation significantly
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prolonged neuronal depolarization and resultant depolarization should further
activate NMDAR by preventing voltage-dependent Mg2+ block. Thus preventing
persistent depolarization without affecting NMDAR should be beneficial for
decreasing injurious NMDAR activation. Interestingly PKC and PKA inhibitors
have been shown to enhance recoverability of neurons from cellular
depolarization following oxygen glucose deprivation (OGD) (Liu et al., 2005;
Murai et al., 2012). As described in the Introduction, OGD is a model of
irrecoverable anoxic depolarization and is very difficult to prevent. Furthermore,
once neurons were completely depolarized during OGD, neurons did not
spontaneously recover even after superfusion with oxygenated saline. However
in the presence of kinase inhibitors, neurons promptly recovered from OGD
challenges (Liu et al., 2005; Murai et al., 2012). Similar protective effects of
protein kinase inhibitors were observed in an excitotoxicity model. As discussed
in the Chapter 2, SD induced Ca2+ deregulation resembles closely those
observed in excitotoxicity models. Interestingly previous studies showed that
prolonged Ca2+ deregulation induced by NMDA or glutamate applications was
reliably prevented by a nonspecific kinase C inhibitor (Connor et al., 1988;
Wadman and Connor, 1992). These findings suggest that Ca2+ deregulation and
prolonged depolarization may not be simple loss of intracellular energy, but
rather is a consequence of activation of injurious signaling pathways.
In addition to Ca2+ deregulation, membrane compromise has been observed
in previous studies and several contributors have been identified.

Another

pathway potentially relevant to the present studies is opening of hemichannels. It
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was previously shown that anoxic depolarization can effectively open
hemichannels (Thompson et al., 2006). In that work, opening of hemichannels
was a downstream event of NMDAR activation and this pathway was augmented
by intracellular ATP depletion (Thompson et al., 2006; Thompson et al., 2008),
which is quite similar to the conditions in the current studies, where SD triggered
irrecoverable Ca2+ deregulation and membrane compromise. In several settings,
hemichannels are regulated by protein kinases (Bao et al., 2007; Liu et al., 2011)
but the significance of this regulation for neuronal injury has not been confirmed.
In the present studies, the contribution of hemichannels was evaluated in some
additional experiments evaluating the pharmacology of lucifer yellow leak in
metabolically compromised neurons. However carbenoxolone, a nonspecific
blocker for hemichannels did not prevent intracellular Lucifer yellow leak (n=2,
data not shown). While not conclusive, the present studies could not verify an
involvement of hemichannel activation in SD induced neuronal damage.
Another potential mechanism is activation of volume regulated anion channels
(VRAC) (Zhang et al., 2011). VRAC are activated by volume increases and allow
permeation not only of small anions (Cl-, SO4-), but also large molecules such as
ATP (MW: 507.18).

As seen in my studies, SD involves significant tissue

swelling responses and it is feasible that SD opens VRAC. Interestingly, PKC
was shown to be involved in activation of VRAC in some cell types
(Rudkouskaya et al., 2008), while the significance of this observation is not yet
confirmed for neurons. In addition to these possibilities, it is also possible that
loss of membrane integrity reflected membrane damage. It has been shown
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previously that NMDARs activate NADPH oxidase and generation of reactive
oxygen species caused lipid oxidation and potential damage plasma membrane
(Brennan et al., 2009). Interestingly this pathway also involves PKC activity and
some of the protective effect provided by kinase inhibitor could involve this
pathway.

6.3.5 Potential differences in cell signaling pathways in excitotoxicity and SD
Because of technical limitations, the present study focused mainly on acute
phases of injury.

However it is possible that SD can also trigger cytotoxic

signaling pathways involved in progressive cell death pathways such as
apoptosis, especially with milder insults. While necrotic cell death is prominent in
most excitotoxic models, apoptotic cell death can also be induced in by milder
stimuli in excitotoxicity models (Wang et al., 2009; Concannon et al., 2010;
Carlsson et al., 2011; D'Orsi et al., 2012; Sibarov et al., 2012). For example,
when neurons were exposed to a low concentration of NMDA (30-100 µM, 5
min), some fraction of neurons underwent rapid necrotic cell death, but a
considerable remaining fraction of neurons survived for hours, and progressively
died (D'Orsi et al., 2012). This delayed neuronal death was associated with
activation of apoptosis-associated molecules. However the relevance of these
pathways to SD dependent brain damage is not currently known. Understanding
of cell signaling pathways activated by SD is currently very limited, but includes
one report that SD in healthy tissue can upregulate MAPK activation, which in
turn was implicated in preconditioning effects (Chow et al., 2002).
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In order to evaluate contributions of SD to apoptotic pathways, future studies
of intracellular signaling pathways seem essential. Studies of cellular signaling
pathways associated with SD are currently very limited and further comparison
between panoptic signaling pathways activated by excitotoxicity and SD
becomes quite speculative.

However because cell signaling pathways are

amongst the most well studied topics in excitotoxicity, it seems appropriate to
consider some key differences between these pathways for SD mechanisms.
One of the differences between excitotoxicity and SD would be metabolic
burdens involved in these events and, while speculative, it is possible that
intracellular ATP depletion during SD can influence activities of some kinases not
seen in classical excitotoxicity. Kinases generally transfer the γ-phosphate of
ATP to target molecules and thus the activity is intrinsically ATP dependent.
Intracellular ATP concentration was previously estimated to be within a range of
0.8-1.4 mM (Ainscow et al., 2002), and with intracellular 1 mM Mg2+, free
intracellular ATP concentration is estimated to be ~400 µM (calculation based on
Maxchelator

(http://www.stanford.edu/~cpatton/maxc.html)).

The

apparent

affinities of relevant kinases for ATP are in the range of 10-30 µM (e.g. apparent
KD values for ATP: PKCα 20 µM, CaMKII 60 µM, ERK1 16 µM (values from
Setyawan et al., 1999)). Na+/K+ ATPase are another important ATP consumer
under conditions of ionic deregulation. The apparent affinity of Na +/K+ ATPase
for ATP significantly changes depending on the Na+/K+ concentration. At high
intracellular K+ (at rest), KD values for ATP are 200-400 µM, while at high
intracellular Na+ concentrations (e.g. during severe depolarization) K D values
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become ~30-100 nM (Jorgensen and Pedersen, 2001). If intracellular ATP is
severely depleted and all reactions follow simple linear thermodynamic gradients,
a large portion of the available ATP can be consumed by Na +/K+ ATPase, with
little ATP then being available for kinases. Simultaneously, some phosphatases
should be activated by Ca2+ flux through NMDAR and the ratio of protein
phosphorylation and dephosphorylation may significantly decrease. Therefore,
an intriguing possibility is that ATP availability could influence cell signaling being
activated following SD. For example, when large NMDAR activation occurs, Ca2+
influx likely simultaneously activates protein kinases and phosphatases.

In

healthy brain tissue, high kinase activity is supported by normal intracellular ATP
concentration and may overwhelm phosphatase activity and downstream effector
molecules that are activated. However, during SD, ionic deregulation (involving
high intracellular Na+ concentration) strongly activates Na+/K+ ATPase activity,
depletes intracellular ATP and may limit available ATP for kinases during the late
SD phase. Under such conditions, simultaneously activated phosphatases could
become dominant and silence signaling pathways. However as SD can be a
physiologically occurring excitotoxic signal, intracellular ATP concentration may
be an important factor and SD may potentially activate signaling cascades that
are quite different from those activated by a simple glutamate exposures.
The real situation may not be as simple as described above, as some kinases
are activated by decreased ATP/AMP ratio (e.g. AMP activated kinases
(Ramamurthy and Ronnett, 2012)). In addition hemichannel opening by NMDAR
activation was more pronounced when intracellular ATP concentrations were
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decreased (Thompson et al., 2006). However intracellular ATP concentration
changes may be a significant factor that influence the consequent kinase
cascades, and may not be revealed by the classic excitotoxicity models in which
stimulation would be accompanied by much milder metabolic stress.
Another important issue to consider is that most excitotoxic studies are
conducted in culture models in which mature vesicular Zn2+ content is absent. As
seen in Chapter 4, synaptic Zn2+ significantly contributes to intracellular Zn2+
accumulation of postsynaptic neurons. Some kinases such as Src kinase are
upregulated by Zn2+ and may enhance NMDAR currents (Manzerra et al., 2001).
Thus the absence of synaptic Zn2+ translocation mechanisms in excitotoxicity
models of cultured neurons may also be quite different from signaling pathways
following SD in more complex preparations.

6.4 Roles of synaptic Zn2+ release in the regulation of SD

6.4.1 Extracellular action of synaptic Zn2+ release
One of the aims of the present studies was to ask whether extracellular
Zn2+ has any deleterious effect in the context of SD.

The present study

concluded that Zn2+ was actually inhibitory for some SD. While the sensitivity to
hypoxia-dependent redox modulation suggested a limited protective effect in
ischemic injury, such mechanism may be important in some injury such as brain
trauma. While direct tests could not be achieved (see Discussion in Chapter 3),
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the strong correlation between Zn2+ inhibition of NMDAR and SD suggested
NMDAR as a relevant target of Zn2+ that contributes to SD inhibition.
Extracellular Zn2+ concentrations can reach 300 µM at the synaptic cleft
(Howell et al., 1984) and extracellular Zn2+ at this concentration has been shown
to inhibit many ion channels.

The present studies showed that 100 µM of

exogenously applied ZnCl2 is sufficient to inhibit SD propagation (Chapter 3&4).
Based on previous literature (Frederickson et al., 2005), it is likely that many
channels were inhibited by extracellular Zn2+ at this concentration.

However

screening of potential Zn2+ targets in the present study did not show effects of
ZnCl2 on intrinsic excitability, or paired pulse facilitation. In addition to the data
shown in Chapter 3, Zn2+ effects was tested on sEPSCs and sIPSCs in additional
experiments (Appendix Figure A8).

Interestingly sEPSC frequency (but not

amplitude) was increased by bath application of 100 µM Zn 2+, whereas neither
sIPSC frequency nor amplitude was significantly affected. While the sEPSC
frequency increase was significant, based on Zn2+ effects on other neuronal
functions, from these screening experiments it was concluded that 100 µM ZnCl 2
had relatively minor effects on overall excitability in the hippocampal slice model.
The absence of a strong Zn2+ effect on GABA currents was unexpected because
GABAA currents was one of the first identified Zn2+ sensitive targets (Westbrook
and Mayer, 1987). The lack of effect here is likely because the system used to
assess Zn2+ sensitivity is quite different. Thus Zn2+ sensitive GABAA receptors
seen in prior work has been receptors lacking γ-subunits (Hosie et al., 2003).
This effect may therefore be relevant for some brain subregion or in recordings
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from immature preparations, but these sensitive channels are likely absent in
cortex and hippocampus of adult animals where αβγ-containing GABAA receptors
predominate (Moss and Smart, 2001; Smart et al., 2004). This emphasizes the
importance of testing Zn2+ sensitivity of targets in comparable experimental
conditions.
Zn2+ recently has been shown to upregulate KCC2 activity via interaction
with the metabotropic receptor GPR39 (Chorin et al., 2011).

The resultant

increased Cl- extrusion rate will increase charge transfer by GABAA channels and
likely decrease excitability. The contribution of KCC2 upregulation could have
been missed in the present studies because intracellular Cl- concentrations were
clamped by the pipette solution. While the discussion here did not cover all Zn 2+
sensitive or responsive molecules, these studies illustrate that Zn 2+ is not toxic as
long as it is present in the extracellular space and Zn2+ can even be protective for
neurons by decreasing excitability. These studies support the idea that
selectively blocking intracellular Zn2+ accumulation, with minimally affecting
extracellular Zn2+ concentration could be more beneficial for stroke injury (but see
Discussion section of Chapter 4, regarding Zn2+ effects on SD propagation).

6.4.2 Intracellular Zn2+ accumulation following synaptically released Zn2+
The present study identified a significant contribution of synaptic Zn 2+
release to intracellular Zn2+ accumulation in postsynaptic neurons (Chapter 5,
Supplemental Figure A10). This was done by comparison between intracellular
Zn2+ responses in WT and ZnT3 KO preparations. Prior to the studies in Chapter
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5, most single cell Zn2+ imaging study aimed to minimally-disrupt intracellular
Zn2+ homeostasis by loading the Zn2+ indicator into neurons using either sharp
microelectrodes electrode (Dietz et al., 2008) or very brief dialysis of intracellular
component with conventional patch pipettes (Medvedeva et al., 2009; Vander
Jagt et al., 2009). However under those recording conditions, it was not clarified
whether or not synaptic Zn2+ translocation was detected.
The studies in Chapter 4 examined the effects of dialysis on intracellular
Zn2+ accumulation, and concluded that standard electrophysiological recording
methods (e.g. 20 min dialysis) markedly disrupted intracellular Zn 2+ signals. This
appears to be due to loss of intracellular Zn2+ buffering, and is matched by
decreases in Zn2+ liberation from intracellular stores by oxidant exposure. These
findings, together with the fact that supplementation with recombinant MT3 was
sufficient to reverse this effect, suggests that washout of metallothionein 3 (or a
related Zn2+ buffer) could underlie the observations. By comparison between
responses seen with different dialysis conditions, in both WT and ZnT3 KO
preparations, it was possible to conclude that both intracellular liberation of Zn 2+,
and accumulation of synaptically-released Zn2+ contributes to intracellular
increases after synaptic stimulation. Thus intracellular Zn2+ dialysis may be a
very valuable method to accurately assess contributions from synaptic Zn 2+
translocation. These methods may be applicable to other stimuli and be used to
identify/evaluate contribution of synaptic Zn2+ translocation and intracellular Zn2+
release to, for example, intracellular Zn2+ accumulation contributing to ischemic
neuronal brain injury.
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Many Zn2+ studies have focused on neurotoxic roles of intracellular Zn 2+
accumulation in the context of ischemic brain injury. Synaptic Zn2+ release is one
potential source for intracellular Zn2+ accumulation. However most Zn2+ toxicity
has been tested by exogenous Zn2+ applications (Koh and Choi, 1988; , but see
Aizenman et al., 2000; Sheline et al., 2000; Bonanni et al., 2006), and the
source(s) of toxic intracellular Zn2+ accumulation is not well studied. These
sources are important for understanding the mechanism for neuroprotective
effects of CaEDTA in stroke studies.
CaEDTA is a high affinity Zn2+ chelator, but its kinetics are limited by the
need for dissociation of Ca2+ prior to stable interaction with Zn2+. This restricts its
ability to eliminate rapid extracellular Zn2+ concentration elevations.

In brain

slices, Zn2+ release following synaptic stimulation or SD results in a biphasic
response, an initial sharp extracellular Zn2+ elevation and secondary slow
accumulation response (Appendix Figure A10, (Qian and Noebels, 2005; Carter
et al., 2011a). My studies of intracellular Zn2+ imaging suggest that CaEDTA
cannot capture the fast component of Zn2+ release and this allows significant
Zn2+ influx into postsynaptic neurons. Thus it is unlikely that neuroprotection
provided with CaEDTA is due to prevention of fast synaptic Zn 2+ translocation.
My studies also indicate that a slow component of extracellular Zn2+ responses
unlikely contributes to postsynaptic Zn2+ accumulation. When intracellular Zn2+
accumulation responses were compared between with or without CaEDTA,
intracellular Zn2+ responses during SD were significantly decreased by CaEDTA
but the effect on kinetics was very small compared with the CaEDTA effect on
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extracellular Zn2+ response (Appendix Figure A10). In brain slice experiments,
ACSF is contaminated by Zn2+ originating from the surface of glassware or in
recording solutions (Kay, 2004), and this significantly contributed to Zn2+
responses in ZnT3 KO preparations. By considering the effects of removal of
contaminating Zn2+ on the kinetics of intracellular FluoZin3 responses, it is likely
that the contribution of slow components of extracellular Zn2+ release to
intracellular accumulation is quite small. Therefore synaptic Zn2+ translocation
appears mainly mediated by the rapid Zn2+ release following the SD stimulation
and the slow component of the released Zn 2+ is unlikely to contribute to acute
Zn2+ accumulation.
In addition to acute Zn2+ accumulation by synaptic Zn2+ translocation,
transmembrane Zn2+ flux can occur when extracellular Zn2+ concentration is
elevated by exogenous application of ZnCl2.

In fact the studies with bath

application of 100 µM ZnCl2 revealed that a significant amount of Zn2+ can
accumulate in the neurons (Figure 3.1E) likely via passive Zn 2+ uptake by the
activities of Zn2+ transporters.

Studies of ZIP transporters suggest that

neurotoxic intracellular Zn2+ accumulation is mediated by ZIP1 and ZIP3
transporters during seizures (Qian et al., 2011). This raises the possibility that
during seizure or ischemia, Zn2+ accumulates in the extracellular space and
neurons passively uptake Zn2+ in amounts sufficient to trigger neurotoxic
pathways.
In contrast to uptake mechanisms, regulatory mechanisms for extracellular
Zn2+ accumulation and clearance are not well under stood.
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This is partly

because regulation of extracellular Zn2+ concentrations in vivo has not been very
actively studied.

Early studies using radiolabeled Zn2+ showed that dietary

administered Zn2+ was found mainly in the choroid plexus (CP), and some in
brain tissue (Kasarskis, 1984).
contained relatively higher
the presence of high

Among brain tissues, periventricular tissue
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Zn2+ levels. Although the evidence is very limited,

65

Zn2+ concentrations in the CP suggests that most serum

Zn2+ is filtered at the CP and this system first limits Zn2+ entry into brain tissue. In
addition, the localization of

65

Zn2+ in the periventricular zone, and the absence of

65

Zn2+ in the CSF suggest that small amounts of Zn2+ are provided to CSF, but

most can be effectively absorbed by brain tissues. Effective Zn 2+ absorption by
brain tissue does not necessarily mean uptake by neurons or glia (although
cellular uptake is feasible). One of the interesting possibilities is that Zn 2+ forms
precipitates in the extracellular space. Zn2+ is very insoluble in phosphatecontaining solutions. In ACSF containing 1.25 mM phosphate, Zn2+ above 10 µM
immediately formed precipitates (unpublished observation, consistent with
(Rumschik et al., 2009)).

Thus it is possible that most Zn2+ actually forms

precipitates and did not contribute to extracellular Zn2+ concentration in vivo. In
addition to precipitation, there is evidence that metallothionein is expressed in the
extracellular space and can chelate extracellular Zn2+ in brain tissue (Chung et
al., 2008). This immobilized Zn2+ may be solubilized by acidification (e.g. after
SD) and then may be slowly taken up by local neurons or glia.
A more complete understanding of extracellular Zn2+ homeostasis will be
important for fully understanding of synaptic Zn2+ release, its contribution to
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intracellular Zn2+ accumulation and extracellular actions.

It is not known, for

example, for how long Zn2+ may block NMDAR at synaptic sites. In addition, little
is known concerning how mobilized or immobilized extracellular Zn 2+ can interact
with Zn2+ influx proteins (ZIP) to internalize into postsynaptic neurons.

6.4.3 Tentative quantitative analysis of intracellular Zn2+ accumulation
Intracellular Zn2+ homeostasis was characterized in studies Chapter 5 and
confirmed a strong intracellular Zn2+ buffer capacity of CA1 neurons in acute slice
preparations. While that result was expected from prior experiments in neuronal
cultures, the new results suggest that intracellular Zn2+ homeostasis can be
studies even in acute rain slice preparations, which retain many important
features of intact brain tissue. One of the interesting new findings data was that
intracellular Zn2+ concentration of resting neurons is extremely low, regardless of
the degree of neuronal dialysis. In fact indicator saturation seen after exposures
to 100 µM ZnPyr was extremely large and revealed ΔF/F0: 4000%. Following
exposure to the Zn2+ chelator TPEN, intracellular FluoZin3 signals were almost
ΔF/F0: 0. A KD value of FluoZin3 for Zn2+ was reported to be ~15 nM. By using
an approach described in (Grynkiewicz et al., 1985) (while it may not be fully
appropriate) the resting intracellular Zn2+ concentration was estimated to be ~500
pM. This result itself is not surprising as many papers report intracellular free
Zn2+ that are extremely low, or even absent (Colvin et al., 2008; Sensi et al.,
2011). However if this estimated value is true, or at least approximates true
intracellular Zn2+ concentrations, it is possible that the magnitude of intracellular
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Zn2+ responses described throughout this dissertation are actually very small,
and may not be sufficient to trigger degenerative signaling.
To assess this possibility, the magnitude of intracellular Zn 2+ responses
during SD generated with KCl (K-SD) were assessed as part of an additional
study conducted in collaboration during the time of this dissertation work (Carter
et al., 2011a). Those experiments revealed that the intracellular FluoZin3 signal
changes were between ΔF/F0:100-200% during SD. From a simple estimation
based on initial resting Zn2+ concentrations discussed above, the intracellular
Zn2+ concentration change was estimated to be <1 nM. Previously work has not
determined the exact amount of Zn2+ required to exert its toxicity, but one of the
lowest Zn2+ concentrations demonstrated to exert toxicity was about 10-100 nM,
which can be sufficient to open mitochondrial permeability transition pores in
isolated mitochondria (Jiang et al., 2001). Because of the low intracellular Zn2+
responses and relatively rapid recovery seen after SD (~1 minute, Figure A10), it
unlikely that intracellular Zn2+ response during K-SD reached threshold
concentrations required to trigger neurotoxic pathways. Such low intracellular
Zn2+ concentrations achieved during K-SD may be reasonable, considering the
full recoverability of brain tissue to this form of SD. .
It is important to consider that these values are estimated from soma, and
dendritic Zn2+ concentrations have not been accurately determined. Because of
the large surface to volume ratio and higher synaptic density in dendrites,
intracellular Zn2+

concentrations are

expected

to be

higher in

these

compartments. Dendritic imaging with FluoZin3 was technically challenging
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because of the high background fluorescence and low FluoZin3 signal due to the
low intracellular Zn2+ concentrations. While higher concentrations of FluoZin3
should improve visualization of dendrite, FluoZin3 will significantly disrupt
endogenous Zn2+

buffering.

For example,

intracellular metallothionein

concentration is estimated to be ~300 nM, and the Zn 2+ affinity of the weakest
Zn2+ binding sites in MT3 is lower than of FluoZin3. In my experimental setup, 40
µM FluoZin3 was required for detection, even in soma. With 40 µM intracellular
FluoZin3, a substantial fraction of Zn2+ should be bound by FluoZin3. Higher
concentrations should have a further impact on intracellular Zn2+ buffering and
would likely compromise endogenous responses.

Based on the low basal

intracellular Zn2+ concentration and small Zn2+ responses, a fluorescence
indicator quenched by Zn2+ (rather than activated by it) may be more beneficial
for dendritic Zn2+ measurements.
Throughout the studies, toxicity of endogenous Zn 2+ was not obvious in
the acute toxicity models, while intracellular Zn2+ loading with ZnPyr showed
some toxicity. Based on these intracellular Zn2+ measurements from soma, low
intracellular Zn2+ concentrations achieved by endogenous Zn2+ release
mechanisms seem to be the reason for the lack of acute Zn 2+ toxicity. However
based on excitotoxicity studies, dendrites are the most vulnerable neuronal
compartment. Visualization of dendritic Zn2+ concentration may be necessary to
examine whether endogenous Zn2+ can reach toxic concentrations in those
compartments.
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6.4.4 Tissue metabolism and intracellular Zn2+homeostasis
One interesting question is whether intracellular Zn2+ homeostasis can be
modulated by tissue metabolism. Intracellular Zn 2+ buffer capacity could be a
particularly important component of intracellular Zn2+ homeostasis in the context
of metabolic compromise because, as discussed earlier, presynaptic activity is
aberrantly increased under conditions of metabolic stress (section 5.2.2.). Thus
neurons are expected to be exposed to synaptically released Zn 2+ under
metabolically compromised tissue and without significant intracellular buffering,
intracellular Zn2+ concentrations could readily elevate.
There are reports suggesting that endogenous Zn2+ buffer systems,
especially MT, can be sensitive to intracellular ATP concentrations (Jiang et al.,
1998). While MT is generally a short peptide, MT directly bind with glutathione
and ATP, and such interactions can significantly change MT’s ability to transfer
Zn2+ to high affinity binding sites (Jiang et al., 1998). Thus ATP binding can
increase transfer of MT3 bound Zn2+ to higher affinity sites. ATP binding to MT is
also modulated by the ratio of reduced/oxidized glutathione (GSH/GSSG). The
presence of GSH decreases MT3-ATP binding whereas GSSG promotes MTATP interactions. An important consideration is the low affinity of MT for ATP,
and this was estimated to be ~170 µM (Jiang et al., 1998). These values were
obtained in the absence of Mg2+ and the apparent affinity in vivo will likely be
lower. Under ischemic conditions, intracellular ATP can drop to ~12% (Mies and
Paschen, 1984), and potentially saturate intracellular MT with Zn2+, thereby
decreasing buffering capacity. In the present study, this was tested by imaging
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intracellular Zn2+ in briefly dialyzed neurons during OGD (Supplementary Figure
A11).

OGD significantly elevated intracellular Zn2+ prior to SD, but Zn2+

accumulation was absent or very small in ZnT3 KO preparations. During OGD,
presynaptic activity significantly increased (Figure A1&2). The correlation with
presynaptic activity suggests that significant synaptic Zn2+ translocation occurred
during the exposure to OGD. It is noted that synaptic stimulation in some
preparations resulted in almost equal intracellular Zn2+ accumulation in WT and
ZnT3 KO preparations (Chapter 5). These preliminary results support the idea
that metabolic stress significantly decreases intracellular Zn2+ buffering in
neurons and makes neurons more sensitive to Zn2+ influx. Further studies will be
needed to validate this possibility.

6.5 Confounds of the present study and future directions

6.5.1 Model to test neuronal injury following SD
Ischemic brain injury is usually studied in one of three different
preparations; neuronal cultures, acute brain slices or in vivo.

These three

preparations are quite different and data obtained from different system should
be carefully compared.
One of the important differences is their thresholds for metabolic
inhibition. This seems to be attributable to differences in energy metabolism
between these preparations; however this aspect is rarely addressed. The most
significant difference would be their oxygen demands. Neuronal cultures are
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successfully maintained in mixed gas containing 21% O 2, which is higher than in
vivo oxygen concentrations in vivo, which in turn is usually considered to be
~10% (Ndubuizu and LaManna, 2007).

However such a difference is much

smaller when compared with the fact that acute brain slices are generally
maintained in 95% O2.

It is noted here that the experiments in chapter 4

revealed that 21% is already hypoxic for neurons and evoked synaptic
transmission was severely suppressed at this O2 concentration.

The high

sensitivity of brain slices to oxygen concentration is due to the extremely high
oxygen demand of these preparations. There are several studies of tissue
oxygenation of brain slices and these studies generally report a remarkably high
oxygen consumption of brain slice even at rest (Hall and Attwell, 2008; Galeffi et
al., 2011; Hall et al., 2012). A study using O2 sensitive electrode and 300 µm
thick hippocampal slices revealed an O2 concentration drop from 550 µM (95%
O2/5% CO2 mix gas) to ~400 µM (or 70% saturation) at the slice surface, and
further decreased to 220 µM O2 (or >50% saturation) at 100 µm below the
surface of the slice (Hall et al., 2012). It is important note that O2 concentration
in brain slices is purely determined by diffusion from superfusate and thus the
low tissue O2 concentrations is mainly due to consumption by brain tissue.
Neuronal cell bodies are usually ~20 µm in diameter and thus in a 300 µm slice
there are at least 15 layers of neurons. This is quite different from neurons in
culture medium, which are often maintained as a single layer at much lower
densities. Because of the lower local O2 consumption rate and direct exposure
to O2 containing media, 21% O2 should be sufficient for maintaining cultured
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neurons. In brain, O2 may be even more effectively delivered to local tissue with
capillary delivery. Functional neurovascular coupling should be also effective for
providing O2 on demand after SD.
In brain slice experiments, the steep O2 gradient may not be a problem as
long as neuronal activities are recorded from the slice surface; however SD
propagation involves a volume of tissue, including the surface, center and
possibly also bottom of the brain slice. The metabolic burden during SD will
increase oxygen consumption rate and generate tissue hypoxia (Galeffi et al.,
2011). Because of poor supply to center part of the slice, brain slices may be
experiencing more severe hypoxic stress during SD than neurons in vivo, despite
the fact that brain slice is oxygenated with 95% O 2 and O2 concentrations in vivo
are often assumed to be much lower. A previous study in vivo showed that
decreased tissue oxygenation can significantly prolong DC shift (Takano et al.,
2007). Thus the low oxygenation of brain slice may explain why saddle-like DC
shifts are reliably detected in brain slices, whereas monophasic DC shifts are
common in the SD generated by KCl in healthy tissue.

Most single cell

recordings in the present studies were conducted from neurons present >100 µm
distant from the surface the brain surface. Given the exposure to high oxygen
concentration, these single cell responses may not represent average tissue
responses to SD.
One of the other confounds in the present studies is that all experiments
were conducted in healthy brain slices or animals.

As described in the

Introduction, a significant recent finding is the fact that SD can contribute to
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secondary injury.

While metabolic inhibition was used to model partially

metabolically compromised tissue in the present study, differences in brain tissue
after injury is not limited to differences in cellular metabolism. One of the most
important possibilities is that of modified channel expression and neuronal
excitability in injured brain tissue. There is evidence that injured brain initiates
regenerative processes and these include enhanced synaptic plasticity (Lo,
2008; Murphy and Corbett, 2009). Importantly, such modulation can occur when
secondary injury processes are still ongoing (Lo, 2008). Among the multiple
possibilities, one of the potentially most important processes is the down
regulation of the AMPA-type glutamate receptor subunit GluA2.

AMPARs in

adult brain usually contain GluA2. GluA2 AMPAR subunits are important for
determining selective permeability, and receptors lacking GluR2 are highly
permeable to Ca2+ and Zn2+ (Weiss and Sensi, 2000; Jia et al., 2002). It has
been shown that there is a significant reduction in GluR2 following ischemic
injury (Gorter et al., 1997; Calderone et al., 2004). Such increased Ca2+ and Zn2+
permeability

of

AMPAR

should

be

important

for

promoting

synaptic

reorganization in the injured brain however this would significantly increase
vulnerability to SD. It is obviously possible that such increases in Ca 2+ and
potentially Zn2+ permeability of neurons should increase their vulnerability. Thus
experiments in preparations from post-ischemic animals could reveal significantly
different sensitivities to SD as well as Zn2+ toxicity, when compared with studies
here in slices prepared from healthy animals.
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In addition to neuronal modulation, astrocytes are generally activated in the
injured brain (Chen and Swanson, 2003; Escartin and Bonvento, 2008). These
astrocytes are activated by inflammatory cytokines and plays important roles in
tissue remodeling following CNS injury (Escartin and Bonvento, 2008). However
reactive astrocytes are also important for their capacity for glutamate uptake.
From earlier studies from our laboratory (conducted by Jessica Seidel Ph.D.), it
was shown that astrocyte activity can limit SD in brain slices.

One of the

interesting possibilities is whether increased activities of astrocytes modify
sensitivity of SD to NMDAR antagonists. Reactive astrocytes usually occupy a
large volume of tissue and potentially have a higher capacity to prevent
extracellular potassium accumulation (Escartin and Bonvento, 2008). If
potassium concentrations are reduced, NMDAR antagonists are expected to
more effectively block SD.
Importantly there is a model to test these possibilities. In the gerbil, bilateral
common carotid occlusion induces global ischemia and selectively damages
hippocampus CA1. Previous studies have shown that GluR2 downregulation in
this model and brain slices prepared from these gerbils showed some alternation
in Ca2+ signaling (Gorter et al., 1997; Connor et al., 1999; Shuttleworth et al.,
2000).

Comparisons of sensitivities between healthy and once metabolically

compromised tissues to the injurious stimulus in vitro could provide important
insights into roles of tissue remodeling and vulnerability to injurious stimuli.
These experiments could potentially identify important insights into the toxicity of
SD in secondary injury.
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Abbreviations Used
ACSF

artificial cerebral spinal fluid

AMPA

α-amino-3-hydroxy-5-methylsozazole-4-propionic acid

DC

direct current

DTNB

5,5′-Dithiobis(2-nitrobenzoic acid)

EDTA

ethylenediaminetetraacetic acid

EPSC

excitatory postsynaptic current

EPSP

excitatory postsynaptic potential

FAD

flavoprotein

GABA

gamma-aminobutyric acid

Im

whole-cell current

IPSC

inhibitory postsynaptic current

NMDA

N-methyl-D-asparate

NADH

nicotinamide adenine dinucleotide

NADPH

nicotinamide adenine dinucleotide phosphate

OGD

oxygen glucose deprivation

PCP

phencyclidine

SD

spreading depolarization

SEM

standard error of th emean

tPA

tissue plasminogen activator

Vm

membrane potential

WT

wild-type

ZnT3

zinc transpoter 3

237

References
Aarts, M., Liu, Y., Liu, L., Besshoh, S., Arundine, M., Gurd, J. W., Wang,
Y. T., Salter, M. W. and Tymianski, M. (2002) Treatment of
ischemic brain damage by perturbing NMDA receptor- PSD-95
protein interactions. Science, 298, 846-850.
Abele, A. E., Scholz, K. P., Scholz, W. K. and Miller, R. J. (1990)
Excitotoxicity induced by enhanced excitatory neurotransmission in
cultured hippocampal pyramidal neurons. Neuron, 4, 413-419.
Adlard, P. A., Parncutt, J. M., Finkelstein, D. I. and Bush, A. I. (2010)
Cognitive loss in zinc transporter-3 knock-out mice: a phenocopy
for the synaptic and memory deficits of Alzheimer's disease? The
Journal of neuroscience : the official journal of the Society for
Neuroscience, 30, 1631-1636.
Aiba, I., Carlson, A. P., Sheline, C. T. and Shuttleworth, C. W. (2012)
Synaptic release and extracellular actions of Zn2+ limit propagation
of spreading depression and related events in vitro and in vivo.
Journal of neurophysiology, 107, 1032-1041.
Ainscow, E. K., Mirshamsi, S., Tang, T., Ashford, M. L. and Rutter, G. A.
(2002) Dynamic imaging of free cytosolic ATP concentration during
fuel sensing by rat hypothalamic neurones: evidence for ATPindependent control of ATP-sensitive K(+) channels. The Journal of
physiology, 544, 429-445.
Aizenman, E., Lipton, S. A. and Loring, R. H. (1989) Selective modulation
of NMDA responses by reduction and oxidation. Neuron, 2, 12571263.
Aizenman, E., Stout, A. K., Hartnett, K. A., Dineley, K. E., McLaughlin, B.
and Reynolds, I. J. (2000) Induction of neuronal apoptosis by thiol
oxidation: putative role of intracellular zinc release. Journal of
neurochemistry, 75, 1878-1888.
Anderson, T. R. and Andrew, R. D. (2002) Spreading depression: imaging
and blockade in the rat neocortical brain slice. Journal of
neurophysiology, 88, 2713-2725.
Andrade, A. L. and Rossi, D. J. (2010) Simulated ischaemia induces Ca 2+independent glutamatergic vesicle release through actin filament
depolymerization in area CA1 of the hippocampus. The Journal of
physiology, 588, 1499-1514.
Aras, M. A. and Aizenman, E. (2011) Redox regulation of intracellular zinc:
molecular signaling in the life and death of neurons. Antioxidants &
redox signaling, 15, 2249-2263.
Aronowski, J. and Zhao, X. (2011) Molecular pathophysiology of cerebral
hemorrhage: secondary brain injury. Stroke; a journal of cerebral
circulation, 42, 1781-1786.
Assaf, S. Y. and Chung, S. H. (1984) Release of endogenous Zn 2+ from
brain tissue during activity. Nature, 308, 734-736.
Atasoy, D., Ertunc, M., Moulder, K. L., Blackwell, J., Chung, C., Su, J. and

238

Kavalali, E. T. (2008) Spontaneous and evoked glutamate release
activates two populations of NMDA receptors with limited overlap.
The Journal of neuroscience : the official journal of the Society for
Neuroscience, 28, 10151-10166.
Avoli, M., Drapeau, C., Louvel, J., Pumain, R., Olivier, A. and Villemure, J.
G. (1991) Epileptiform activity induced by low extracellular
magnesium in the human cortex maintained in vitro. Annals of
neurology, 30, 589-596.
Azevedo, F. A., Carvalho, L. R., Grinberg, L. T., Farfel, J. M., Ferretti, R.
E., Leite, R. E., Jacob Filho, W., Lent, R. and Herculano-Houzel, S.
(2009) Equal numbers of neuronal and nonneuronal cells make the
human brain an isometrically scaled-up primate brain. The Journal
of comparative neurology, 513, 532-541.
Balestrino, M., Young, J. and Aitken, P. (1999) Block of (Na+,K+)ATPase
with ouabain induces spreading depression-like depolarization in
hippocampal slices. Brain research, 838, 37-44.
Bano, D., Young, K. W., Guerin, C. J., Lefeuvre, R., Rothwell, N. J.,
Naldini, L., Rizzuto, R., Carafoli, E. and Nicotera, P. (2005)
Cleavage of the plasma membrane Na+/Ca2+ exchanger in
excitotoxicity. Cell, 120, 275-285.
Bao, X., Lee, S. C., Reuss, L. and Altenberg, G. A. (2007) Change in
permeant size selectivity by phosphorylation of connexin 43 gapjunctional hemichannels by PKC. Proceedings of the National
Academy of Sciences of the United States of America, 104, 49194924.
Basarsky, T. A., Feighan, D. and MacVicar, B. A. (1999) Glutamate
release through volume-activated channels during spreading
depression. The Journal of neuroscience : the official journal of the
Society for Neuroscience, 19, 6439-6445.
Beal, M. F. (1992) Mechanisms of excitotoxicity in neurologic diseases.
FASEB journal : official publication of the Federation of American
Societies for Experimental Biology, 6, 3338-3344.
Benveniste, H., Drejer, J., Schousboe, A. and Diemer, N. H. (1984)
Elevation of the extracellular concentrations of glutamate and
aspartate in rat hippocampus during transient cerebral ischemia
monitored by intracerebral microdialysis. Journal of neurochemistry,
43, 1369-1374.
Blatow, M., Caputi, A., Burnashev, N., Monyer, H. and Rozov, A. (2003)
Ca2+ buffer saturation underlies paired pulse facilitation in calbindinD28k-containing terminals. Neuron, 38, 79-88.
Bonanni, L., Chachar, M., Jover-Mengual, T. et al. (2006) Zinc-dependent
multi-conductance channel activity in mitochondria isolated from
ischemic brain. The Journal of neuroscience : the official journal of
the Society for Neuroscience, 26, 6851-6862.
Bosche, B., Graf, R., Ernestus, R. I., Dohmen, C., Reithmeier, T., Brinker,
G., Strong, A. J., Dreier, J. P. and Woitzik, J. (2010) Recurrent

239

spreading depolarizations after subarachnoid hemorrhage
decreases oxygen availability in human cerebral cortex. Annals of
neurology, 67, 607-617.
Busija, D. W., Bari, F., Domoki, F., Horiguchi, T. and Shimizu, K. (2008)
Mechanisms involved in the cerebrovascular dilator effects of
cortical spreading depression. Prog Neurobiol, 86, 379-395.
Calderone, A., Jover, T., Mashiko, T., Noh, K. M., Tanaka, H., Bennett, M.
V. and Zukin, R. S. (2004) Late calcium EDTA rescues
hippocampal CA1 neurons from global ischemia-induced death.
The Journal of neuroscience : the official journal of the Society for
Neuroscience, 24, 9903-9913.
Carlsson, Y., Schwendimann, L., Vontell, R. et al. (2011) Genetic inhibition
of caspase-2 reduces hypoxic-ischemic and excitotoxic neonatal
brain injury. Annals of neurology, 70, 781-789.
Carter, R. E., Aiba, I., Dietz, R. M., Sheline, C. T. and Shuttleworth, C. W.
(2011) Spreading depression and related events are significant
sources of neuronal Zn2+ release and accumulation. Journal of
cerebral blood flow and metabolism : official journal of the
International Society of Cerebral Blood Flow and Metabolism, 31,
1073-1084.
Chatterton, J. E., Awobuluyi, M., Premkumar, L. S. et al. (2002) Excitatory
glycine receptors containing the NR3 family of NMDA receptor
subunits. Nature, 415, 793-798.
Chen, Y. and Swanson, R. A. (2003) Astrocytes and brain injury. Journal
of cerebral blood flow and metabolism : official journal of the
International Society of Cerebral Blood Flow and Metabolism, 23,
137-149.
Choi, D. W., Maulucci-Gedde, M. and Kriegstein, A. R. (1987) Glutamate
neurotoxicity in cortical cell culture. The Journal of neuroscience :
the official journal of the Society for Neuroscience, 7, 357-368.
Choi, D. W. and Rothman, S. M. (1990) The role of glutamate
neurotoxicity in hypoxic-ischemic neuronal death. Annual review of
neuroscience, 13, 171-182.
Choi, Y., Chen, H. V. and Lipton, S. A. (2001) Three pairs of cysteine
residues mediate both redox and zn2+ modulation of the nmda
receptor. The Journal of neuroscience : the official journal of the
Society for Neuroscience, 21, 392-400.
Chorin, E., Vinograd, O., Fleidervish, I., Gilad, D., Herrmann, S., Sekler, I.,
Aizenman, E. and Hershfinkel, M. (2011) Upregulation of KCC2
activity by zinc-mediated neurotransmission via the mZnR/GPR39
receptor. The Journal of neuroscience : the official journal of the
Society for Neuroscience, 31, 12916-12926.
Christie, J. M. and Jahr, C. E. (2008) Dendritic NMDA receptors activate
axonal calcium channels. Neuron, 60, 298-307.
Chung, R. S., Penkowa, M., Dittmann, J. et al. (2008) Redefining the role
of metallothionein within the injured brain: extracellular

240

metallothioneins play an important role in the astrocyte-neuron
response to injury. The Journal of biological chemistry, 283, 1534915358.
Ciabarra, A. M., Sullivan, J. M., Gahn, L. G., Pecht, G., Heinemann, S.
and Sevarino, K. A. (1995) Cloning and characterization of chi-1: a
developmentally regulated member of a novel class of the
ionotropic glutamate receptor family. The Journal of neuroscience :
the official journal of the Society for Neuroscience, 15, 6498-6508.
Clarkson, A. N., Huang, B. S., Macisaac, S. E., Mody, I. and Carmichael,
S. T. (2010) Reducing excessive GABA-mediated tonic inhibition
promotes functional recovery after stroke. Nature, 468, 305-309.
Cole, S. L. and Corday, E. (1956) Four-minute limit for cardiac
resuscitation. Journal of the American Medical Association, 161,
1454-1458.
Cole, T. B., Martyanova, A. and Palmiter, R. D. (2001) Removing zinc
from synaptic vesicles does not impair spatial learning, memory, or
sensorimotor functions in the mouse. Brain research, 891, 253-265.
Cole, T. B., Robbins, C. A., Wenzel, H. J., Schwartzkroin, P. A. and
Palmiter, R. D. (2000) Seizures and neuronal damage in mice
lacking vesicular zinc. Epilepsy research, 39, 153-169.
Cole, T. B., Wenzel, H. J., Kafer, K. E., Schwartzkroin, P. A. and Palmiter,
R. D. (1999) Elimination of zinc from synaptic vesicles in the intact
mouse brain by disruption of the ZnT3 gene. Proceedings of the
National Academy of Sciences of the United States of America, 96,
1716-1721.
Colvin, R. A., Holmes, W. R., Fontaine, C. P. and Maret, W. (2010)
Cytosolic zinc buffering and muffling: their role in intracellular zinc
homeostasis. Metallomics : integrated biometal science, 2, 306317.
Concannon, C. G., Tuffy, L. P., Weisova, P. et al. (2010) AMP kinasemediated activation of the BH3-only protein Bim couples energy
depletion to stress-induced apoptosis. The Journal of cell biology,
189, 83-94.
Connor, J. A. and Cormier, R. J. (2000) Cumulative effects of glutamate
microstimulation on Ca(2+) responses of CA1 hippocampal
pyramidal neurons in slice. Journal of neurophysiology, 83, 90-98.
Connor, J. A., Razani-Boroujerdi, S., Greenwood, A. C., Cormier, R. J.,
Petrozzino, J. J. and Lin, R. C. (1999) Reduced voltage-dependent
Ca2+ signaling in CA1 neurons after brief ischemia in gerbils.
Journal of neurophysiology, 81, 299-306.
Connor, J. A., Wadman, W. J., Hockberger, P. E. and Wong, R. K. (1988)
Sustained dendritic gradients of Ca2+ induced by excitatory amino
acids in CA1 hippocampal neurons. Science, 240, 649-653.
Cook, D. J., Teves, L. and Tymianski, M. (2012) Treatment of stroke with
a PSD-95 inhibitor in the gyrencephalic primate brain. Nature, 483,
213-217.

241

Czeh, G., Aitken, P. G. and Somjen, G. G. (1993) Membrane currents in
CA1 pyramidal cells during spreading depression (SD) and SD-like
hypoxic depolarization. Brain research, 632, 195-208.
D'Ambrosio, R., Gordon, D. S. and Winn, H. R. (2002) Differential role of
KIR channel and Na(+)/K(+)-pump in the regulation of extracellular
K(+) in rat hippocampus. Journal of neurophysiology, 87, 87-102.
Delaney, A. J., Power, J. M. and Sah, P. (2012) Ifenprodil reduces
excitatory synaptic transmission by blocking presynaptic P/Q type
calcium channels. Journal of neurophysiology, 107, 1571-1575.
Dietz, R. M., Weiss, J. H. and Shuttleworth, C. W. (2008) Zn 2+ influx is
critical for some forms of spreading depression in brain slices. The
Journal of neuroscience : the official journal of the Society for
Neuroscience, 28, 8014-8024.
Dirnagl, U., Iadecola, C. and Moskowitz, M. A. (1999) Pathobiology of
ischaemic stroke: an integrated view. Trends in neurosciences, 22,
391-397.
Doering, P., Stoltenberg, M., Penkowa, M., Rungby, J., Larsen, A. and
Danscher, G. (2010) Chemical blocking of zinc ions in CNS
increases neuronal damage following traumatic brain injury (TBI) in
mice. PloS one, 5, e10131.
Dohmen, C., Sakowitz, O. W., Fabricius, M. et al. (2008) Spreading
depolarizations occur in human ischemic stroke with high
incidence. Annals of neurology, 63, 720-728.
Dominguez, M. I., Blasco-Ibanez, J. M., Crespo, C., Marques-Mari, A. I.
and Martinez-Guijarro, F. J. (2003) Zinc chelation during nonlesioning overexcitation results in neuronal death in the mouse
hippocampus. Neuroscience, 116, 791-806.
D'Orsi, B., Bonner, H., Tuffy, L. P., Dussmann, H., Woods, I., Courtney, M.
J., Ward, M. W. and Prehn, J. H. (2012) Calpains are downstream
effectors of bax-dependent excitotoxic apoptosis. The Journal of
neuroscience : the official journal of the Society for Neuroscience,
32, 1847-1858.
Dreier, J. P. (2011) The role of spreading depression, spreading
depolarization and spreading ischemia in neurological disease. Nat
Med, 17, 439-447.
Dreier, J. P., Korner, K., Ebert, N. et al. (1998) Nitric oxide scavenging by
hemoglobin or nitric oxide synthase inhibition by N-nitro-L-arginine
induces cortical spreading ischemia when K+ is increased in the
subarachnoid space. Journal of cerebral blood flow and metabolism
: official journal of the International Society of Cerebral Blood Flow
and Metabolism, 18, 978-990.
Dreier, J. P., Major, S., Manning, A. et al. (2009) Cortical spreading
ischaemia is a novel process involved in ischaemic damage in
patients with aneurysmal subarachnoid haemorrhage. Brain : a
journal of neurology, 132, 1866-1881.
Dreier, J. P., Major, S., Pannek, H. W. et al. (2012) Spreading

242

convulsions, spreading depolarization and epileptogenesis in
human cerebral cortex. Brain : a journal of neurology, 135, 259275.
Drenckhahn, C., Winkler, M. K., Major, S. et al. (2012) Correlates of
spreading depolarization in human scalp electroencephalography.
Brain : a journal of neurology, 135, 853-868.
Eikermann-Haerter, K., Lee, J. H., Yuzawa, I. et al. (2012) Migraine
mutations increase stroke vulnerability by facilitating ischemic
depolarizations. Circulation, 125, 335-345.
Erreger, K., Dravid, S. M., Banke, T. G., Wyllie, D. J. and Traynelis, S. F.
(2005) Subunit-specific gating controls rat NR1/NR2A and
NR1/NR2B NMDA channel kinetics and synaptic signalling profiles.
The Journal of physiology, 563, 345-358.
Escartin, C. and Bonvento, G. (2008) Targeted activation of astrocytes: a
potential neuroprotective strategy. Molecular neurobiology, 38, 231241.
Fabricius, M., Fuhr, S., Bhatia, R., Boutelle, M., Hashemi, P., Strong, A. J.
and Lauritzen, M. (2006) Cortical spreading depression and periinfarct depolarization in acutely injured human cerebral cortex.
Brain : a journal of neurology, 129, 778-790.
Fabricius, M., Jensen, L. H. and Lauritzen, M. (1993) Microdialysis of
interstitial amino acids during spreading depression and anoxic
depolarization in rat neocortex. Brain research, 612, 61-69.
Faden, A. I., Demediuk, P., Panter, S. S. and Vink, R. (1989) The role of
excitatory amino acids and NMDA receptors in traumatic brain
injury. Science, 244, 798-800.
Faller, P. and Vasak, M. (1997) Distinct metal-thiolate clusters in the Nterminal domain of neuronal growth inhibitory factor. Biochemistry,
36, 13341-13348.
Faria, L. C. and Mody, I. (2004) Protective effect of ifenprodil against
spreading depression in the mouse entorhinal cortex. Journal of
neurophysiology, 92, 2610-2614.
Fernandez-Klett, F., Offenhauser, N., Dirnagl, U., Priller, J. and Lindauer,
U. (2010) Pericytes in capillaries are contractile in vivo, but
arterioles mediate functional hyperemia in the mouse brain.
Proceedings of the National Academy of Sciences of the United
States of America, 107, 22290-22295.
Frederickson, C. J., Koh, J. Y. and Bush, A. I. (2005) The neurobiology of
zinc in health and disease. Nature reviews. Neuroscience, 6, 449462.
Frederickson, C. J., Rampy, B. A., Reamy-Rampy, S. and Howell, G. A.
(1992) Distribution of histochemically reactive zinc in the forebrain
of the rat. Journal of chemical neuroanatomy, 5, 521-530.
Frederickson, C. J., Suh, S. W., Koh, J. Y., Cha, Y. K., Thompson, R. B.,
LaBuda, C. J., Balaji, R. V. and Cuajungco, M. P. (2002) Depletion
of intracellular zinc from neurons by use of an extracellular chelator

243

in vivo and in vitro. The journal of histochemistry and cytochemistry
: official journal of the Histochemistry Society, 50, 1659-1662.
Galeffi, F., Somjen, G. G., Foster, K. A. and Turner, D. A. (2011)
Simultaneous monitoring of tissue PO2 and NADH fluorescence
during synaptic stimulation and spreading depression reveals a
transient dissociation between oxygen utilization and mitochondrial
redox state in rat hippocampal slices. Journal of cerebral blood flow
and metabolism : official journal of the International Society of
Cerebral Blood Flow and Metabolism, 31, 626-639.
Gielen, M., Siegler Retchless, B., Mony, L., Johnson, J. W. and Paoletti,
P. (2009) Mechanism of differential control of NMDA receptor
activity by NR2 subunits. Nature, 459, 703-707.
Gill, R., Andine, P., Hillered, L., Persson, L. and Hagberg, H. (1992) The
effect of MK-801 on cortical spreading depression in the penumbral
zone following focal ischaemia in the rat. Journal of cerebral blood
flow and metabolism : official journal of the International Society of
Cerebral Blood Flow and Metabolism, 12, 371-379.
Glitsch, M. and Marty, A. (1999) Presynaptic effects of NMDA in cerebellar
Purkinje cells and interneurons. The Journal of neuroscience : the
official journal of the Society for Neuroscience, 19, 511-519.
Gniel, H. M. and Martin, R. L. (2010) Changes in membrane potential and
the intracellular calcium concentration during CSD and OGD in
layer V and layer II/III mouse cortical neurons. Journal of
neurophysiology, 104, 3203-3212.
Goldberg, W. J., Kadingo, R. M. and Barrett, J. N. (1986) Effects of
ischemia-like conditions on cultured neurons: protection by low
Na+, low Ca2+ solutions. The Journal of neuroscience : the official
journal of the Society for Neuroscience, 6, 3144-3151.
Gorter, J. A., Petrozzino, J. J., Aronica, E. M., Rosenbaum, D. M., Opitz,
T., Bennett, M. V., Connor, J. A. and Zukin, R. S. (1997) Global
ischemia induces downregulation of Glur2 mRNA and increases
AMPA receptor-mediated Ca2+ influx in hippocampal CA1 neurons
of gerbil. The Journal of neuroscience : the official journal of the
Society for Neuroscience, 17, 6179-6188.
Grafstein, B. (1956) Mechanism of spreading cortical depression. Journal
of neurophysiology, 19, 154-171.
Grenell, R. G. (1946) Central nervous system resistance; the effects of
temporary arrest of cerebral circulation for periods of two to ten
minutes. Journal of neuropathology and experimental neurology, 5,
131-154.
Grynkiewicz, G., Poenie, M. and Tsien, R. Y. (1985) A new generation of
Ca2+ indicators with greatly improved fluorescence properties. The
Journal of biological chemistry, 260, 3440-3450.
Hablitz, J. J. and Heinemann, U. (1989) Alterations in the
microenvironment during spreading depression associated with
epileptiform activity in the immature neocortex. Brain research.

244

Developmental brain research, 46, 243-252.
Hacke, W., Donnan, G., Fieschi, C. et al. (2004) Association of outcome
with early stroke treatment: pooled analysis of ATLANTIS, ECASS,
and NINDS rt-PA stroke trials. Lancet, 363, 768-774.
Haddad, S. H. and Arabi, Y. M. (2012) Critical care management of severe
traumatic brain injury in adults. Scandinavian journal of trauma,
resuscitation and emergency medicine, 20, 12.
Hagberg, H., Lehmann, A., Sandberg, M., Nystrom, B., Jacobson, I. and
Hamberger, A. (1985) Ischemia-induced shift of inhibitory and
excitatory amino acids from intra- to extracellular compartments.
Journal of cerebral blood flow and metabolism : official journal of
the International Society of Cerebral Blood Flow and Metabolism, 5,
413-419.
Hall, C. N. and Attwell, D. (2008) Assessing the physiological
concentration and targets of nitric oxide in brain tissue. The Journal
of physiology, 586, 3597-3615.
Hall, C. N., Klein-Flugge, M. C., Howarth, C. and Attwell, D. (2012)
Oxidative phosphorylation, not glycolysis, powers presynaptic and
postsynaptic mechanisms underlying brain information processing.
The Journal of neuroscience : the official journal of the Society for
Neuroscience, 32, 8940-8951.
Hamann, M., Rossi, D. J., Marie, H. and Attwell, D. (2002) Knocking out
the glial glutamate transporter GLT-1 reduces glutamate uptake but
does not affect hippocampal glutamate dynamics in early simulated
ischaemia. The European journal of neuroscience, 15, 308-314.
Hammond, C., Crepel, V., Gozlan, H. and Ben-Ari, Y. (1994) Anoxic LTP
sheds light on the multiple facets of NMDA receptors. Trends in
neurosciences, 17, 497-503.
Hardingham, G. E. and Bading, H. (2010) Synaptic versus extrasynaptic
NMDA receptor signalling: implications for neurodegenerative
disorders. Nature reviews. Neuroscience, 11, 682-696.
Hartings, J. A., Bullock, M. R., Okonkwo, D. O. et al. (2011) Spreading
depolarisations and outcome after traumatic brain injury: a
prospective observational study. Lancet neurology, 10, 1058-1064.
Hartings, J. A., Rolli, M. L., Lu, X. C. and Tortella, F. C. (2003) Delayed
secondary phase of peri-infarct depolarizations after focal cerebral
ischemia: relation to infarct growth and neuroprotection. The
Journal of neuroscience : the official journal of the Society for
Neuroscience, 23, 11602-11610.
Hartings, J. A., Watanabe, T., Bullock, M. R. et al. (2011) Spreading
depolarizations have prolonged direct current shifts and are
associated with poor outcome in brain trauma. Brain : a journal of
neurology, 134, 1529-1540.
Herin, G. A., Du, S. and Aizenman, E. (2001) The neuroprotective agent
ebselen modifies NMDA receptor function via the redox modulatory
site. Journal of neurochemistry, 78, 1307-1314.

245

Hernandez-Caceres, J., Macias-Gonzalez, R., Brozek, G. and Bures, J.
(1987) Systemic ketamine blocks cortical spreading depression but
does not delay the onset of terminal anoxic depolarization in rats.
Brain research, 437, 360-364.
Herreras, O., Largo, C., Ibarz, J. M., Somjen, G. G. and Martin del Rio, R.
(1994) Role of neuronal synchronizing mechanisms in the
propagation of spreading depression in the in vivo hippocampus.
The Journal of neuroscience : the official journal of the Society for
Neuroscience, 14, 7087-7098.
Herreras, O. and Somjen, G. G. (1993) Analysis of potential shifts
associated with recurrent spreading depression and prolonged
unstable spreading depression induced by microdialysis of elevated
K+ in hippocampus of anesthetized rats. Brain research, 610, 283294.
Herreras, O. and Somjen, G. G. (1993) Propagation of spreading
depression among dendrites and somata of the same cell
population. Brain research, 610, 276-282.
Hershkowitz, N., Katchman, A. N. and Veregge, S. (1993) Site of synaptic
depression during hypoxia: a patch-clamp analysis. Journal of
neurophysiology, 69, 432-441.
Hertle, D. N., Dreier, J. P., Woitzik, J. et al. (2012) Effect of analgesics and
sedatives on the occurrence of spreading depolarizations
accompanying acute brain injury. Brain : a journal of neurology.
Heuchel, R., Radtke, F., Georgiev, O., Stark, G., Aguet, M. and Schaffner,
W. (1994) The transcription factor MTF-1 is essential for basal and
heavy metal-induced metallothionein gene expression. The EMBO
journal, 13, 2870-2875.
Homayoun, H. and Moghaddam, B. (2007) NMDA receptor hypofunction
produces opposite effects on prefrontal cortex interneurons and
pyramidal neurons. The Journal of neuroscience : the official
journal of the Society for Neuroscience, 27, 11496-11500.
Hosie, A. M., Dunne, E. L., Harvey, R. J. and Smart, T. G. (2003) Zincmediated inhibition of GABA(A) receptors: discrete binding sites
underlie subtype specificity. Nature neuroscience, 6, 362-369.
Howell, G. A., Welch, M. G. and Frederickson, C. J. (1984) Stimulationinduced uptake and release of zinc in hippocampal slices. Nature,
308, 736-738.
Hoyte, L., Barber, P. A., Buchan, A. M. and Hill, M. D. (2004) The rise and
fall of NMDA antagonists for ischemic stroke. Current molecular
medicine, 4, 131-136.
Huang, Y. Z., Pan, E., Xiong, Z. Q. and McNamara, J. O. (2008) Zincmediated transactivation of TrkB potentiates the hippocampal
mossy fiber-CA3 pyramid synapse. Neuron, 57, 546-558.
Hwang, J. J., Lee, S. J., Kim, T. Y., Cho, J. H. and Koh, J. Y. (2008) Zinc
and
4-hydroxy-2-nonenal
mediate
lysosomal
membrane
permeabilization induced by H2O2 in cultured hippocampal

246

neurons. The Journal of neuroscience : the official journal of the
Society for Neuroscience, 28, 3114-3122.
Hyun, H. J., Sohn, J., Ahn, Y. H., Shin, H. C., Koh, J. Y. and Yoon, Y. H.
(2000) Depletion of intracellular zinc induces macromolecule
synthesis- and caspase-dependent apoptosis of cultured retinal
cells. Brain research, 869, 39-48.
Iijima, T., Mies, G. and Hossmann, K. A. (1992) Repeated negative DC
deflections in rat cortex following middle cerebral artery occlusion
are abolished by MK-801: effect on volume of ischemic injury.
Journal of cerebral blood flow and metabolism : official journal of
the International Society of Cerebral Blood Flow and Metabolism,
12, 727-733.
Iijima, T., Shimase, C., Iwao, Y. and Sankawa, H. (1998) Relationships
between glutamate release, blood flow and spreading depression:
real-time monitoring using an electroenzymatic dialysis electrode.
Neuroscience research, 32, 201-207.
Ikonomidou, C. and Turski, L. (2002) Why did NMDA receptor antagonists
fail clinical trials for stroke and traumatic brain injury? Lancet
neurology, 1, 383-386.
Investigators, C. A. S. P. R. C. (2005) Prioritizing interventions to improve
rates of thrombolysis for ischemic stroke. Neurology, 64, 654-659.
Izumi, Y., Auberson, Y. P. and Zorumski, C. F. (2006) Zinc modulates
bidirectional hippocampal plasticity by effects on NMDA receptors.
The Journal of neuroscience : the official journal of the Society for
Neuroscience, 26, 7181-7188.
Jaiswal, B. S. and Conti, M. (2003) Calcium regulation of the soluble
adenylyl cyclase expressed in mammalian spermatozoa.
Proceedings of the National Academy of Sciences of the United
States of America, 100, 10676-10681.
Jarvis, C. R., Anderson, T. R. and Andrew, R. D. (2001) Anoxic
depolarization mediates acute damage independent of glutamate in
neocortical brain slices. Cereb Cortex, 11, 249-259.
Jarvis, C. R., Lilge, L., Vipond, G. J. and Andrew, R. D. (1999)
Interpretation of intrinsic optical signals and calcein fluorescence
during acute excitotoxic insult in the hippocampal slice.
NeuroImage, 10, 357-372.
Jia, Y., Jeng, J. M., Sensi, S. L. and Weiss, J. H. (2002) Zn2+ currents are
mediated by calcium-permeable AMPA/kainate channels in cultured
murine hippocampal neurones. The Journal of physiology, 543, 3548.
Jiang, D., Sullivan, P. G., Sensi, S. L., Steward, O. and Weiss, J. H.
(2001) Zn(2+) induces permeability transition pore opening and
release of pro-apoptotic peptides from neuronal mitochondria. The
Journal of biological chemistry, 276, 47524-47529.
Jiang, L. J., Maret, W. and Vallee, B. L. (1998) The ATP-metallothionein
complex. Proceedings of the National Academy of Sciences of the

247

United States of America, 95, 9146-9149.
Jorgensen, P. L. and Pedersen, P. A. (2001) Structure-function
relationships of Na(+), K(+), ATP, or Mg(2+) binding and energy
transduction in Na,K-ATPase. Biochimica et biophysica acta, 1505,
57-74.
Joshi, I. and Andrew, R. D. (2001) Imaging anoxic depolarization during
ischemia-like conditions in the mouse hemi-brain slice. Journal of
neurophysiology, 85, 414-424.
Kasarskis, E. J. (1984) Zinc metabolism in normal and zinc-deficient rat
brain. Experimental neurology, 85, 114-127.
Katchman, A. N. and Hershkowitz, N. (1993) Early anoxia-induced
vesicular glutamate release results from mobilization of calcium
from intracellular stores. Journal of neurophysiology, 70, 1-7.
Kerchner, G. A. and Nicoll, R. A. (2008) Silent synapses and the
emergence of a postsynaptic mechanism for LTP. Nature reviews.
Neuroscience, 9, 813-825.
Kitamura, Y., Iida, Y., Abe, J. et al. (2006) Protective effect of zinc against
ischemic neuronal injury in a middle cerebral artery occlusion
model. Journal of pharmacological sciences, 100, 142-148.
Koh, J. Y. (2001) Zinc and disease of the brain. Molecular neurobiology,
24, 99-106.
Koh, J. Y. and Choi, D. W. (1988) Zinc alters excitatory amino acid
neurotoxicity on cortical neurons. The Journal of neuroscience : the
official journal of the Society for Neuroscience, 8, 2164-2171.
Koh, J. Y., Suh, S. W., Gwag, B. J., He, Y. Y., Hsu, C. Y. and Choi, D. W.
(1996) The role of zinc in selective neuronal death after transient
global cerebral ischemia. Science, 272, 1013-1016.
Kohout, S. C., Corbalan-Garcia, S., Torrecillas, A., Gomez-Fernandez, J.
C. and Falke, J. J. (2002) C2 domains of protein kinase C isoforms
alpha, beta, and gamma: activation parameters and calcium
stoichiometries of the membrane-bound state. Biochemistry, 41,
11411-11424.
Kohr, G., Eckardt, S., Luddens, H., Monyer, H. and Seeburg, P. H. (1994)
NMDA receptor channels: subunit-specific potentiation by reducing
agents. Neuron, 12, 1031-1040.
Koumura, A., Kakefuda, K., Honda, A. et al. (2009) Metallothionein-3
deficient mice exhibit abnormalities of psychological behaviors.
Neuroscience letters, 467, 11-14.
Krezel, A. and Maret, W. (2007) Dual nanomolar and picomolar Zn(II)
binding properties of metallothionein. Journal of the American
Chemical Society, 129, 10911-10921.
Kruger, H., Heinemann, U. and Luhmann, H. J. (1999) Effects of
ionotropic glutamate receptor blockade and 5-HT1A receptor
activation on spreading depression in rat neocortical slices.
Neuroreport, 10, 2651-2656.
Kunkler, P. E. and Kraig, R. P. (2004) P/Q Ca2+ channel blockade stops

248

spreading depression and related pyramidal neuronal Ca 2+ rise in
hippocampal organ culture. Hippocampus, 14, 356-367.
Langmade, S. J., Ravindra, R., Daniels, P. J. and Andrews, G. K. (2000)
The transcription factor MTF-1 mediates metal regulation of the
mouse ZnT1 gene. The Journal of biological chemistry, 275, 3480334809.
Larrosa, B., Pastor, J., Lopez-Aguado, L. and Herreras, O. (2006) A role
for glutamate and glia in the fast network oscillations preceding
spreading depression. Neuroscience, 141, 1057-1068.
Larsen, R. S., Corlew, R. J., Henson, M. A. et al. (2011) NR3A-containing
NMDARs promote neurotransmitter release and spike timingdependent plasticity. Nature neuroscience, 14, 338-344.
Lauritzen, M., Dreier, J. P., Fabricius, M., Hartings, J. A., Graf, R. and
Strong, A. J. (2011) Clinical relevance of cortical spreading
depression in neurological disorders: migraine, malignant stroke,
subarachnoid and intracranial hemorrhage, and traumatic brain
injury. Journal of cerebral blood flow and metabolism : official
journal of the International Society of Cerebral Blood Flow and
Metabolism, 31, 17-35.
Lauritzen, M. and Hansen, A. J. (1992) The effect of glutamate receptor
blockade on anoxic depolarization and cortical spreading
depression. Journal of cerebral blood flow and metabolism : official
journal of the International Society of Cerebral Blood Flow and
Metabolism, 12, 223-229.
Lavoie, N., Peralta, M. R., 3rd, Chiasson, M., Lafortune, K., Pellegrini, L.,
Seress, L. and Toth, K. (2007) Extracellular chelation of zinc does
not affect hippocampal excitability and seizure-induced cell death in
rats. The Journal of physiology, 578, 275-289.
Leao (1944) Spreading depression of activity in the cerebral cortex.
Journal of Neurophysiology, 7, 359–390.
Lee, J. M., Zipfel, G. J., Park, K. H., He, Y. Y., Hsu, C. Y. and Choi, D. W.
(2002) Zinc translocation accelerates infarction after mild transient
focal ischemia. Neuroscience, 115, 871-878.
Lee, J. Y., Cole, T. B., Palmiter, R. D. and Koh, J. Y. (2000) Accumulation
of zinc in degenerating hippocampal neurons of ZnT3-null mice
after seizures: evidence against synaptic vesicle origin. The Journal
of neuroscience : the official journal of the Society for
Neuroscience, 20, RC79.
Lee, J. Y., Kim, J. S., Byun, H. R., Palmiter, R. D. and Koh, J. Y. (2011)
Dependence of the histofluorescently reactive zinc pool on zinc
transporter-3 in the normal brain. Brain research, 1418, 12-22.
Leonard, W. R., Snodgrass, J. J. and Robertson, M. L. (2007) Effects of
brain evolution on human nutrition and metabolism. Annual review
of nutrition, 27, 311-327.
Li, J., Henman, M. C., Doyle, K. M., Strbian, D., Kirby, B. P., Tatlisumak,
T. and Shaw, G. G. (2004) The pre-ischaemic neuroprotective

249

effect of a novel polyamine antagonist, N1-dansyl-spermine in a
permanent focal cerebral ischaemia model in mice. Brain research,
1029, 84-92.
Li, Y., Hough, C. J., Frederickson, C. J. and Sarvey, J. M. (2001) Induction
of mossy fiber --> Ca3 long-term potentiation requires translocation
of synaptically released Zn2+. The Journal of neuroscience : the
official journal of the Society for Neuroscience, 21, 8015-8025.
Lindquist, B. S. and Shuttleworth, C. W. (2011) Adenosine activation of A 1
receptors depresses synaptic activity after spreading depolarization
Annual meeting of Society for Neuroscience abstract.
Lipton, S. A. (2006) Paradigm shift in neuroprotection by NMDA receptor
blockade: memantine and beyond. Nature reviews. Drug discovery,
5, 160-170.
Liu, L., Wong, T. P., Pozza, M. F., Lingenhoehl, K., Wang, Y., Sheng, M.,
Auberson, Y. P. and Wang, Y. T. (2004) Role of NMDA receptor
subtypes in governing the direction of hippocampal synaptic
plasticity. Science, 304, 1021-1024.
Liu, L. Y., Wei, E. Q., Zhao, Y. M., Chen, F. X., Wang, M. L., Zhang, W. P.
and Chen, Z. (2005) Protective effects of baicalin on
oxygen/glucose deprivation- and NMDA-induced injuries in rat
hippocampal slices. The Journal of pharmacy and pharmacology,
57, 1019-1026.
Liu, S. J. and Zukin, R. S. (2007) Ca2+-permeable AMPA receptors in
synaptic plasticity and neuronal death. Trends in neurosciences,
30, 126-134.
Lo, E. H. (2008) A new penumbra: transitioning from injury into repair after
stroke. Nat Med, 14, 497-500.
Lu, X. C., Williams, A. J., Wagstaff, J. D., Tortella, F. C. and Hartings, J. A.
(2005) Effects of delayed intrathecal infusion of an NMDA receptor
antagonist on ischemic injury and peri-infarct depolarizations. Brain
research, 1056, 200-208.
MacDonald, J. F., Bartlett, M. C., Mody, I., Pahapill, P., Reynolds, J. N.,
Salter, M. W., Schneiderman, J. H. and Pennefather, P. S. (1991)
Actions of ketamine, phencyclidine and MK-801 on NMDA receptor
currents in cultured mouse hippocampal neurones. The Journal of
physiology, 432, 483-508.
Maclean, D. M. and Bowie, D. (2011) Transmembrane AMPA receptor
regulatory protein regulation of competitive antagonism: a problem
of interpretation. The Journal of physiology, 589, 5383-5390.
Maclean, K. H., Cleveland, J. L. and Porter, J. B. (2001) Cellular zinc
content is a major determinant of iron chelator-induced apoptosis of
thymocytes. Blood, 98, 3831-3839.
Manev, H., Favaron, M., Guidotti, A. and Costa, E. (1989) Delayed
increase of Ca2+ influx elicited by glutamate: role in neuronal death.
Molecular pharmacology, 36, 106-112.
Manzerra, P., Behrens, M. M., Canzoniero, L. M., Wang, X. Q., Heidinger,

250

V., Ichinose, T., Yu, S. P. and Choi, D. W. (2001) Zinc induces a
Src family kinase-mediated up-regulation of NMDA receptor activity
and excitotoxicity. Proceedings of the National Academy of
Sciences of the United States of America, 98, 11055-11061.
Marrannes, R., Willems, R., De Prins, E. and Wauquier, A. (1988)
Evidence for a role of the N-methyl-D-aspartate (NMDA) receptor in
cortical spreading depression in the rat. Brain research, 457, 226240.
Martel, M. A., Ryan, T. J., Bell, K. F. et al. (2012) The subtype of GluN2 Cterminal domain determines the response to excitotoxic insults.
Neuron, 74, 543-556.
Martins-Ferreira, H., Nedergaard, M. and Nicholson, C. (2000)
Perspectives on spreading depression. Brain research. Brain
research reviews, 32, 215-234.
McGuinness, L., Taylor, C., Taylor, R. D. et al. (2010) Presynaptic
NMDARs in the hippocampus facilitate transmitter release at theta
frequency. Neuron, 68, 1109-1127.
McGuinness, L., Taylor, C., Taylor, R. D. et al. (2011) Presynaptic
NMDARs in the hippocampus facilitate transmitter release at theta
frequency. Neuron, 68, 1109-1127.
Medvedeva, Y. V., Lin, B., Shuttleworth, C. W. and Weiss, J. H. (2009)
Intracellular Zn2+ accumulation contributes to synaptic failure,
mitochondrial depolarization, and cell death in an acute slice
oxygen-glucose deprivation model of ischemia. The Journal of
neuroscience : the official journal of the Society for Neuroscience,
29, 1105-1114.
Mies, G. and Paschen, W. (1984) Regional changes of blood flow,
glucose, and ATP content determined on brain sections during a
single passage of spreading depression in rat brain cortex.
Experimental neurology, 84, 249-258.
Mody, I., Lambert, J. D. and Heinemann, U. (1987) Low extracellular
magnesium induces epileptiform activity and spreading depression
in rat hippocampal slices. Journal of neurophysiology, 57, 869-888.
Moleirinho, A., Carneiro, J., Matthiesen, R., Silva, R. M., Amorim, A. and
Azevedo, L. (2011) Gains, losses and changes of function after
gene duplication: study of the metallothionein family. PloS one, 6,
e18487.
Moss, S. J. and Smart, T. G. (2001) Constructing inhibitory synapses.
Nature reviews. Neuroscience, 2, 240-250.
Murai, Y., Okabe, Y. and Tanaka, E. (2012) Activation of protein kinase A
and C prevents recovery from persistent depolarization produced
by oxygen and glucose deprivation in rat hippocampal neurons.
Journal of neurophysiology, 107, 2517-2525.
Murphy, T. H. and Corbett, D. (2009) Plasticity during stroke recovery:
from synapse to behaviour. Nature reviews. Neuroscience, 10, 861872.

251

Murphy, T. H., Li, P., Betts, K. and Liu, R. (2008) Two-photon imaging of
stroke onset in vivo reveals that NMDA-receptor independent
ischemic depolarization is the major cause of rapid reversible
damage to dendrites and spines. The Journal of neuroscience : the
official journal of the Society for Neuroscience, 28, 1756-1772.
Murray, J. B. (2002) Phencyclidine (PCP): a dangerous drug, but useful in
schizophrenia research. The Journal of psychology, 136, 319-327.
Nakamura, H., Strong, A. J., Dohmen, C. et al. (2010) Spreading
depolarizations cycle around and enlarge focal ischaemic brain
lesions. Brain : a journal of neurology, 133, 1994-2006.
Ndubuizu, O. and LaManna, J. C. (2007) Brain tissue oxygen
concentration measurements. Antioxidants & redox signaling, 9,
1207-1219.
Nedergaard, M. and Hansen, A. J. (1993) Characterization of cortical
depolarizations evoked in focal cerebral ischemia. Journal of
cerebral blood flow and metabolism : official journal of the
International Society of Cerebral Blood Flow and Metabolism, 13,
568-574.
Neher, E. (1995) The use of fura-2 for estimating Ca buffers and Ca
fluxes. Neuropharmacology, 34, 1423-1442.
Nicoll, R. A., Tomita, S. and Bredt, D. S. (2006) Auxiliary subunits assist
AMPA-type glutamate receptors. Science, 311, 1253-1256.
Nikam, S. S. and Meltzer, L. T. (2002) NR2B selective NMDA receptor
antagonists. Current pharmaceutical design, 8, 845-855.
Ohta, K., Graf, R., Rosner, G. and Heiss, W. D. (2001) Calcium ion
transients in peri-infarct depolarizations may deteriorate ion
homeostasis and expand infarction in focal cerebral ischemia in
cats. Stroke; a journal of cerebral circulation, 32, 535-543.
Oliveira-Ferreira, A. I., Milakara, D., Alam, M. et al. (2010) Experimental
and preliminary clinical evidence of an ischemic zone with
prolonged negative DC shifts surrounded by a normally perfused
tissue belt with persistent electrocorticographic depression. Journal
of cerebral blood flow and metabolism : official journal of the
International Society of Cerebral Blood Flow and Metabolism, 30,
1504-1519.
Olney, J. W. (1969) Brain lesions, obesity, and other disturbances in mice
treated with monosodium glutamate. Science, 164, 719-721.
Olney, J. W. and Sharpe, L. G. (1969) Brain lesions in an infant rhesus
monkey treated with monsodium glutamate. Science, 166, 386-388.
Pachernegg, S., Strutz-Seebohm, N. and Hollmann, M. (2012) GluN3
subunit-containing NMDA receptors: not just one-trick ponies.
Trends in neurosciences, 35, 240-249.
Palumaa, P., Tammiste, I., Kruusel, K., Kangur, L., Jornvall, H. and Sillard,
R. (2005) Metal binding of metallothionein-3 versus metallothionein2: lower affinity and higher plasticity. Biochimica et biophysica acta,
1747, 205-211.

252

Pan, E., Zhang, X. A., Huang, Z., Krezel, A., Zhao, M., Tinberg, C. E.,
Lippard, S. J. and McNamara, J. O. (2011) Vesicular zinc promotes
presynaptic and inhibits postsynaptic long-term potentiation of
mossy fiber-CA3 synapse. Neuron, 71, 1116-1126.
Paoletti, P., Ascher, P. and Neyton, J. (1997) High-affinity zinc inhibition of
NMDA NR1-NR2A receptors. The Journal of neuroscience : the
official journal of the Society for Neuroscience, 17, 5711-5725.
Paoletti, P. and Neyton, J. (2007) NMDA receptor subunits: function and
pharmacology. Current opinion in pharmacology, 7, 39-47.
Paoletti, P., Vergnano, A. M., Barbour, B. and Casado, M. (2009) Zinc at
glutamatergic synapses. Neuroscience, 158, 126-136.
Papouin, T., Ladepeche, L., Ruel, J. et al. (2012) Synaptic and
Extrasynaptic NMDA Receptors Are Gated by Different
Endogenous Coagonists. Cell, 150, 633-646.
Park, J. S., Bateman, M. C. and Goldberg, M. P. (1996) Rapid alterations
in dendrite morphology during sublethal hypoxia or glutamate
receptor activation. Neurobiology of disease, 3, 215-227.
Pedarzani, P., Mosbacher, J., Rivard, A., Cingolani, L. A., Oliver, D.,
Stocker, M., Adelman, J. P. and Fakler, B. (2001) Control of
electrical activity in central neurons by modulating the gating of
small conductance Ca2+-activated K+ channels. The Journal of
biological chemistry, 276, 9762-9769.
Peeters, M., Gunthorpe, M. J., Strijbos, P. J., Goldsmith, P., Upton, N. and
James, M. F. (2007) Effects of pan- and subtype-selective Nmethyl-D-aspartate receptor antagonists on cortical spreading
depression in the rat: therapeutic potential for migraine. J
Pharmacol Exp Ther, 321, 564-572.
Perrais, D., Veran, J. and Mulle, C. (2010) Gating and permeation of
kainate receptors: differences unveiled. Trends Pharmacol Sci, 31,
516-522.
Petrozzino, J. J., Pozzo Miller, L. D. and Connor, J. A. (1995) Micromolar
Ca2+ transients in dendritic spines of hippocampal pyramidal
neurons in brain slice. Neuron, 14, 1223-1231.
Pittenger, C., Sanacora, G. and Krystal, J. H. (2007) The NMDA receptor
as a therapeutic target in major depressive disorder. CNS &
neurological disorders drug targets, 6, 101-115.
Pomper, J. K., Haack, S., Petzold, G. C., Buchheim, K., Gabriel, S.,
Hoffmann, U. and Heinemann, U. (2006) Repetitive spreading
depression-like events result in cell damage in juvenile
hippocampal slice cultures maintained in normoxia. Journal of
neurophysiology, 95, 355-368.
Pringle, A. K., Self, J., Eshak, M. and Iannotti, F. (2000) Reducing
conditions significantly attenuate the neuroprotective efficacy of
competitive, but not other NMDA receptor antagonists in vitro. The
European journal of neuroscience, 12, 3833-3842.
Qian, J. and Noebels, J. L. (2005) Visualization of transmitter release with

253

zinc fluorescence detection at the mouse hippocampal mossy fibre
synapse. The Journal of physiology, 566, 747-758.
Qian, J. and Noebels, J. L. (2006) Exocytosis of vesicular zinc reveals
persistent depression of neurotransmitter release during
metabotropic glutamate receptor long-term depression at the
hippocampal CA3-CA1 synapse. The Journal of neuroscience : the
official journal of the Society for Neuroscience, 26, 6089-6095.
Qian, J., Xu, K., Yoo, J., Chen, T. T., Andrews, G. and Noebels, J. L.
(2011) Knockout of Zn transporters Zip-1 and Zip-3 attenuates
seizure-induced CA1 neurodegeneration. The Journal of
neuroscience : the official journal of the Society for Neuroscience,
31, 97-104.
Ramamurthy, S. and Ronnett, G. (2012) AMP-Activated Protein Kinase
(AMPK) and Energy-Sensing in the Brain. Experimental
neurobiology, 21, 52-60.
Reynolds, I. J., Rush, E. A. and Aizenman, E. (1990) Reduction of NMDA
receptors with dithiothreitol increases [3H]-MK-801 binding and
NMDA-induced Ca2+ fluxes. British journal of pharmacology, 101,
178-182.
Rossen, L., Kabat, H. and Anderson, J. (1943) Acute arrest of cerebral
circulation in man. Archives of Neurology and Psychiatry, 50, 510528.
Rossi, D. J., Brady, J. D. and Mohr, C. (2007) Astrocyte metabolism and
signaling during brain ischemia. Nature neuroscience, 10, 13771386.
Rossi, D. J., Oshima, T. and Attwell, D. (2000) Glutamate release in
severe brain ischaemia is mainly by reversed uptake. Nature, 403,
316-321.
Rothman, S. (1984) Synaptic release of excitatory amino acid
neurotransmitter mediates anoxic neuronal death. The Journal of
neuroscience : the official journal of the Society for Neuroscience,
4, 1884-1891.
Rothman, S. M. (1983) Synaptic activity mediates death of hypoxic
neurons. Science, 220, 536-537.
Rudkouskaya, A., Chernoguz, A., Haskew-Layton, R. E. and Mongin, A. A.
(2008) Two conventional protein kinase C isoforms, alpha and beta
I, are involved in the ATP-induced activation of volume-regulated
anion channel and glutamate release in cultured astrocytes. Journal
of neurochemistry, 105, 2260-2270.
Rudolphi, K. A., Schubert, P., Parkinson, F. E. and Fredholm, B. B. (1992)
Neuroprotective role of adenosine in cerebral ischaemia. Trends
Pharmacol Sci, 13, 439-445.
Rumschik, S. M., Nydegger, I., Zhao, J. and Kay, A. R. (2009) The
interplay between inorganic phosphate and amino acids determines
zinc solubility in brain slices. Journal of neurochemistry, 108, 13001308.

254

Sakowitz, O. W., Kiening, K. L., Krajewski, K. L., Sarrafzadeh, A. S.,
Fabricius, M., Strong, A. J., Unterberg, A. W. and Dreier, J. P.
(2009) Preliminary evidence that ketamine inhibits spreading
depolarizations in acute human brain injury. Stroke; a journal of
cerebral circulation, 40, e519-522.
Sanchez, R. M., Wang, C., Gardner, G., Orlando, L., Tauck, D. L.,
Rosenberg, P. A., Aizenman, E. and Jensen, F. E. (2000) Novel
role for the NMDA receptor redox modulatory site in the
pathophysiology of seizures. The Journal of neuroscience : the
official journal of the Society for Neuroscience, 20, 2409-2417.
Sara, Y., Mozhayeva, M. G., Liu, X. and Kavalali, E. T. (2002) Fast vesicle
recycling supports neurotransmission during sustained stimulation
at hippocampal synapses. The Journal of neuroscience : the official
journal of the Society for Neuroscience, 22, 1608-1617.
Sebastiao, A. M., de Mendonca, A., Moreira, T. and Ribeiro, J. A. (2001)
Activation of synaptic NMDA receptors by action potentialdependent release of transmitter during hypoxia impairs recovery of
synaptic transmission on reoxygenation. The Journal of
neuroscience : the official journal of the Society for Neuroscience,
21, 8564-8571.
Sensi, S. L., Paoletti, P., Bush, A. I. and Sekler, I. (2009) Zinc in the
physiology and pathology of the CNS. Nature reviews.
Neuroscience, 10, 780-791.
Setyawan, J., Koide, K., Diller, T. C., Bunnage, M. E., Taylor, S. S.,
Nicolaou, K. C. and Brunton, L. L. (1999) Inhibition of protein
kinases by balanol: specificity within the serine/threonine protein
kinase subfamily. Molecular pharmacology, 56, 370-376.
Sheline, C. T., Behrens, M. M. and Choi, D. W. (2000) Zinc-induced
cortical neuronal death: contribution of energy failure attributable to
loss of NAD(+) and inhibition of glycolysis. The Journal of
neuroscience : the official journal of the Society for Neuroscience,
20, 3139-3146.
Shin, H. K., Dunn, A. K., Jones, P. B., Boas, D. A., Moskowitz, M. A. and
Ayata, C. (2006) Vasoconstrictive neurovascular coupling during
focal ischemic depolarizations. Journal of cerebral blood flow and
metabolism : official journal of the International Society of Cerebral
Blood Flow and Metabolism, 26, 1018-1030.
Shuttleworth, C. W. and Connor, J. A. (2001) Strain-dependent differences
in calcium signaling predict excitotoxicity in murine hippocampal
neurons. The Journal of neuroscience : the official journal of the
Society for Neuroscience, 21, 4225-4236.
Shuttleworth, C. W., Greenwood, A. C. and Connor, J. A. (2000) Ca 2+
signaling in gerbil CA3 hippocampal neurons following transient in
vivo ischemia. Neuroscience letters, 286, 75-78.
Sibarov, D. A., Bolshakov, A. E., Abushik, P. A., Krivoi, II and Antonov, S.
M. (2012) The Na+,K+-ATPase Functionally Interacts with the

255

Plasma Membrane Na+,Ca2+-Exchanger to Prevent Ca2+ Overload
and Neuronal Apoptosis in Excitotoxic Stress. J Pharmacol Exp
Ther.
Simon, R. P., Swan, J. H., Griffiths, T. and Meldrum, B. S. (1984)
Blockade of N-methyl-D-aspartate receptors may protect against
ischemic damage in the brain. Science, 226, 850-852.
Sinner, B. and Graf, B. M. (2008) Ketamine. Handbook of experimental
pharmacology, 313-333.
Smart, T. G., Hosie, A. M. and Miller, P. S. (2004) Zn 2+ ions: modulators of
excitatory and inhibitory synaptic activity. The Neuroscientist : a
review journal bringing neurobiology, neurology and psychiatry, 10,
432-442.
Somjen, G. G. (2001) Mechanisms of spreading depression and hypoxic
spreading depression-like depolarization. Physiol Rev, 81, 10651096.
Somjen, G. G. (2002) Ion regulation in the brain: implications for
pathophysiology. The Neuroscientist : a review journal bringing
neurobiology, neurology and psychiatry, 8, 254-267.
Spruston, N., Jonas, P. and Sakmann, B. (1995) Dendritic glutamate
receptor channels in rat hippocampal CA3 and CA1 pyramidal
neurons. The Journal of physiology, 482 ( Pt 2), 325-352.
Stark, D. T. and Bazan, N. G. (2011) Synaptic and extrasynaptic NMDA
receptors differentially modulate neuronal cyclooxygenase-2
function, lipid peroxidation, and neuroprotection. The Journal of
neuroscience : the official journal of the Society for Neuroscience,
31, 13710-13721.
Stemer, A. and Lyden, P. (2010) Evolution of the thrombolytic treatment
window for acute ischemic stroke. Current neurology and
neuroscience reports, 10, 29-33.
Straub, C., Hunt, D. L., Yamasaki, M., Kim, K. S., Watanabe, M., Castillo,
P. E. and Tomita, S. (2011) Distinct functions of kainate receptors
in the brain are determined by the auxiliary subunit Neto1. Nature
neuroscience, 14, 866-873.
Strong, A. J., Fabricius, M., Boutelle, M. G., Hibbins, S. J., Hopwood, S.
E., Jones, R., Parkin, M. C. and Lauritzen, M. (2002) Spreading
and synchronous depressions of cortical activity in acutely injured
human brain. Stroke; a journal of cerebral circulation, 33, 27382743.
Strong, A. J., Hartings, J. A. and Dreier, J. P. (2007) Cortical spreading
depression: an adverse but treatable factor in intensive care?
Current opinion in critical care, 13, 126-133.
Strong, A. J. and Macdonald, R. L. (2012) Cortical spreading ischemia in
the absence of proximal vasospasm after aneurysmal subarachnoid
hemorrhage: evidence for a dual mechanism of delayed cerebral
ischemia. Journal of cerebral blood flow and metabolism : official
journal of the International Society of Cerebral Blood Flow and

256

Metabolism, 32, 201-202.
Strong, A. J., Smith, S. E., Whittington, D. J., Meldrum, B. S., Parsons, A.
A., Krupinski, J., Hunter, A. J., Patel, S. and Robertson, C. (2000)
Factors influencing the frequency of fluorescence transients as
markers of peri-infarct depolarizations in focal cerebral ischemia.
Stroke; a journal of cerebral circulation, 31, 214-222.
Suh, S. W. (2009) Detection of zinc translocation into apical dendrite of
CA1 pyramidal neuron after electrical stimulation. Journal of
neuroscience methods, 177, 1-13.
Sun, H. S., Feng, Z. P., Miki, T., Seino, S. and French, R. J. (2006)
Enhanced neuronal damage after ischemic insults in mice lacking
Kir6.2-containing ATP-sensitive K+ channels. Journal of
neurophysiology, 95, 2590-2601.
Sykova, E. and Nicholson, C. (2008) Diffusion in brain extracellular space.
Physiol Rev, 88, 1277-1340.
Takahashi, H., Shin, Y., Cho, S. J. et al. (2007) Hypoxia enhances Snitrosylation-mediated NMDA receptor inhibition via a thiol oxygen
sensor motif. Neuron, 53, 53-64.
Takamatsu, H., Kondo, K., Ikeda, Y. and Umemura, K. (1998)
Neuroprotective effects depend on the model of focal ischemia
following middle cerebral artery occlusion. European journal of
pharmacology, 362, 137-142.
Takano, T., Tian, G. F., Peng, W., Lou, N., Lovatt, D., Hansen, A. J.,
Kasischke, K. A. and Nedergaard, M. (2007) Cortical spreading
depression causes and coincides with tissue hypoxia. Nature
neuroscience, 10, 754-762.
Takeda, A., Hirate, M., Tamano, H., Nisibaba, D. and Oku, N. (2003)
Susceptibility to kainate-induced seizures under dietary zinc
deficiency. Journal of neurochemistry, 85, 1575-1580.
Takeda, Y., Zhao, L., Jacewicz, M., Pulsinelli, W. A. and Nowak, T. S., Jr.
(2011) Metabolic and perfusion responses to recurrent peri-infarct
depolarization during focal ischemia in the Spontaneously
Hypertensive Rat: dominant contribution of sporadic CBF
decrements to infarct expansion. Journal of cerebral blood flow and
metabolism : official journal of the International Society of Cerebral
Blood Flow and Metabolism, 31, 1863-1873.
Tanaka, E., Yasumoto, S., Hattori, G., Niiyama, S., Matsuyama, S. and
Higashi, H. (2001) Mechanisms underlying the depression of
evoked fast EPSCs following in vitro ischemia in rat hippocampal
CA1 neurons. Journal of neurophysiology, 86, 1095-1103.
Tang, L. H. and Aizenman, E. (1993) Allosteric modulation of the NMDA
receptor by dihydrolipoic and lipoic acid in rat cortical neurons in
vitro. Neuron, 11, 857-863.
Tauck, D. L. (1992) Redox modulation of NMDA receptor-mediated
synaptic activity in the hippocampus. Neuroreport, 3, 781-784.
Thompson, R. J., Jackson, M. F., Olah, M. E., Rungta, R. L., Hines, D. J.,

257

Beazely, M. A., MacDonald, J. F. and MacVicar, B. A. (2008)
Activation of pannexin-1 hemichannels augments aberrant bursting
in the hippocampus. Science, 322, 1555-1559.
Thompson, R. J., Zhou, N. and MacVicar, B. A. (2006) Ischemia opens
neuronal gap junction hemichannels. Science, 312, 924-927.
Toriumi, S., Saito, T., Hosokawa, T., Takahashi, Y., Numata, T. and
Kurasaki, M. (2005) Metal binding ability of metallothionein-3
expressed in Escherichia coli. Basic & clinical pharmacology &
toxicology, 96, 295-301.
Tottene, A., Conti, R., Fabbro, A., Vecchia, D., Shapovalova, M., Santello,
M., van den Maagdenberg, A. M., Ferrari, M. D. and Pietrobon, D.
(2009) Enhanced excitatory transmission at cortical synapses as
the basis for facilitated spreading depression in Ca(v)2.1 knockin
migraine mice. Neuron, 61, 762-773.
Tsien, R. Y. (1980) New calcium indicators and buffers with high
selectivity against magnesium and protons: design, synthesis, and
properties of prototype structures. Biochemistry, 19, 2396-2404.
Tsuda, M., Imaizumi, K., Katayama, T., Kitagawa, K., Wanaka, A.,
Tohyama, M. and Takagi, T. (1997) Expression of zinc transporter
gene, ZnT-1, is induced after transient forebrain ischemia in the
gerbil. The Journal of neuroscience : the official journal of the
Society for Neuroscience, 17, 6678-6684.
Tymianski, M., Charlton, M. P., Carlen, P. L. and Tator, C. H. (1993)
Secondary Ca2+ overload indicates early neuronal injury which
precedes staining with viability indicators. Brain research, 607, 319323.
Tymianski, M., Wallace, M. C., Spigelman, I., Uno, M., Carlen, P. L., Tator,
C. H. and Charlton, M. P. (1993) Cell-permeant Ca2+ chelators
reduce early excitotoxic and ischemic neuronal injury in vitro and in
vivo. Neuron, 11, 221-235.
Uchida, Y., Takio, K., Titani, K., Ihara, Y. and Tomonaga, M. (1991) The
growth inhibitory factor that is deficient in the Alzheimer's disease
brain is a 68 amino acid metallothionein-like protein. Neuron, 7,
337-347.
Van Harreveld, A. (1959) Compounds in brain extracts causing spreading
depression of cerebral cortical activity and contraction of
crustacean muscle. Journal of neurochemistry, 3, 300-315.
Van Harreveld, A. and Stamm, J. S. (1953) Spreading cortical convulsions
and depressions. Journal of neurophysiology, 16, 352-366.
Vance, K. M., Hansen, K. B. and Traynelis, S. F. (2012) GluN1 splice
variant control of GluN1/GluN2D NMDA receptors. The Journal of
physiology.
Vander Jagt, T. A., Connor, J. A. and Shuttleworth, C. W. (2008) Localized
loss of Ca2+ homeostasis in neuronal dendrites is a downstream
consequence of metabolic compromise during extended NMDA
exposures. The Journal of neuroscience : the official journal of the

258

Society for Neuroscience, 28, 5029-5039.
Vander Jagt, T. A., Connor, J. A., Weiss, J. H. and Shuttleworth, C. W.
(2009) Intracellular Zn2+ increases contribute to the progression of
excitotoxic Ca2+ increases in apical dendrites of CA1 pyramidal
neurons. Neuroscience, 159, 104-114.
Vergara, C., Latorre, R., Marrion, N. V. and Adelman, J. P. (1998)
Calcium-activated potassium channels. Current opinion in
neurobiology, 8, 321-329.
Vogt, K., Mellor, J., Tong, G. and Nicoll, R. (2000) The actions of
synaptically released zinc at hippocampal mossy fiber synapses.
Neuron, 26, 187-196.
Wadman, W. J. and Connor, J. A. (1992) Persisting modification of
dendritic calcium influx by excitatory amino acid stimulation in
isolated Ca1 neurons. Neuroscience, 48, 293-305.
Wagner, C. A., Waldegger, S., Osswald, H., Biber, J., Murer, H., Busch, A.
E. and Lang, F. (1996) Heavy metals inhibit Pi-induced currents
through human brush-border NaPi-3 cotransporter in Xenopus
oocytes. The American journal of physiology, 271, F926-930.
Walter, S., Kostopoulos, P., Haass, A. et al. (2012) Diagnosis and
treatment of patients with stroke in a mobile stroke unit versus in
hospital: a randomised controlled trial. Lancet neurology, 11, 397404.
Wang, H. X. and Gao, W. J. (2012) Prolonged exposure to NMDAR
antagonist induces cell-type specific changes of glutamatergic
receptors in rat prefrontal cortex. Neuropharmacology, 62, 18081822.
Wang, Y., Dong, X. X., Cao, Y., Liang, Z. Q., Han, R., Wu, J. C., Gu, Z. L.
and Qin, Z. H. (2009) p53 induction contributes to excitotoxic
neuronal death in rat striatum through apoptotic and autophagic
mechanisms. The European journal of neuroscience, 30, 22582270.
Weiss, J. H., Hartley, D. M., Koh, J. Y. and Choi, D. W. (1993) AMPA
receptor activation potentiates zinc neurotoxicity. Neuron, 10, 4349.
Weiss, J. H. and Sensi, S. L. (2000) Ca2+-Zn2+ permeable AMPA or
kainate
receptors:
possible
key
factors
in
selective
neurodegeneration. Trends in neurosciences, 23, 365-371.
Westbrook, G. L. and Mayer, M. L. (1987) Micromolar concentrations of
Zn2+ antagonize NMDA and GABA responses of hippocampal
neurons. Nature, 328, 640-643.
Woitzik, J., Dreier, J. P., Hecht, N. et al. (2012) Delayed cerebral ischemia
and spreading depolarization in absence of angiographic
vasospasm after subarachnoid hemorrhage. Journal of cerebral
blood flow and metabolism : official journal of the International
Society of Cerebral Blood Flow and Metabolism, 32, 203-212.
Woitzik, J. and Schilling, L. (2007) A new method for superselective

259

middle cerebral artery infusion in the rat. Journal of neurosurgery,
106, 872-878.
Wroge, C. M., Hogins, J., Eisenman, L. and Mennerick, S. (2012) Synaptic
NMDA receptors mediate hypoxic excitotoxic death. The Journal of
neuroscience : the official journal of the Society for Neuroscience,
32, 6732-6742.
Xiong, Z. Q. and Stringer, J. L. (2000) Sodium pump activity, not glial
spatial buffering, clears potassium after epileptiform activity induced
in the dentate gyrus. Journal of neurophysiology, 83, 1443-1451.
Ye, H., Jalini, S., Zhang, L., Charlton, M. and Carlen, P. L. (2010) Early
ischemia enhances action potential-dependent, spontaneous
glutamatergic responses in CA1 neurons. Journal of cerebral blood
flow and metabolism : official journal of the International Society of
Cerebral Blood Flow and Metabolism, 30, 555-565.
Yu, S. P., Yeh, C., Strasser, U., Tian, M. and Choi, D. W. (1999) NMDA
receptor-mediated K+ efflux and neuronal apoptosis. Science, 284,
336-339.
Zeng, L. H., Xu, L., Rensing, N. R., Sinatra, P. M., Rothman, S. M. and
Wong, M. (2007) Kainate seizures cause acute dendritic injury and
actin depolymerization in vivo. The Journal of neuroscience : the
official journal of the Society for Neuroscience, 27, 11604-11613.
Zhang, H., Cao, H. J., Kimelberg, H. K. and Zhou, M. (2011) Volume
regulated anion channel currents of rat hippocampal neurons and
their contribution to oxygen-and-glucose deprivation induced
neuronal death. PloS one, 6, e16803.
Zhao, Y. J., Yang, G. Y. and Domino, E. F. (1996) Zinc protoporphyrin,
zinc ion, and protoporphyrin reduce focal cerebral ischemia. Stroke;
a journal of cerebral circulation, 27, 2299-2303.
Zhou, N., Gordon, G. R., Feighan, D. and MacVicar, B. A. (2010)
Transient swelling, acidification, and mitochondrial depolarization
occurs in neurons but not astrocytes during spreading depression.
Cereb Cortex, 20, 2614-2624.
Zhou, N., Rungta, R. L., Feighan, D. and MacVicar, B. A. (2010) A novel
form of regenerative glutamate release causes spreading
depression Annual meeting of Society for Neuroscience abstract.

260

